# BugSigDB 0.0.1, License: Creative Commons Attribution 4.0 International, URL: https://bugsigdb.org
bsdb:1/1/1_adenoma:conventional-adenoma-cases_vs_controls_UP	NA	1654	1716	1301	162289	189330	33024	40544	1386
bsdb:1/1/2_adenoma:conventional-adenoma-cases_vs_controls_DOWN	NA	100883
bsdb:1/2/1_hyperplastic-polyp:hyperplastic-polyp-cases_vs_controls_UP	NA	207244
bsdb:1/2/2_hyperplastic-polyp:hyperplastic-polyp-cases_vs_controls_DOWN	NA	100883
bsdb:1/4/1_adenoma:Proximal-conventional-adenoma-cases_vs_controls_UP	NA	1654	1716	1485	836	162289	1301	165779	283168	207244	189330	40544	33024
bsdb:1/4/2_adenoma:Proximal-conventional-adenoma-cases_vs_controls_DOWN	NA	100883
bsdb:1/5/1_adenoma:Distal-conventional-adenoma-cases_vs_controls_DOWN	NA	1485	1350
bsdb:1/6/1_adenoma:Non-advanced-conventional-adenoma-cases_vs_controls_UP	NA	1654	283168	1301	189330	40544	33024
bsdb:1/7/1_adenoma:advanced-conventional-adenoma-cases_vs_controls_UP	NA	1654	1716	836	165779	150022	162289	724
bsdb:1/7/2_adenoma:advanced-conventional-adenoma-cases_vs_controls_DOWN	NA	140625	28050
bsdb:2/1/1_squamous-cell-carcinoma:squamous-cell-carcinoma-tissues_vs_normal-adjacent-tissues_UP	NA	543311
bsdb:2/1/2_squamous-cell-carcinoma:squamous-cell-carcinoma-tissues_vs_normal-adjacent-tissues_DOWN	NA	1654
bsdb:2/2/1_squamous-cell-carcinoma:T3-T4-high-tumor-stages-patients_vs_T0-T2-low-tumor-stages-patients_UP	NA	543311
bsdb:2/2/2_squamous-cell-carcinoma:T3-T4-high-tumor-stages-patients_vs_T0-T2-low-tumor-stages-patients_DOWN	NA	1654
bsdb:2/3/1_squamous-cell-carcinoma:T3-T4-stages-patients_vs_T0-T2-stages-patients_UP	NA	543311
bsdb:3/1/1_colorectal-cancer:adenocarcinoma-of-colon-and-rectum-patients_vs_controls_UP	NA	848	836
bsdb:4/1/1_hepatitis:HCV-stage-4-male-patients_vs_male-healthy-controls_UP	NA	469	838	29465	33024
bsdb:4/1/2_hepatitis:HCV-stage-4-male-patients_vs_male-healthy-controls_DOWN	NA	375288	1263	574697	1678	53246	39948
bsdb:5/1/1_chronic-obstructive-pulmonary-disease:Chronic-obstructive-pulmonary-disease_vs_controls_UP	NA	46123	1654	642	653683	1380	1678	118747	830	194	1016	43996	82202	84162	893	39948	156973	1730	848	52228	32067	186650	1839	133925	265975	543311	1257	838	32207	970	613	123375	1301	195950	29465
bsdb:5/1/2_chronic-obstructive-pulmonary-disease:Chronic-obstructive-pulmonary-disease_vs_controls_DOWN	NA	1485	88138	2023	544	1663
bsdb:5/2/1_chronic-obstructive-pulmonary-disease:Severe_vs_moderate-Chronic-obstructive-pulmonary-disease_UP	NA	1839	289201	1485	186650	642
bsdb:7/1/1_autism:severely-autistic_vs_non-sibling-control_UP	NA	191303	816	286729	872	258514	375288
bsdb:7/1/2_autism:severely-autistic_vs_non-sibling-control_DOWN	NA	114627	52784	109326	1678	1485	102106	39948	253238	31983	1578	1243	113286	1263	1301	46255
bsdb:10/1/1_cervical-glandular-intraepithelial-neoplasia:Cervical-Intraepithelial-Lesion-HIV-patients_vs_Normal-tissue-HIV-patients_UP	NA	437755
bsdb:10/2/1_cervical-glandular-intraepithelial-neoplasia:Cervical-Intraepithelial-Lesion-HIV-patients_vs_Normal-tissue-HIV-patients_UP	NA	1375
bsdb:14/1/1_oral-halitosis:Oral-Halitosis_vs_Control_UP	NA	194	195950	39948	1257	970	32067	2740	543311	157	1016	416916	838
bsdb:14/1/2_oral-halitosis:Oral-Halitosis_vs_Control_DOWN	NA	1301	437755	265975	724	416916	838
bsdb:15/1/1_gestational-diabetes:Gestational-diabetes-mellitus_vs_controls_UP	NA	33057
bsdb:15/1/2_gestational-diabetes:Gestational-diabetes-mellitus_vs_controls_DOWN	NA	55080	935200	1578	231454	44675
bsdb:16/1/1_obesity:high-fat-diet_vs_normal-chow-diet_UP	NA	31980	1263	248744	239759	572511
bsdb:16/1/2_obesity:high-fat-diet_vs_normal-chow-diet_DOWN	NA	816	283168	109326	574697	209	990721	35832	459786
bsdb:16/2/1_obesity:high-fat-diet-+-melatonin_vs_high-fat-diet_UP	NA	583	283168	209	109326	872	574697	239934	1920251
bsdb:16/2/2_obesity:high-fat-diet-+-melatonin_vs_high-fat-diet_DOWN	NA	239759	244127
bsdb:17/1/1_anxiety-disorder:treatment-active-Generalized-Anxiety-disorder_vs_healthy-controls_UP	NA	848	816	946234	1432051	1505663
bsdb:17/1/2_anxiety-disorder:treatment-active-Generalized-Anxiety-disorder_vs_healthy-controls_DOWN	NA	35832	580596	39948	216851	28050	46205	841	292632	40544
bsdb:17/2/1_anxiety-disorder:treatment-naiive-Generalized-Anxiety-disorder_vs_healthy-controls_UP	NA	1578	848	816	561	620	375288	1505663	946234
bsdb:17/2/2_anxiety-disorder:treatment-naiive-Generalized-Anxiety-disorder_vs_healthy-controls_DOWN	NA	28050	841	292632	216851	244127	574697	577310	102106	580596	397864	1407607	846	437755	2740
bsdb:18/1/1_obesity:Sv129--Low-Fat_vs_BL6--Low-Fat_UP	NA	244127	816	572511	830	1485	189330	1730	216851	1578	459786	1017280	841	1263	292632
bsdb:18/1/2_obesity:Sv129--Low-Fat_vs_BL6--Low-Fat_DOWN	NA	239934	195950	838	239759	283168	375288
bsdb:18/2/1_obesity:Sv129-High-Fat-without-enomithacin_vs_BL6-High-Fat-without-enomithacin_UP	NA	1485	841
bsdb:18/2/2_obesity:Sv129-High-Fat-without-enomithacin_vs_BL6-High-Fat-without-enomithacin_DOWN	NA	239934
bsdb:18/3/1_obesity:Sv129-High-Fat-with-enomithacin_vs_BL6-High-Fat-with-enomithacin_UP	NA	816
bsdb:18/3/2_obesity:Sv129-High-Fat-with-enomithacin_vs_BL6-High-Fat-with-enomithacin_DOWN	NA	239934	244127
bsdb:19/1/1_schizophrenia:Schizophrenia_vs_Healthy-controls_UP	NA	838	83770	848	906	1578	544	33024	904	872
bsdb:19/1/2_schizophrenia:Schizophrenia_vs_Healthy-controls_DOWN	NA	1301	33042	841	572511
bsdb:20/1/1_non-alcoholic-fatty-liver-disease:NASH_vs_Non-NASH_UP	NA	816
bsdb:20/1/2_non-alcoholic-fatty-liver-disease:NASH_vs_Non-NASH_DOWN	NA	838
bsdb:20/2/1_non-alcoholic-fatty-liver-disease:significant-fibrosis-(F>2)_vs_mild-fibrosis-(F-0-1)_UP	NA	1263	816
bsdb:20/2/2_non-alcoholic-fatty-liver-disease:significant-fibrosis-(F>2)_vs_mild-fibrosis-(F-0-1)_DOWN	NA	838
bsdb:21/1/1_obesity:Cameron-County-Hispanic-Cohort-samples_vs_Human-Microbiome-Project-samples_UP	NA	838	102106	841	1301	39948
bsdb:21/1/2_obesity:Cameron-County-Hispanic-Cohort-samples_vs_Human-Microbiome-Project-samples_DOWN	NA	816	375288	239759
bsdb:22/1/1_parkinson's-disease:Parkinson's_vs_Healthy-controls_UP	NA	1578	990721	270497	119852	1678
bsdb:22/1/2_parkinson's-disease:Parkinson's_vs_Healthy-controls_DOWN	NA	189330	816	838	216851
bsdb:23/1/1_alzheimer's-disease:Alzheimer's_vs_Healhty-controls_UP	NA	572511	816	239759	33024	35832	1378
bsdb:23/1/2_alzheimer's-disease:Alzheimer's_vs_Healhty-controls_DOWN	NA	1678	39948	1485	447020
bsdb:24/1/1_chronic-fatigue-syndrome:Chronic-Fatigue-patients_vs_Healthy-controls_UP	NA	331654	816	194	848	1378
bsdb:24/1/2_chronic-fatigue-syndrome:Chronic-Fatigue-patients_vs_Healthy-controls_DOWN	NA	29465	724	836	475	286
bsdb:25/1/1_psoriasis:Psoriasis-Male_vs_Female_UP	NA	1301	150022	165779	29465	360541	1716	43668	32207	33882	57495	1016	469	36739	171412
bsdb:25/1/2_psoriasis:Psoriasis-Male_vs_Female_DOWN	NA	1578	1743	2701	212791	1696
bsdb:26/1/1_sex-design:female_vs_male_UP	NA	35832
bsdb:26/2/1_obesity:BMI->33-female_vs_male_UP	NA	816
bsdb:27/1/1_obesity:foster-mother-wild-type-pre-HFD_vs_foster-mother-fat1-pre-HFD_UP	NA	1485	191303	2740	946234	574697	580596	375288
bsdb:27/1/2_obesity:foster-mother-wild-type-pre-HFD_vs_foster-mother-fat1-pre-HFD_DOWN	NA	816	239759	397864	209	283168	872	174708	28138	1331051
bsdb:27/2/1_obesity:foster-mother-wild-type-post-HFD_vs_foster-mother-fat1-post-HFD_UP	NA	172900	256846	1485	28138	244127	459786	946234	1578	2740	574697	375288
bsdb:27/2/2_obesity:foster-mother-wild-type-post-HFD_vs_foster-mother-fat1-post-HFD_DOWN	NA	209	816	283168	1331051
bsdb:28/1/1_chronic-fatigue-syndrome:CFS-cases_vs_Healthy-controls_UP	NA	119852	84111	1357	244127	100883
bsdb:28/1/2_chronic-fatigue-syndrome:CFS-cases_vs_Healthy-controls_DOWN	NA	2740	724	1380	1485	216851	1263	416916	1678	102106	40544
bsdb:29/1/1_unipolar-depression:Active-Major-Depressive-Disorder_vs_Healthy-Controls_UP	NA	946234	574697	375288	239759
bsdb:29/1/2_unipolar-depression:Active-Major-Depressive-Disorder_vs_Healthy-Controls_DOWN	NA	216851	39948	1263	724	561	620
bsdb:29/2/1_unipolar-depression:Responded-Major-Depressive-Disorder_vs_Healthy-Controls_UP	NA	574697
bsdb:29/2/2_unipolar-depression:Responded-Major-Depressive-Disorder_vs_Healthy-Controls_DOWN	NA	1263	724	1485
bsdb:30/1/1_chronic-fatigue-syndrome:Norweigan-controls_vs_Belgian-controls_UP	NA	841	61170
bsdb:30/1/2_chronic-fatigue-syndrome:Norweigan-controls_vs_Belgian-controls_DOWN	NA	816	239759	397864	838	375288
bsdb:30/2/1_chronic-fatigue-syndrome:Norweigan-CFS/ME-patients_vs_Norweigan-controls_UP	NA	239759	420345
bsdb:30/2/2_chronic-fatigue-syndrome:Norweigan-CFS/ME-patients_vs_Norweigan-controls_DOWN	NA	841	61170	39948	84036
bsdb:30/3/1_chronic-fatigue-syndrome:Belgian-CFS/ME-patients_vs_Belgian-controls_UP	NA	420345
bsdb:30/3/2_chronic-fatigue-syndrome:Belgian-CFS/ME-patients_vs_Belgian-controls_DOWN	NA	553372
bsdb:31/1/1_chronic-fatigue-syndrome:CFS/ME-patients_vs_controls_UP	NA	1485	100883	1017280	207244
bsdb:31/1/2_chronic-fatigue-syndrome:CFS/ME-patients_vs_controls_DOWN	NA	724	189330	1378	33042	216851	841
bsdb:31/2/1_chronic-fatigue-syndrome:CFS/ME-patients-with-IBS_vs_controls_UP	NA	1485	207244
bsdb:31/2/2_chronic-fatigue-syndrome:CFS/ME-patients-with-IBS_vs_controls_DOWN	NA	841	189330	33042	216851
bsdb:31/3/1_chronic-fatigue-syndrome:CFS/ME-patients-without-IBS_vs_controls_UP	NA	100883	1485	286	1017280	84111
bsdb:31/3/2_chronic-fatigue-syndrome:CFS/ME-patients-without-IBS_vs_controls_DOWN	NA	189330
bsdb:32/1/2_anorexia-nervosa:Aonerxia-Nervosa-patients_vs_Controls_DOWN	NA	1263	841	1485
bsdb:34/1/2_bipolar-disorder:Bipolar-disorder_vs_Controls_DOWN	NA	216851
bsdb:34/2/1_bipolar-disorder:Bipolar-patients-with-high-IL-6_vs_low-IL-6_UP	NA	1578	1301
bsdb:34/4/1_bipolar-disorder:Bipolar-patients-with-high-LDL_vs_low-LDL_DOWN	NA	838
bsdb:34/5/1_bipolar-disorder:Bipolar-patients-with-high-TRP_vs_low-TRP_UP	NA	1578
bsdb:34/6/1_bipolar-disorder:Bipolar-patients-with-high-TBARS-level_vs_low-TBARS-level_UP	NA	1730
bsdb:34/7/1_bipolar-disorder:Bipolar-patients-with-high-MDA-level_vs_low-MDA-level_DOWN	NA	216851
bsdb:34/8/1_bipolar-disorder:Bipolar-patients-with-high-BMI_vs_low-BMI_UP	NA	1578
bsdb:34/9/1_bipolar-disorder:Bipolar-patients-with-metabolic-syndrome_vs_no-metabolic-syndrome_UP	NA	1578
bsdb:34/10/2_bipolar-disorder:Bipolar-patients-with-depressive-syndrome_vs_healthier-bipolar-patients_DOWN	NA	841
bsdb:34/11/2_bipolar-disorder:Bipolar-disorder_vs_Controls_DOWN	NA	216851
bsdb:35/1/1_sjogren's-syndrome:PSS_vs_Control_UP	NA	29465
bsdb:35/1/2_sjogren's-syndrome:PSS_vs_Control_DOWN	NA	1654	724	482	32207	836	1257
bsdb:36/1/1_obesity:obese-adolescent_vs_control-adult_UP	NA	1654
bsdb:36/1/2_obesity:obese-adolescent_vs_control-adult_DOWN	NA	119852
bsdb:36/2/1_obesity:obese-adult_vs_contorl-adolescent_UP	NA	1301
bsdb:36/2/2_obesity:obese-adult_vs_contorl-adolescent_DOWN	NA	119852
bsdb:36/3/1_obesity:control-adolescent_vs_control-adult_UP	NA	119852
bsdb:36/3/2_obesity:control-adolescent_vs_control-adult_DOWN	NA	1301
bsdb:36/4/1_obesity:obese-adolescent_vs_obese-adult_UP	NA	1654	447020
bsdb:36/5/1_obesity:obese-adolescent_vs_control-adolescent_UP	NA	1654	447020	1301
bsdb:36/5/2_obesity:obese-adolescent_vs_control-adolescent_DOWN	NA	119852
bsdb:37/1/1_colorectal-cancer:CRC-patients_vs_Healthy-controls_UP	NA	1378	1730	1257	236752	459786	165779	543311	61170	848	32067	32257	283168	375288	836	194	123375
bsdb:37/1/2_colorectal-cancer:CRC-patients_vs_Healthy-controls_DOWN	NA	1243	1301
bsdb:38/1/1_body-odor-measurement:teen-head_vs_child-head_UP	NA	1912216
bsdb:38/1/2_body-odor-measurement:teen-head_vs_child-head_DOWN	NA	55193	1279
bsdb:38/2/1_body-odor-measurement:teen-neck_vs_child-neck_UP	NA	1912216	55193
bsdb:38/2/2_body-odor-measurement:teen-neck_vs_child-neck_DOWN	NA	1279
bsdb:39/1/2_body-odor-measurement:youth-underarm-before_vs_after-excercise_DOWN	NA	265
bsdb:39/2/1_body-odor-measurement:youth-Neck-before_vs_after-excercise_DOWN	NA	469
bsdb:39/3/1_body-odor-measurement:Children-underarm-before_vs_after-excercise_DOWN	NA	265
bsdb:39/4/1_body-odor-measurement:Children-Neck-before_vs_after-excercise_UP	NA	1279
bsdb:39/4/2_body-odor-measurement:Children-Neck-before_vs_after-excercise_DOWN	NA	1912216
bsdb:39/5/1_body-odor-measurement:teen-underarm-before_vs_after-excercise_DOWN	NA	265
bsdb:39/6/1_body-odor-measurement:teen-Neck-before_vs_after-excercise_DOWN	NA	469
bsdb:40/1/1_attention-deficit-hyperactivity-disorder:ADHD_vs_Controls_UP	NA	1678	84111	283168	375288	239759
bsdb:40/1/2_attention-deficit-hyperactivity-disorder:ADHD_vs_Controls_DOWN	NA	292632	1263	35829	33042
bsdb:41/1/1_psychosis:FIrst-episode-Psychosis_vs_Controls_UP	NA	2038	528	316625	56688	1578	53572	109262
bsdb:41/1/2_psychosis:FIrst-episode-Psychosis_vs_Controls_DOWN	NA	96	35798	1163
bsdb:42/1/1_extrahepatic-cholestasis:cholestasis-infants_vs_healthy-infants_UP	NA	1301	1350	1279	906	28100	158846
bsdb:42/1/2_extrahepatic-cholestasis:cholestasis-infants_vs_healthy-infants_DOWN	NA	1678	816	572511	216851	841	207244	102106
bsdb:43/1/1_behcet's-syndrome:behcet's-disease_vs_controls_UP	NA	1283313
bsdb:43/2/1_behcet's-syndrome:immunosuppressant-users_vs_non-immunosuppressent-users-among-behcet's-patients_UP	NA	59735	838
bsdb:44/1/2_obesity:pediatric-obese_vs_controls_DOWN	NA	816
bsdb:45/1/1_obesity:Rats-fed--HFHS_vs_control-rats_UP	NA	572511	1678	33024	174708
bsdb:46/1/1_obesity:pediatric-obese_vs_controls_DOWN	NA	816	838
bsdb:47/1/1_obesity:low_vs_high-dietary-fiber_UP	NA	1263
bsdb:47/2/2_obesity:low_vs_hight-moderate-to-vigrous-physical-activity_DOWN	NA	189330	28050
bsdb:48/1/1_obesity:obese-adolescent_vs_control-adolescent_UP	NA	838
bsdb:48/1/2_obesity:obese-adolescent_vs_control-adolescent_DOWN	NA	816	239759	216851	459786
bsdb:48/2/1_obesity:high-BMI-zscore_vs_low-BMI-zscores_UP	NA	838
bsdb:48/2/2_obesity:high-BMI-zscore_vs_low-BMI-zscores_DOWN	NA	816	239759
bsdb:48/3/1_obesity:high-triglycerides_vs_low-triglycerides_UP	NA	838
bsdb:48/3/2_obesity:high-triglycerides_vs_low-triglycerides_DOWN	NA	816
bsdb:48/4/1_obesity:high-total-cholesterol_vs_low-total-cholesterol_DOWN	NA	816
bsdb:48/5/1_obesity:high-HDL-C_vs_low-HDL-C_UP	NA	816
bsdb:48/6/1_obesity:high-senstive-C-reactive-protein_vs_low-sensetive-C-reactive-protein_UP	NA	838
bsdb:48/6/2_obesity:high-senstive-C-reactive-protein_vs_low-sensetive-C-reactive-protein_DOWN	NA	816	459786
bsdb:49/1/1_obesity:Obesity-group_vs_controls_UP	NA	838	117563	1257	123375	43996	86331
bsdb:49/1/2_obesity:Obesity-group_vs_controls_DOWN	NA	724	2717	1016	47670	1716	1279	40323
bsdb:50/1/1_colorectal-cancer:Colrectal-cancer-patients_vs_healthy-controls_UP	NA	836	561	620	1350	1301	1257
bsdb:50/1/2_colorectal-cancer:Colrectal-cancer-patients_vs_healthy-controls_DOWN	NA	816	841	239759	1730	577310
bsdb:51/1/1_colorectal-cancer:Carcinoma-patients_vs_postoperation-patients_UP	NA	1578	838	150022	48736	1380	404402	1283313	1716	135858	1573535	543311	286	1378	1257	836	46255	117563	1654
bsdb:51/1/2_colorectal-cancer:Carcinoma-patients_vs_postoperation-patients_DOWN	NA	32067	196082	1678	33882	1847725	1573534	40544	28050	1506577	570
bsdb:51/2/1_colorectal-cancer:NDA(new-dev.-adenoma)_vs_CIT(cleain-intestine)_UP	NA	46123	1380	581	838	123375
bsdb:51/2/2_colorectal-cancer:NDA(new-dev.-adenoma)_vs_CIT(cleain-intestine)_DOWN	NA	574697	1263	1485	33042	150022	437755	459786	872	244127
bsdb:52/1/1_substance-related-disorder:Substance-use-disorder-patients_vs_Healthy-controls_UP	NA	838	265	1485	33057
bsdb:52/1/2_substance-related-disorder:Substance-use-disorder-patients_vs_Healthy-controls_DOWN	NA	35832	189330	375288	1301	207244	906	1407607	239759	204475	816	1263
bsdb:52/2/1_substance-related-disorder:Substance-use-disorder-patients_vs_adjusted-Healthy-controls_UP	NA	33057	265	838
bsdb:52/2/2_substance-related-disorder:Substance-use-disorder-patients_vs_adjusted-Healthy-controls_DOWN	NA	207244	375288	204475	35832	1301	906	1407607
bsdb:55/1/1_stimulus-or-stress-design:grid-floor-induced-stress_vs_control_UP	NA	283168	239759
bsdb:56/1/1_type-II-diabetes-mellitus:Healthy-baby-meconium_vs_adult-stool_UP	NA	283	561	570	583	620
bsdb:56/2/1_gestational-diabetes:Baby-meconium-with-GDM-mothers_vs_Healthy-baby-meconium_DOWN	NA	507	106589	283	80865	40323
bsdb:56/3/1_type-II-diabetes-mellitus:Baby-meconium-with-DM-mothers_vs_Healthy-baby-meconium_UP	NA	904	267408	1380	1678	574697	135858	102106	33042	39948	189330	156973	1730	1378	2053	61170	57493	33882	88138	459786	375288	162291	836	838	841	125216	1263	191303
bsdb:57/1/1_inflammatory-bowel-disease:irritable-bowel-syndrome_vs_control_UP	NA	838	1485	79206	1257	507	32008	482
bsdb:57/1/2_inflammatory-bowel-disease:irritable-bowel-syndrome_vs_control_DOWN	NA	1716	1743	1301	13687	286
bsdb:57/2/1_inflammatory-bowel-disease:overweight-irritabe-bowel-syndrome_vs_control_UP	NA	1716	1678	1380	133925	1386	162291	1578	113286	265975	177971	39948	906	970	92793	80865	194	286	157	838	1279
bsdb:57/2/2_inflammatory-bowel-disease:overweight-irritabe-bowel-syndrome_vs_control_DOWN	NA	396388	59732	109244	670486	1378	1301	482	724	838	1279
bsdb:58/1/1_high-fat-diet:newborns-of-maternal-high-fat-diet_vs_nebowrns-of-maternal-control_UP	NA	1357	117563	1350
bsdb:58/1/2_high-fat-diet:newborns-of-maternal-high-fat-diet_vs_nebowrns-of-maternal-control_DOWN	NA	40544	375288	816	283
bsdb:58/2/1_high-fat-diet:6-months-babies-of-maternal-high-fat-diet_vs_6-months-babies-control_UP	NA	1301	561
bsdb:58/2/2_high-fat-diet:6-months-babies-of-maternal-high-fat-diet_vs_6-months-babies-control_DOWN	NA	816
bsdb:60/1/1_type-II-diabetes-mellitus:Type-2-DM-cases_vs_controls_UP	NA	458839	111142	504481	255204
bsdb:60/1/2_type-II-diabetes-mellitus:Type-2-DM-cases_vs_controls_DOWN	NA	92793	338	1847
bsdb:60/2/1_type-II-diabetes-mellitus:Type-2-DM-cariers-of-pathogens_vs_carier-of-pathogens-controls_UP	NA	504481
bsdb:60/2/2_type-II-diabetes-mellitus:Type-2-DM-cariers-of-pathogens_vs_carier-of-pathogens-controls_DOWN	NA	816
bsdb:61/1/1_obesity:infants-of-overweight-mothers_vs_infants-of-normal-weight-mother-at-age-1-month_DOWN	NA	816	838
bsdb:61/3/1_obesity:infants-of-excessive-maternal-weight-gain-mothers_vs_infants-of-normal-maternal-weight-gain-mothers-at-age-1-month_DOWN	NA	816	838
bsdb:62/1/1_cesarean-section:C-section-delivery_vs_vaginal-delivery-in-mecomium_DOWN	NA	1578
bsdb:63/2/1_cesarean-section:C-section-delivery_vs_vaginal-delivery-after-3-months-of-delivery_DOWN	NA	1578
bsdb:64/1/2_periodontitis:periodnotitis_vs_No-Periodontitis-within-negative-diabetic-background-only_DOWN	NA	416916	32067
bsdb:64/4/1_periodontitis:periodnotitis_vs_No-Periodontitis-within-positive-diabetic-background-only_UP	NA	32067
bsdb:64/4/2_periodontitis:periodnotitis_vs_No-Periodontitis-within-positive-diabetic-background-only_DOWN	NA	29465	482
bsdb:65/1/1_type-II-diabetes-mellitus:Diabetic_vs_Non-diabetic_UP	NA	416916	482	1378	538	1654	1016	848	29465	1301	970
bsdb:65/1/2_type-II-diabetes-mellitus:Diabetic_vs_Non-diabetic_DOWN	NA	1730	44259	836	195950	157
bsdb:66/1/1_neonatal-jaundice:cesarean-infants-with-jaundice_vs_control_UP	NA	106589
bsdb:66/2/2_neonatal-jaundice:infants-with-jaundice_vs_control_DOWN	NA	1301
bsdb:67/2/1_autism:autistic_vs_neurotypical_UP	NA	1578	102106	1716	189330
bsdb:67/2/2_autism:autistic_vs_neurotypical_DOWN	NA	239759	39948	375288	29465	35832
bsdb:67/3/1_autism:constipated-autistic_vs_non-constipated-autistic_UP	NA	561	620	1485
bsdb:67/4/1_autism:constipated-neurotypical_vs_non-constipated-neurotypical_DOWN	NA	204475
bsdb:68/1/1_obesity:obese_vs_normal-weight_UP	NA	1578	1301	572511	140625	1263	35832	1485	33042
bsdb:68/1/2_obesity:obese_vs_normal-weight_DOWN	NA	375288	51514	189330	119852	1485	33042
bsdb:68/2/1_obesity:overweight_vs_normal-weight_UP	NA	816	1578	1301	1485	572511	140625	1263	35832
bsdb:68/2/2_obesity:overweight_vs_normal-weight_DOWN	NA	375288	51514	119852
bsdb:68/3/1_obesity:obese-men_vs_normal-weight-men_UP	NA	1578	1301	572511
bsdb:68/3/2_obesity:obese-men_vs_normal-weight-men_DOWN	NA	1716	51514	1263
bsdb:68/4/1_obesity:overweight-men_vs_normal-weight-men_UP	NA	816	1578	1301	572511	33042	140625
bsdb:68/4/2_obesity:overweight-men_vs_normal-weight-men_DOWN	NA	1716	150022	51514	1263	906
bsdb:68/5/1_obesity:obese-women_vs_normal-weight-women_UP	NA	1301	140625	1263
bsdb:68/5/2_obesity:obese-women_vs_normal-weight-women_DOWN	NA	51514
bsdb:68/6/1_obesity:overweight-women_vs_normal-weight-women_UP	NA	1301	1263	140625
bsdb:69/1/1_sex-design:female_vs_male_UP	NA	1263
bsdb:69/2/1_obesity:female-obese_vs_female-normal-weight_DOWN	NA	33024
bsdb:69/3/1_obesity:male-obese_vs_male-normal-weight_UP	NA	574697	848
bsdb:69/4/1_obesity:obese_vs_normal-weight_UP	NA	848
bsdb:70/1/1_obesity:pediatric-obese_vs_pediatric-normal-weight_UP	NA	39948	816	838
bsdb:70/1/2_obesity:pediatric-obese_vs_pediatric-normal-weight_DOWN	NA	207244	40544	816
bsdb:70/2/2_obesity:female-pediatric-obese_vs_female-pediatric-normal-weight_DOWN	NA	283168
bsdb:71/1/1_cesarean-section:cesarean-premature-birth_vs_vaginally-born-controls_UP	NA	1243	909928	2737	830
bsdb:71/2/1_premature-birth:infants-<33-weeks-gestational-age_vs_>/=33-weeks_UP	NA	1386	1279	1350	2737	1578	1243	1485	29465	909928	1678	547	544	551	570	160674	53335	29487	195950
bsdb:71/2/2_premature-birth:infants-<33-weeks-gestational-age_vs_>/=33-weeks_DOWN	NA	223927
bsdb:72/1/2_autism:autism_vs_typically-developing-controls_DOWN	NA	1301	29465	561	1654	543311	118747	162289
bsdb:73/1/1_obesity:obese_vs_normal-weight_UP	NA	216851	841	28050	33042
bsdb:73/1/2_obesity:obese_vs_normal-weight_DOWN	NA	816
bsdb:73/2/1_obesity:obese-+-metabolic-syndrome_vs_normal-weight_UP	NA	216851	841	28050	33042
bsdb:73/2/2_obesity:obese-+-metabolic-syndrome_vs_normal-weight_DOWN	NA	816
bsdb:74/1/2_obesity:obese_vs_non-obese_DOWN	NA	239759	195950
bsdb:74/2/2_obesity:obese_vs_Nonobese-microbiota-cluster_DOWN	NA	239759
bsdb:74/3/1_obesity:high-BMI_vs_low-BMI_UP	NA	55079	1678	662	629
bsdb:74/3/2_obesity:high-BMI_vs_low-BMI_DOWN	NA	239759	195950
bsdb:74/4/1_obesity:high-C-Reactive-Protein_vs_low-C-Reactive-Protein_UP	NA	55079
bsdb:74/4/2_obesity:high-C-Reactive-Protein_vs_low-C-Reactive-Protein_DOWN	NA	239759	195950
bsdb:75/1/1_smoking-behavior:right-oropharynx-of-smokers_vs_right-oropharynx-of-nonsmokers_UP	NA	1016	1257	848	12916	724	482
bsdb:75/1/2_smoking-behavior:right-oropharynx-of-smokers_vs_right-oropharynx-of-nonsmokers_DOWN	NA	906	29465	52228	1301
bsdb:75/2/1_smoking-behavior:left-oropharynx-of-smokers_vs_left-oropharynx-of-nonsmokers_UP	NA	1016	848	482	416916
bsdb:75/2/2_smoking-behavior:left-oropharynx-of-smokers_vs_left-oropharynx-of-nonsmokers_DOWN	NA	1654	84111	906	29465	34104
bsdb:75/3/1_smoking-behavior:right-nasopharynx-of-smokers_vs_right-nasopharynx-of-nonsmokers_UP	NA	1654	1243	469	407217	620	349
bsdb:75/3/2_smoking-behavior:right-nasopharynx-of-smokers_vs_right-nasopharynx-of-nonsmokers_DOWN	NA	84111	189330	1730	46123	174708	109326	33042	150022	1378	84036	52784
bsdb:75/4/1_smoking-behavior:left-nasopharynx-of-smokers_vs_left-nasopharynx-of-nonsmokers_UP	NA	237	1647	1378	620	40544
bsdb:75/4/2_smoking-behavior:left-nasopharynx-of-smokers_vs_left-nasopharynx-of-nonsmokers_DOWN	NA	84111	836	46123	52784	109326	189330	1730	841	84036	194	724	40323
bsdb:76/1/1_type-I-diabetes-mellitus:type-I-diabetes-mellitus-children_vs_controls_UP	NA	572511	904
bsdb:76/1/2_type-I-diabetes-mellitus:type-I-diabetes-mellitus-children_vs_controls_DOWN	NA	39948	724	1392389
bsdb:77/1/2_bipolar-disorder:atypical-antipsychotic-users_vs_non-users_DOWN	NA	239934
bsdb:78/1/1_stimulus-or-stress-design:limited-nesting-stress_vs_controls_UP	NA	1350	1301	2740	1375	227979	66831	1485	1716	872	117563	32207	583	100883	1357	191303	2316
bsdb:78/1/2_stimulus-or-stress-design:limited-nesting-stress_vs_controls_DOWN	NA	1263	841	33042	1573535	1279	375288	28050	244127	724	283168
bsdb:79/1/1_obesity:Laparoscopic-sleeve-gastrectomy-baseline_vs_Laparoscopic-sleeve-gastrectomy-after-3-months-and-6-Months-combined_UP	NA	33042	189330	1263
bsdb:79/2/1_obesity:Very-low-calorie-diet-baseline_vs_very-low-calorie-diet-after-3-months-and-6-months_DOWN	NA	1350	1578	265975	1263	100883	61170
bsdb:80/1/1_type-I-diabetes-mellitus:Type-I-diabetic-children-at-onset_vs_controls_UP	NA	816
bsdb:80/1/2_type-I-diabetes-mellitus:Type-I-diabetic-children-at-onset_vs_controls_DOWN	NA	838	904	158846
bsdb:83/1/1_obesity:before-surgery_vs_after-surgery_UP	NA	216851	33042	209	207244
bsdb:83/1/2_obesity:before-surgery_vs_after-surgery_DOWN	NA	547	544	29465	590
bsdb:85/1/1_cesarean-section:two-day-aged-babies-c-section_vs_vaginal-delivery_UP	NA	570	1266
bsdb:85/2/1_cesarean-section:two-day-aged-babies-c-section_vs_vaginal-delivery_DOWN	NA	816
bsdb:85/3/1_cesarean-section:seven-day-aged-babies-c-section_vs_vaginal-delivery_UP	NA	570	1266
bsdb:85/4/1_cesarean-section:seven-day-aged-babies-c-section_vs_vaginal-delivery_DOWN	NA	816	102106
bsdb:86/1/1_cesarean-section:c-section_vs_vaginal-delivery-at-day-3_UP	NA	1279	1578
bsdb:86/3/1_cesarean-section:c-section_vs_vaginal-delivery-at-day-28_DOWN	NA	816
bsdb:86/4/1_cesarean-section:c-section_vs_vaginal-delivery-at-day-150_DOWN	NA	816
bsdb:86/7/1_cesarean-section:overall-time-point-infants-samples-of-c-section_vs_vaginal-delivery_UP	NA	32207	547	1350	39948	1301	239934	1279	724	1485	1378	946234	207244	1743	1578
bsdb:86/7/2_cesarean-section:overall-time-point-infants-samples-of-c-section_vs_vaginal-delivery_DOWN	NA	375288	816	239759
bsdb:87/1/1_type-I-diabetes-mellitus:Type-I-Diabetics_vs_maturity-onset-diabetes-of-the-young-2-(MODY2)-and-healthy-Controls_UP	NA	572511	816	29465	1263	1301	547	40544
bsdb:87/2/1_type-I-diabetes-mellitus:Type-I-Diabetics-and-maturity-onset-diabetes-of-the-young-2-(MODY2)_vs_healthy-Controls_DOWN	NA	28050	841	207244	216851
bsdb:88/1/1_schizophrenia:schizophrenia_vs_non-psychiatric-controls_UP	NA	165779	906	572511
bsdb:88/1/2_schizophrenia:schizophrenia_vs_non-psychiatric-controls_DOWN	NA	724	40544	1485
bsdb:89/1/1_cesarean-section:C-section-delivery_vs_vaginal-delivery-in-transitional-stools_DOWN	NA	816	1485	375288
bsdb:90/1/1_cesarean-section:transitional-stool_vs_mecomium-in-vaginal-delivery_UP	NA	209
bsdb:90/1/2_cesarean-section:transitional-stool_vs_mecomium-in-vaginal-delivery_DOWN	NA	469	70774	1301	13687	1716	42255	165695	129337	482	165779	407	29465	1269	1357	357	212791	29580	80865
bsdb:90/2/1_cesarean-section:transitional-stool_vs_mecomium-in-C-section-delivery_UP	NA	29465	1350
bsdb:90/2/2_cesarean-section:transitional-stool_vs_mecomium-in-C-section-delivery_DOWN	NA	286	400634	1716	1301	106589	32067	1654	848	13687	42255	2745	157	724	41275	2717	165695
bsdb:91/1/1_cesarean-section:C-section-delivery_vs_vaginal-delivery_UP	NA	1298	216851	40323	1730	1386
bsdb:91/1/2_cesarean-section:C-section-delivery_vs_vaginal-delivery_DOWN	NA	1743	283	286
bsdb:92/2/1_non-alcoholic-fatty-liver-disease:non-alcoholic-fatty-liver-disease-patients_vs_healthy-controls_UP	NA	838
bsdb:92/3/1_non-alcoholic-fatty-liver-disease:non-alcoholic-fatty-liver-disease-patients_vs_obese-without-non-alcoholic-fatty-liver-disease_UP	NA	838
bsdb:93/1/1_cesarean-section:C-section-delivery_vs_vaginal-delivery_DOWN	NA	1279
bsdb:93/2/1_cesarean-section:Antimicrobials-use-during-delivery-yes_vs_no_UP	NA	1678
bsdb:93/3/1_cesarean-section:Maternal-consumption-of-probiotics-yes_vs_no_UP	NA	1578
bsdb:93/4/1_cesarean-section:Furry-pets-at-home-yes_vs_no_UP	NA	216851
bsdb:93/4/2_cesarean-section:Furry-pets-at-home-yes_vs_no_DOWN	NA	1279
bsdb:95/1/1_obesity:overweight/obese-babies_vs_control-babies-at-the-age-of-3_UP	NA	189330	841
bsdb:95/1/2_obesity:overweight/obese-babies_vs_control-babies-at-the-age-of-3_DOWN	NA	375288
bsdb:96/1/1_obesity:obese_vs_controls_UP	NA	239759	165779	33042	848	543311
bsdb:96/1/2_obesity:obese_vs_controls_DOWN	NA	816	872	216851	150022	1164882	133925	292632
bsdb:97/2/1_obesity:Roux-en-Y-gastric-bypass-(RYGB)_vs_healthy-controls_UP	NA	1678	906
bsdb:97/3/1_obesity:obese-patients-three-months-after-Sleeve-gastrectomy-SG3_vs_obese-patients-prior-to-Sleeve-gastrectomy-SG0_DOWN	NA	239759	1301
bsdb:97/4/1_obesity:obese-patients-3-moths-after-Roux-en-Y-gastric-bypass-RYGB3_vs_patients-prior-to-Roux-en-Y-gastric-bypass-RYGB0_UP	NA	216851
bsdb:97/4/2_obesity:obese-patients-3-moths-after-Roux-en-Y-gastric-bypass-RYGB3_vs_patients-prior-to-Roux-en-Y-gastric-bypass-RYGB0_DOWN	NA	1301
bsdb:98/1/1_chronic-kidney-disease:CKD_vs_controls_UP	NA	286	629	504481	445	1664383	613	469	68	81	1386
bsdb:98/1/2_chronic-kidney-disease:CKD_vs_controls_DOWN	NA	40323	1506577	911113	1210119	1705353	265	13687	1716
bsdb:99/1/2_obesity:obese_vs_controls_DOWN	NA	816	239759
bsdb:100/1/1_obesity:High-BMI_vs_low-BMI_UP	NA	613	838
bsdb:100/2/1_obesity:Abdominal-obesity_vs_non-abdominal-obesity_UP	NA	613	838
bsdb:100/2/2_obesity:Abdominal-obesity_vs_non-abdominal-obesity_DOWN	NA	119852
bsdb:101/1/1_obesity:obese_vs_lean-controls_UP	NA	1578
bsdb:102/1/1_type-II-diabetes-mellitus:Women-with-gestational-DM_vs_normoglycemic-controls_UP	NA	838	1263
bsdb:102/1/2_type-II-diabetes-mellitus:Women-with-gestational-DM_vs_normoglycemic-controls_DOWN	NA	572511	239759
bsdb:103/1/1_unipolar-depression:depressed-female_vs_Healthy-Controls_UP	NA	572511	1654	1678	553372	1380	84111	644652	133925	1730	207244	841	216851	872
bsdb:103/1/2_unipolar-depression:depressed-female_vs_Healthy-Controls_DOWN	NA	404402	40544	638847
bsdb:103/2/1_unipolar-depression:depressed-male_vs_Healthy-Controls_UP	NA	816	29465	1380
bsdb:103/2/2_unipolar-depression:depressed-male_vs_Healthy-Controls_DOWN	NA	644652	109326	638847
bsdb:104/1/1_unipolar-depression:major-depressive-disoreder-(visit-1)_vs_healthy-controls_UP	NA	838	570	1301
bsdb:104/2/1_unipolar-depression:major-depressive-disoreder-(visit-2)_vs_healthy-controls_UP	NA	838	1301
bsdb:105/1/1_unipolar-depression:bipolar_vs_healthy-controls_DOWN	NA	216851
bsdb:106/1/1_bipolar-disorder:bipolar_vs_healthy-controls_UP	NA	946234
bsdb:107/1/2_anorexia-nervosa:anorexia_vs_healthy-controls_DOWN	NA	207244	216851
bsdb:107/2/1_anorexia-nervosa:anorexia_vs_healthy-controls_UP	NA	375288
bsdb:108/1/1_anorexia-nervosa:anorexia-nervosa-patients_vs_healthy-controls_DOWN	NA	1301
bsdb:109/1/1_anorexia-nervosa:anorexia-patients-before-weight-gain_vs_HC_UP	NA	1678	244127	207244
bsdb:109/1/2_anorexia-nervosa:anorexia-patients-before-weight-gain_vs_HC_DOWN	NA	204475	841
bsdb:109/2/1_anorexia-nervosa:anorexia-patients-after-weight-gain_vs_HC_UP	NA	207244	44748	1263	1678	1578	1017280	1357
bsdb:109/2/2_anorexia-nervosa:anorexia-patients-after-weight-gain_vs_HC_DOWN	NA	816
bsdb:110/1/1_schizophrenia:schizophrenia_vs_healthy-controls_DOWN	NA	1678	1578
bsdb:111/1/1_attention-deficit-hyperactivity-disorder:ADHD_vs_healthy-control_UP	NA	40323	469	1473205	100883	990721	1573534	1505652
bsdb:111/1/2_attention-deficit-hyperactivity-disorder:ADHD_vs_healthy-control_DOWN	NA	1506553	39948
bsdb:112/1/1_attention-deficit-hyperactivity-disorder:ADHD-males_vs_controls_UP	NA	482	816
bsdb:112/1/2_attention-deficit-hyperactivity-disorder:ADHD-males_vs_controls_DOWN	NA	838	375288
bsdb:113/1/1_unipolar-depression:MDD_vs_controls_DOWN	NA	1678
bsdb:114/1/1_unipolar-depression:MDD_vs_controls_UP	NA	846	543311	118747	286	1257	1378
bsdb:114/1/2_unipolar-depression:MDD_vs_controls_DOWN	NA	216851	33042	572511	189330
bsdb:115/1/1_unipolar-depression:MDD_vs_controls_UP	NA	1485	1678	459786	1301	970	906	904	838
bsdb:115/1/2_unipolar-depression:MDD_vs_controls_DOWN	NA	816	283168	195950
bsdb:115/2/1_bipolar-disorder:bipolar_vs_healthy-controls_DOWN	NA	816	283168	195950
bsdb:116/1/1_type-I-diabetes-mellitus:children-with-type-1-diabetes_vs_healthy-controls_UP	NA	1485	816	29465
bsdb:116/1/2_type-I-diabetes-mellitus:children-with-type-1-diabetes_vs_healthy-controls_DOWN	NA	838	1678	1578
bsdb:117/1/1_pneumonia:elderly-pneumonia-patients_vs_elderly-controls_UP	NA	32207	1578
bsdb:117/1/2_pneumonia:elderly-pneumonia-patients_vs_elderly-controls_DOWN	NA	196082	32067
bsdb:117/2/1_pneumonia:adult-pneumonia-patients_vs_adult-controls_UP	NA	32207	1578
bsdb:117/2/2_pneumonia:adult-pneumonia-patients_vs_adult-controls_DOWN	NA	32067	724	482
bsdb:118/1/1_cesarean-section:cesarean-born_vs_vaginal-born-children_UP	NA	570	1578
bsdb:118/1/2_cesarean-section:cesarean-born_vs_vaginal-born-children_DOWN	NA	1678
bsdb:118/2/1_cesarean-section:cesarean-born-and-mixed-fed_vs_cesarean-born-and-breastfed_UP	NA	29465	1350
bsdb:118/2/2_cesarean-section:cesarean-born-and-mixed-fed_vs_cesarean-born-and-breastfed_DOWN	NA	1506577	838	216851
bsdb:119/1/1_type-II-diabetes-mellitus:Metaformin-positive_vs_Metaformin-negative-among-Opoid-negative_UP	NA	1678
bsdb:119/2/1_type-II-diabetes-mellitus:Metaformin-positive_vs_Metaformin-negative-among-Opoid-positive_UP	NA	838
bsdb:119/2/2_type-II-diabetes-mellitus:Metaformin-positive_vs_Metaformin-negative-among-Opoid-positive_DOWN	NA	1678
bsdb:119/3/1_type-II-diabetes-mellitus:Opoid-positive_vs_opoid-negative-among-Metaformin-negative_UP	NA	1678
bsdb:119/3/2_type-II-diabetes-mellitus:Opoid-positive_vs_opoid-negative-among-Metaformin-negative_DOWN	NA	838
bsdb:120/1/1_physical-activity:Activity-Based-Anorexia-group_vs_exercise-group_UP	NA	838	1485	1350	816
bsdb:120/1/2_physical-activity:Activity-Based-Anorexia-group_vs_exercise-group_DOWN	NA	1578	1678	816
bsdb:120/2/1_physical-activity:Ad-libitum-group_vs_exercise-group_UP	NA	816	838	1350	1485
bsdb:120/2/2_physical-activity:Ad-libitum-group_vs_exercise-group_DOWN	NA	1578	1678
bsdb:121/1/1_gingivitis:gingivitis_vs_healthy-controls_UP	NA	836	157	195950
bsdb:121/1/2_gingivitis:gingivitis_vs_healthy-controls_DOWN	NA	1016
bsdb:122/1/1_breast-carcinoma:tumor-tissue_vs_normal-tissue_UP	NA	237	407
bsdb:122/1/2_breast-carcinoma:tumor-tissue_vs_normal-tissue_DOWN	NA	13687	914	374
bsdb:123/1/1_diet:high-fat-diet_vs_low-fat-diet_UP	NA	1357	117563	1486725	109326	1485	33042	1730	216851	946234	119852	100175	1017280	44748	1506577	1505663	61170	32207	447020	102106
bsdb:123/1/2_diet:high-fat-diet_vs_low-fat-diet_DOWN	NA	544	397864	816	588605
bsdb:124/1/2_diet:body-builders-(high-protein)_vs_distance-runners-(high-carb)_DOWN	NA	1678	561	1357
bsdb:124/2/1_diet:body-builders-(high-protein)_vs_control_UP	NA	40544	216851	1485	724	1432051
bsdb:124/2/2_diet:body-builders-(high-protein)_vs_control_DOWN	NA	1678	577310	1243
bsdb:124/3/1_diet:distance-runners-(high-carb)_vs_control_UP	NA	40544
bsdb:124/3/2_diet:distance-runners-(high-carb)_vs_control_DOWN	NA	572511	547	46255	1243
bsdb:125/1/1_squamous-cell-carcinoma:Oral-Squamous-Cell-Cancer-patients_vs_noncancer-individuals_UP	NA	1257	848	1283313	1016
bsdb:125/1/2_squamous-cell-carcinoma:Oral-Squamous-Cell-Cancer-patients_vs_noncancer-individuals_DOWN	NA	32207	724
bsdb:126/1/1_oral-leukoplakia:Oral-leukoplakia_vs_healthy-controls_UP	NA	724	1386
bsdb:126/1/2_oral-leukoplakia:Oral-leukoplakia_vs_healthy-controls_DOWN	NA	1301	46123
bsdb:126/2/1_squamous-cell-carcinoma:Oral-Squamous-Cell-Cancer-patients_vs_healthy-controls_UP	NA	724	1386
bsdb:126/2/2_squamous-cell-carcinoma:Oral-Squamous-Cell-Cancer-patients_vs_healthy-controls_DOWN	NA	1301	46123
bsdb:126/3/1_oral-leukoplakia:Oral-leukoplakia_vs_Oral-Squamous-Cell-Cancer-patients_UP	NA	724	1301
bsdb:126/3/2_oral-leukoplakia:Oral-leukoplakia_vs_Oral-Squamous-Cell-Cancer-patients_DOWN	NA	1386
bsdb:127/1/1_alcohol-drinking:alcohol-overconsumers_vs_controls_UP	NA	40544	1485	61170
bsdb:127/1/2_alcohol-drinking:alcohol-overconsumers_vs_controls_DOWN	NA	216851
bsdb:127/2/1_alcohol-drinking:alcohol-overconsumers_vs_controls_UP	NA	561	570	1485	40544	904	581	118747	32207	2383	61170	158846
bsdb:127/2/2_alcohol-drinking:alcohol-overconsumers_vs_controls_DOWN	NA	283168	52225	265975	674963	447020	1279	838	102106	216851
bsdb:128/1/1_gastric-cancer:gastric-cancer_vs_intestinal-metaplasia_UP	NA	1257	848	543311	1578	1301	1283313	838	39948	84108	2740	43996	437755
bsdb:128/1/2_gastric-cancer:gastric-cancer_vs_intestinal-metaplasia_DOWN	NA	469	57739	378210	235572
bsdb:128/2/1_gastric-cancer:gastric-cancer_vs_atrophic-gastric_UP	NA	1301	1257	1378	848	543311	1578	1730	1283313	838	39948	84108	2740	43996	437755
bsdb:128/2/2_gastric-cancer:gastric-cancer_vs_atrophic-gastric_DOWN	NA	57739	235572
bsdb:128/3/1_gastric-cancer:gastric-cancer_vs_superficial-gastric_UP	NA	1301	1578	1257	1378	848	543311	1283313	1730	838	39948	84108	2740	43996	437755
bsdb:128/3/2_gastric-cancer:gastric-cancer_vs_superficial-gastric_DOWN	NA	47420	469	57739	378210	235572
bsdb:129/1/1_multiple-sclerosis:multiple-sclerosis_vs_healthy-controls_UP	NA	237	84567	572511	189330	13159	286
bsdb:129/1/2_multiple-sclerosis:multiple-sclerosis_vs_healthy-controls_DOWN	NA	102106	375288	100883	1578	724
bsdb:130/1/1_diet:high-Southern-European-Atlantic-Diet_vs_low-Southern-European-Atlantic-Diet_UP	NA	1678
bsdb:130/2/1_diet:intermediate-Southern-European-Atlantic-Diet_vs_low-Southern-European-Atlantic-Diet_UP	NA	1678
bsdb:130/5/1_diet:>-30-years-participants_vs_20-30-years-participants_UP	NA	1578
bsdb:130/6/2_diet:BMI->25_vs_BMI-<-20_DOWN	NA	1678
bsdb:130/7/1_diet:BMI-20-25_vs_BMI-<20_DOWN	NA	1678
bsdb:131/1/1_diet:Time-7-days_vs_Time-0-days-controls_DOWN	NA	119852
bsdb:131/2/2_diet:Time-7-days_vs_Time-0-days-Cara-Cara_DOWN	NA	283168
bsdb:131/4/1_diet:Cara-Cara_vs_controls-at-time-7_UP	NA	375288	189330	244127	574697
bsdb:131/5/1_diet:Bahia_vs_controls-at-time-7_UP	NA	447020	1350	1485	244127
bsdb:132/1/1_diet:Meat_vs_mushroom_UP	NA	189330
bsdb:132/1/2_diet:Meat_vs_mushroom_DOWN	NA	816	375288	33042	207244	40544
bsdb:134/1/1_diet:6-months-after-Average-Danish-Diet_vs_before-Average-Danish-Diet_UP	NA	872
bsdb:134/2/1_diet:6-months-after--New-Nordic-Diet_vs_before--New-Nordic-Diet_UP	NA	1485	872
bsdb:134/2/2_diet:6-months-after--New-Nordic-Diet_vs_before--New-Nordic-Diet_DOWN	NA	239759
bsdb:135/1/1_diet:High-animal-protein_vs_low-animal-protein_UP	NA	816
bsdb:136/1/2_diet:Low-vegetable,-fruit,-grains,_vs_high-vegetable,-fruit,-grain_DOWN	NA	1485	1730	459786
bsdb:136/2/1_diet:two-weeks-after-a-dietry-intervention_vs_before-dietary-intervention_UP	NA	84111	1357	1301	1350	1730	102106	1485	1678	572511
bsdb:136/2/2_diet:two-weeks-after-a-dietry-intervention_vs_before-dietary-intervention_DOWN	NA	216851	39948	1263	872	29465	84108
bsdb:137/1/1_colorectal-cancer:CRC_vs_controls_UP	NA	642	848
bsdb:137/1/2_colorectal-cancer:CRC_vs_controls_DOWN	NA	816	35832	544	413496	189330	1730	841
bsdb:138/1/1_lung-cancer:lung-cancer_vs_controls_UP	NA	1350	1505663	69965	1654	1392389	160674	1380	1573535
bsdb:138/1/2_lung-cancer:lung-cancer_vs_controls_DOWN	NA	1678	102106	189330	447020	175304	226	1508657	28050	162289	1348911	46205	437755	40544	1257
bsdb:139/1/2_squamous-cell-carcinoma:HNSCC_vs_controls_DOWN	NA	1716	32257
bsdb:139/2/1_squamous-cell-carcinoma:Larynx-cancer-cases_vs_controls_DOWN	NA	1716	32257	482	46123	1016
bsdb:139/3/1_squamous-cell-carcinoma:Pharynx-cancer-cases_vs_controls_DOWN	NA	1716	32257
bsdb:139/4/1_squamous-cell-carcinoma:Oral-cavity-cancer-cases_vs_controls_UP	NA	1654
bsdb:140/1/1_multiple-sclerosis:multiple-sclerosis_vs_controls_UP	NA	2172	239934	84593
bsdb:140/1/2_multiple-sclerosis:multiple-sclerosis_vs_controls_DOWN	NA	574697
bsdb:140/2/1_multiple-sclerosis:multiple-sclerosis_vs_controls_UP	NA	84593	2172	239934
bsdb:140/2/2_multiple-sclerosis:multiple-sclerosis_vs_controls_DOWN	NA	574697
bsdb:140/3/1_multiple-sclerosis:untreated-multiple-sclerosis_vs_controls_UP	NA	2735	239934
bsdb:140/3/2_multiple-sclerosis:untreated-multiple-sclerosis_vs_controls_DOWN	NA	574697	838	40544
bsdb:140/4/1_multiple-sclerosis:untreated-multiple-sclerosis_vs_controls_UP	NA	2735	2172	239934
bsdb:140/4/2_multiple-sclerosis:untreated-multiple-sclerosis_vs_controls_DOWN	NA	574697	838	40544
bsdb:140/5/1_multiple-sclerosis:treated-multiple-sclerosis_vs_untreated_UP	NA	838	40544
bsdb:140/5/2_multiple-sclerosis:treated-multiple-sclerosis_vs_untreated_DOWN	NA	1266
bsdb:140/6/1_multiple-sclerosis:treated-multiple-sclerosis_vs_untreated_UP	NA	838
bsdb:140/6/2_multiple-sclerosis:treated-multiple-sclerosis_vs_untreated_DOWN	NA	1266
bsdb:141/1/1_preterm-premature-rupture-of-the-membranes:PPROM_vs_controls_UP	NA	165779	39948	162289	543311	43996	838	1301
bsdb:141/1/2_preterm-premature-rupture-of-the-membranes:PPROM_vs_controls_DOWN	NA	1578
bsdb:142/1/1_squamous-cell-carcinoma:HNSCC_vs_Controls_UP	NA	1301	1578	1257	195950	1279	543311	29465
bsdb:142/1/2_squamous-cell-carcinoma:HNSCC_vs_Controls_DOWN	NA	416916	47670	724	482	32067
bsdb:142/2/1_squamous-cell-carcinoma:HPV-+_vs_HPV--_UP	NA	1578	1013
bsdb:142/2/2_squamous-cell-carcinoma:HPV-+_vs_HPV--_DOWN	NA	538	482	32067
bsdb:142/3/1_squamous-cell-carcinoma:chemothrapy-radiation-and-surgery_vs_surgery_UP	NA	1578
bsdb:142/4/1_squamous-cell-carcinoma:chemothrapy-radiation-and-surgery_vs_surgery_DOWN	NA	724	416916	32067
bsdb:144/1/1_air-pollution:moderately-polluted-region-(B)_vs_lightly-poluuted-region-(A)_UP	NA	32207	265975	482	1654
bsdb:144/1/2_air-pollution:moderately-polluted-region-(B)_vs_lightly-poluuted-region-(A)_DOWN	NA	838	29465	836	848	1257	475
bsdb:144/2/2_air-pollution:heavily-polluted-region-(C)_vs_lightly-poluuted-region-(A)_DOWN	NA	838	29465	836	848	1016	1257	475	194
bsdb:144/3/2_air-pollution:heavily-polluted-region-(C)_vs_moderately-poluuted-region-(B)_DOWN	NA	32207	848	265975	1654	194	482
bsdb:146/1/1_oral-squamous-cell-carcinoma:oral-squamous-cell-carcinoma-(OSCC)_vs_Controls_UP	NA	2093	157	194	538	82202	1283313	848	970	39948	1257	44259	2740	43996	543311	1016
bsdb:146/1/2_oral-squamous-cell-carcinoma:oral-squamous-cell-carcinoma-(OSCC)_vs_Controls_DOWN	NA	906	1213720	117563	47670	29465	1301	196081	32207	1654
bsdb:147/1/1_squamous-cell-carcinoma:laryngeal-squamous-cell-carcinoma-(LSCC)_vs_controls_UP	NA	848	838	543311	1257	39948	43996	970	157	32008
bsdb:147/1/2_squamous-cell-carcinoma:laryngeal-squamous-cell-carcinoma-(LSCC)_vs_controls_DOWN	NA	1301	32207
bsdb:147/2/1_squamous-cell-carcinoma:Site-1-(upper-portion-of-throat-near-the-epiglottis)_vs_Site-2-(site-below-the-epiglottis-in-the-throat)_UP	NA	29465	32067	1654	32207	117563	906	265975	1380	437755
bsdb:147/2/2_squamous-cell-carcinoma:Site-1-(upper-portion-of-throat-near-the-epiglottis)_vs_Site-2-(site-below-the-epiglottis-in-the-throat)_DOWN	NA	848	838	543311	1257	836	39948	2093	44259	43996	538	157	416916
bsdb:148/1/1_polycystic-ovary-syndrome:NIR-PCOS_vs_HC_UP	NA	816	28050
bsdb:148/1/2_polycystic-ovary-syndrome:NIR-PCOS_vs_HC_DOWN	NA	838
bsdb:148/2/1_polycystic-ovary-syndrome:IR-PCOS_vs_HC_UP	NA	28050	816
bsdb:148/2/2_polycystic-ovary-syndrome:IR-PCOS_vs_HC_DOWN	NA	838
bsdb:148/3/1_polycystic-ovary-syndrome:NIR-PCOS_vs_IR-PCOS_UP	NA	816
bsdb:148/3/2_polycystic-ovary-syndrome:NIR-PCOS_vs_IR-PCOS_DOWN	NA	216851
bsdb:149/1/1_obesity:Obese_vs_controls_UP	NA	158846
bsdb:149/1/2_obesity:Obese_vs_controls_DOWN	NA	207244	459786	61170	816
bsdb:150/1/1_head-and-neck-carcinoma:Throat-cancer_vs_Healthy-controls_UP	NA	286	416916	216851	1508657	47670	909656	816
bsdb:150/1/2_head-and-neck-carcinoma:Throat-cancer_vs_Healthy-controls_DOWN	NA	713	109326	59735	194	1716	1730	848	724	1506553	32067	475	482	543311	1257	836	838	841	32207	970	157	29465
bsdb:150/2/1_head-and-neck-carcinoma:Cancer_vs_Vocal-cord-polyp_UP	NA	547	416916	286
bsdb:150/2/2_head-and-neck-carcinoma:Cancer_vs_Vocal-cord-polyp_DOWN	NA	848	838	44259	713	209	1730	841	109326	872	43994
bsdb:152/1/1_cervical-cancer:cervical-cancer_vs_healthy-controls_UP	NA	83770	1263	581	22	583	189330
bsdb:152/1/2_cervical-cancer:cervical-cancer_vs_healthy-controls_DOWN	NA	2745	33024
bsdb:152/2/1_cervical-cancer:cervical-cancer_vs_healthy-controls_UP	NA	375288	841
bsdb:152/2/2_cervical-cancer:cervical-cancer_vs_healthy-controls_DOWN	NA	33024
bsdb:153/1/1_prostate-cancer:prostate-cancer_vs_controls_UP	NA	1357	2747	1301	129337	547
bsdb:153/1/2_prostate-cancer:prostate-cancer_vs_controls_DOWN	NA	413496	114627	44249
bsdb:154/1/1_colorectal-cancer:colorectal-cancer_vs_healthy-controls_UP	NA	46913	44249	59732
bsdb:154/1/2_colorectal-cancer:colorectal-cancer_vs_healthy-controls_DOWN	NA	838	1730	570	32067	33024	86331	613
bsdb:155/1/1_esophageal-cancer:Esophageal-Adenocarcinoma-(EAC)_vs_controls_UP	NA	29465	970
bsdb:155/1/2_esophageal-cancer:Esophageal-Adenocarcinoma-(EAC)_vs_controls_DOWN	NA	1283313	265975	123375	482	724
bsdb:155/2/1_esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_controls_UP	NA	59735
bsdb:155/2/2_esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_controls_DOWN	NA	838
bsdb:156/1/1_gastric-adenocarcinoma:Gastric-cancer_vs_healthy-controls_UP	NA	838	561	620	570	1578	1301	239759	29465	1678	990721	375288
bsdb:156/1/2_gastric-adenocarcinoma:Gastric-cancer_vs_healthy-controls_DOWN	NA	216851	841	28050	1506553
bsdb:156/2/1_gastric-adenocarcinoma:Gastric-cancer_vs_healthy-controls_UP	NA	1729679	838	561	620	570	1301	1578	239759	1678	29465
bsdb:156/2/2_gastric-adenocarcinoma:Gastric-cancer_vs_healthy-controls_DOWN	NA	841	28050	1506553
bsdb:157/1/1_esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_Dysplasia_UP	NA	838	1301	836	1578
bsdb:157/1/2_esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_Dysplasia_DOWN	NA	29465	482	848	724	32207	32067	194	416916	265975	1380	47670	118747	43996	1716	2740	2717	963
bsdb:157/2/1_esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_controls_UP	NA	838	1301	836	1016	308865	816
bsdb:157/2/2_esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_controls_DOWN	NA	29465	482	724	32207	157	906	194	970	416916	1257	265975	1654	1380	47670	118747	43996	44259	1716	2147	830	39948	2740	2717
bsdb:158/1/1_lung-cancer:lung-cancer_vs_healthy-volunteers_UP	NA	816	29465	848	33024
bsdb:158/1/2_lung-cancer:lung-cancer_vs_healthy-volunteers_DOWN	NA	579	216851	547	39948	561	620
bsdb:158/2/1_lung-cancer:lung-cancer_vs_healthy-volunteers_UP	NA	570	848
bsdb:158/2/2_lung-cancer:lung-cancer_vs_healthy-volunteers_DOWN	NA	39948	547	216851	561	620
bsdb:159/1/1_gingival-disease:1-month-after-the-placement-of-the-brackets_vs_before_UP	NA	713	1016
bsdb:159/2/1_gingival-disease:3-months-after-the-placement-of-the-brackets_vs_before_UP	NA	1016
bsdb:159/2/2_gingival-disease:3-months-after-the-placement-of-the-brackets_vs_before_DOWN	NA	117563
bsdb:160/1/1_head-and-neck-carcinoma:OCC-&-OPC_vs_High-risk-individuals_DOWN	NA	346096	1716	836	1654	713	1016	848	416916	47670
bsdb:160/2/1_head-and-neck-carcinoma:OCC-&-OPC_vs_Normal-Healthy-Controls_UP	NA	265975
bsdb:160/2/2_head-and-neck-carcinoma:OCC-&-OPC_vs_Normal-Healthy-Controls_DOWN	NA	32207	724	1716	346096	836	1016
bsdb:161/1/1_lung-cancer:NSCLC_vs_healthy-controls_UP	NA	416916	32207	32067	47670	1301	29465
bsdb:161/1/2_lung-cancer:NSCLC_vs_healthy-controls_DOWN	NA	216851	816	838	1283313	836
bsdb:161/2/1_lung-cancer:NSCLC_vs_healthy-controls_UP	NA	1301	47670
bsdb:161/2/2_lung-cancer:NSCLC_vs_healthy-controls_DOWN	NA	838
bsdb:163/1/1_squamous-cell-carcinoma:Oropharyngeal-Squamous-Cell-Carcinoma_vs_Healthy-Controls_UP	NA	872	55506	437755	157	1678	1654	970
bsdb:163/1/2_squamous-cell-carcinoma:Oropharyngeal-Squamous-Cell-Carcinoma_vs_Healthy-Controls_DOWN	NA	43996	29465	482	1301	838	724
bsdb:163/2/1_squamous-cell-carcinoma:Oropharyngeal-Squamous-Cell-Carcinoma_vs_Healthy-Controls_UP	NA	146	29465
bsdb:163/2/2_squamous-cell-carcinoma:Oropharyngeal-Squamous-Cell-Carcinoma_vs_Healthy-Controls_DOWN	NA	1213720
bsdb:164/1/1_gastric-cancer:gastric-cancer_vs_controls_UP	NA	838	1301	29465	1654	32067
bsdb:164/1/2_gastric-cancer:gastric-cancer_vs_controls_DOWN	NA	482	848	724	836
bsdb:165/1/1_chronic-kidney-disease:chronic-kidney-disease_vs_healthy-controls_UP	NA	407	872	577309	1283313	1485
bsdb:165/1/2_chronic-kidney-disease:chronic-kidney-disease_vs_healthy-controls_DOWN	NA	239934	174708	580024	1730	209	1578	1357	1243	248038	133925	265975	577310	1427376	638847	32207	2753
bsdb:166/1/1_chronic-kidney-disease:chronic-kidney-disease_vs_healthy-controls_UP	NA	816	561	620	375288	46255	946234	1508657	1769710	1505663	84111
bsdb:166/1/2_chronic-kidney-disease:chronic-kidney-disease_vs_healthy-controls_DOWN	NA	1506577	102106	580596	1501226	1263	841	33042	292632	28050	2747	39948
bsdb:167/1/1_squamous-cell-carcinoma:Stage-4_vs_healthy-controls_UP	NA	82202
bsdb:167/3/1_squamous-cell-carcinoma:Stage-2-&-3_vs_healthy-controls_UP	NA	1730
bsdb:168/1/1_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-yellow-tongue-coating-patients_vs_healthy-controls_UP	NA	283	47670	482
bsdb:168/1/2_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-yellow-tongue-coating-patients_vs_healthy-controls_DOWN	NA	196081	1481960	1331051	194	543311
bsdb:168/2/1_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-yellow-tongue-coating-patients_vs_chronic-hepatitis-B-white-tongue-coating-patients_UP	NA	2093	482
bsdb:168/2/2_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-yellow-tongue-coating-patients_vs_chronic-hepatitis-B-white-tongue-coating-patients_DOWN	NA	838	43996
bsdb:168/3/1_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-white-tongue-coating-patients_vs_healthy-controls_UP	NA	118747	82202	59735	836
bsdb:168/3/2_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-white-tongue-coating-patients_vs_healthy-controls_DOWN	NA	113286	194195	196081	1654
bsdb:169/1/1_gastric-cancer:white-thin-tongue-coating-GC-patient_vs_other-coatings_UP	NA	47670
bsdb:169/1/2_gastric-cancer:white-thin-tongue-coating-GC-patient_vs_other-coatings_DOWN	NA	1213720
bsdb:169/2/1_gastric-cancer:white-thick-tongue-coating-GC-patient_vs_other-coatings_UP	NA	1730
bsdb:169/3/1_gastric-cancer:yellow-thick-tongue-coating-GC-patient_vs_other-coatings_DOWN	NA	47670	482	1257
bsdb:170/1/1_lung-cancer:cancerous-site_vs_controls_UP	NA	1301
bsdb:170/1/2_lung-cancer:cancerous-site_vs_controls_DOWN	NA	1279
bsdb:170/2/1_lung-cancer:paired-contralateral-non-cancerous-site_vs_controls_UP	NA	724	1301	237	482	32067	1016	970
bsdb:170/2/2_lung-cancer:paired-contralateral-non-cancerous-site_vs_controls_DOWN	NA	469
bsdb:170/3/1_lung-cancer:cancerous-site_vs_paired-contralateral-non-cancerous-site_UP	NA	39948
bsdb:170/4/1_lung-cancer:cacerous-site-with-no-antibiotics_vs_control-groups-with-no-antibiotics_UP	NA	1016
bsdb:170/4/2_lung-cancer:cacerous-site-with-no-antibiotics_vs_control-groups-with-no-antibiotics_DOWN	NA	1279	265
bsdb:171/1/1_digestive-system-cancer:digestive-track-cancers_vs_controls_UP	NA	1716	482	29465	848
bsdb:171/1/2_digestive-system-cancer:digestive-track-cancers_vs_controls_DOWN	NA	838	836	32207
bsdb:171/2/1_tongue-neoplasm:tongue/pharylgeal-cancer_vs_controls_UP	NA	482	1716	838	32067	1301
bsdb:171/2/2_tongue-neoplasm:tongue/pharylgeal-cancer_vs_controls_DOWN	NA	482	1301
bsdb:171/3/1_esophageal-cancer:esophageal-cancer_vs_controls_UP	NA	1716	482
bsdb:171/3/2_esophageal-cancer:esophageal-cancer_vs_controls_DOWN	NA	1654	1301
bsdb:171/4/1_colorectal-cancer:colorectal-cancer_vs_controls_UP	NA	1716	482
bsdb:171/4/2_colorectal-cancer:colorectal-cancer_vs_controls_DOWN	NA	838	1301
bsdb:171/5/1_gastric-cancer:gastric-cancer_vs_controls_UP	NA	1301	482
bsdb:171/5/2_gastric-cancer:gastric-cancer_vs_controls_DOWN	NA	32207	1301	838
bsdb:172/1/1_cannabis-use:marijuana-usage-group_vs_controls-(lateral-border-of-tongue)_UP	NA	80865	32207	85413	88	86331
bsdb:172/1/2_cannabis-use:marijuana-usage-group_vs_controls-(lateral-border-of-tongue)_DOWN	NA	1016	848	59735	836
bsdb:172/2/1_cannabis-use:marijuana-usage-group_vs_controls-(oral-pharynx)_UP	NA	29465	970	86331
bsdb:172/2/2_cannabis-use:marijuana-usage-group_vs_controls-(oral-pharynx)_DOWN	NA	59735	1301
bsdb:172/3/1_cannabis-use:marijuana-usage-group_vs_controls-(lateral-border-of-tongue)_UP	NA	80865	88	286	85413	47670	32207
bsdb:172/3/2_cannabis-use:marijuana-usage-group_vs_controls-(lateral-border-of-tongue)_DOWN	NA	59735
bsdb:173/1/1_pancreatic-carcinoma:pancreatic-cancer_vs_healthy-controls_UP	NA	838	29465	570	970	135858	1578	52228	904	547	200903	82202	194	32067	413496	416916
bsdb:173/1/2_pancreatic-carcinoma:pancreatic-cancer_vs_healthy-controls_DOWN	NA	244127	651554	583	86331	1485	44748	84111	379	41275	239934	906	189330	572511	946234	580596	35832	33042	207244	158846	1678	239759	577310	204475
bsdb:173/2/1_pancreatic-carcinoma:pancreatic-head-cancer-with-obstruction_vs_without-cancer_UP	NA	46205	283	1200657	32067	140625	1301	115543	117563
bsdb:173/2/2_pancreatic-carcinoma:pancreatic-head-cancer-with-obstruction_vs_without-cancer_DOWN	NA	561	620	118966
bsdb:174/1/1_gastric-cancer:cacerous-tissue_vs_paired-adjacent-non-cacerous-tissue_UP	NA	970	838	1164882	1301	1257	13687	469	1386
bsdb:174/1/2_gastric-cancer:cacerous-tissue_vs_paired-adjacent-non-cacerous-tissue_DOWN	NA	613	209	1543704	1357
bsdb:175/1/1_pancreatic-carcinoma:pancreatic-cancer-cases_vs_controls_UP	NA	1283313
bsdb:175/1/2_pancreatic-carcinoma:pancreatic-cancer-cases_vs_controls_DOWN	NA	32067
bsdb:175/2/1_pancreatic-carcinoma:pancreatic-cancer-cases_vs_controls_DOWN	NA	32067	1283313
bsdb:175/3/1_pancreatic-carcinoma:pancreatic-cancer-cases_vs_controls_DOWN	NA	32067
bsdb:176/1/1_leukemia:survivors-of-acute-lymphoblastic-leukemia_vs_controls_UP	NA	1716	162289	150022	1279	1654
bsdb:176/1/2_leukemia:survivors-of-acute-lymphoblastic-leukemia_vs_controls_DOWN	NA	216851	1263	28050
bsdb:177/1/1_colorectal-cancer:mucosa_vs_control_UP	NA	35832	1485	39948	848	2172	119852	1257
bsdb:177/1/2_colorectal-cancer:mucosa_vs_control_DOWN	NA	1301
bsdb:177/2/1_colorectal-cancer:tumor_vs_control_UP	NA	2172	970	1257
bsdb:177/3/1_colorectal-cancer:fecal_vs_control_UP	NA	189330	1257
bsdb:177/3/2_colorectal-cancer:fecal_vs_control_DOWN	NA	841
bsdb:178/1/1_gastric-cancer:gastric-cancer-peritumor-group_vs_normal_UP	NA	2745	22	1350	41275	1663	1763
bsdb:178/1/2_gastric-cancer:gastric-cancer-peritumor-group_vs_normal_DOWN	NA	106589	445
bsdb:178/2/1_gastric-cancer:gastric-cancer-tumor-group_vs_peritumor_UP	NA	1350	970	2745	1678	239759	1263	39948	459786	33042	841	906	1279	572511
bsdb:178/2/2_gastric-cancer:gastric-cancer-tumor-group_vs_peritumor_DOWN	NA	379	158846	22	1763	1578
bsdb:178/3/1_gastric-cancer:gastric-cancer-tumor-group_vs_normal_UP	NA	92793	1678	572511	33042	39948	1378	204475	117563	70774	1578	149698	407	482	1257	1743	841	42255	1263	22	1301	29465
bsdb:178/3/2_gastric-cancer:gastric-cancer-tumor-group_vs_normal_DOWN	NA	1716	106589	1654	1279
bsdb:179/1/1_esophageal-squamous-cell-carcinoma:Oesophageal-cancer_vs_Healthy-controls_UP	NA	1654	1380	2717
bsdb:179/1/2_esophageal-squamous-cell-carcinoma:Oesophageal-cancer_vs_Healthy-controls_DOWN	NA	848	836
bsdb:179/2/1_esophageal-squamous-cell-carcinoma:Oesophageal-cancer_vs_Healthy-controls_UP	NA	1380	1654
bsdb:179/2/2_esophageal-squamous-cell-carcinoma:Oesophageal-cancer_vs_Healthy-controls_DOWN	NA	848	836
bsdb:181/1/1_pancreatic-carcinoma:pancreatic-cancer_vs_controls_UP	NA	1283313
bsdb:181/1/2_pancreatic-carcinoma:pancreatic-cancer_vs_controls_DOWN	NA	32067
bsdb:184/1/1_prostate-cancer:prostate-cancer-patients_vs_controls_UP	NA	816
bsdb:184/2/1_prostate-cancer:prostate-cancer-patients_vs_controls_DOWN	NA	28050	258514	216851
bsdb:185/1/1_gastric-cancer:gastric-cancer_vs_controls_UP	NA	561	620	1485	29465
bsdb:185/1/2_gastric-cancer:gastric-cancer_vs_controls_DOWN	NA	816
bsdb:185/2/1_gastric-cancer:gastric-cancer_vs_healthy-gastric-cancer_UP	NA	570
bsdb:185/2/2_gastric-cancer:gastric-cancer_vs_healthy-gastric-cancer_DOWN	NA	239934	620	1578	39948
bsdb:186/1/1_prostate-cancer:prostrate-cancer_vs_non-prostrate-cancer_UP	NA	1357	2747	1301	129337	547
bsdb:186/1/2_prostate-cancer:prostrate-cancer_vs_non-prostrate-cancer_DOWN	NA	413496	114627	44249
bsdb:187/1/1_medroxyprogesterone-acetate:naive-(baseline-visit)_vs_depot-mdroxyprogesterone-Acetate-vaginal-microbiome-(visit-2)-among-black-participants_UP	NA	838
bsdb:187/2/1_medroxyprogesterone-acetate:white-naiive-vaginal-microbiome_vs_black-naive-vaginal-microbiome-(the-baseline-visit-)_UP	NA	150022
bsdb:187/2/2_medroxyprogesterone-acetate:white-naiive-vaginal-microbiome_vs_black-naive-vaginal-microbiome-(the-baseline-visit-)_DOWN	NA	1485	177971
bsdb:187/3/1_medroxyprogesterone-acetate:white-participants-after-using-depot-medroxyprogesterone_vs_black-participants-after-using-depot-medroxyprogesterone--(the-second-visit-)_UP	NA	1578
bsdb:187/3/2_medroxyprogesterone-acetate:white-participants-after-using-depot-medroxyprogesterone_vs_black-participants-after-using-depot-medroxyprogesterone--(the-second-visit-)_DOWN	NA	838	168808	1485	848	1378
bsdb:187/4/1_medroxyprogesterone-acetate:white-participants-after-using-depot-medroxyprogesterone_vs_black-participants-after-using-depot-medroxyprogesterone--(the-third-visit-)_UP	NA	150022
bsdb:187/4/2_medroxyprogesterone-acetate:white-participants-after-using-depot-medroxyprogesterone_vs_black-participants-after-using-depot-medroxyprogesterone--(the-third-visit-)_DOWN	NA	838	906	1375
bsdb:188/1/1_cervical-cerclage:Vaginal-microbiome-of-symptomatic-women-prior-ro-cerclage_vs_Vaginal-microbiome-of-asymptomatic-women-prior-to-cerclage_UP	NA	2701
bsdb:189/1/1_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-patients_vs_healthy-controls_UP	NA	158846
bsdb:189/1/2_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-patients_vs_healthy-controls_DOWN	NA	816	574697	375288
bsdb:190/1/1_breast-milk-measurement:one-month-age-infants-exposed-to-high-chemical-breast-milk_vs_one-month-age-infants-exposed-to-low-chemical-breast-milk_UP	NA	1485	1350
bsdb:190/1/2_breast-milk-measurement:one-month-age-infants-exposed-to-high-chemical-breast-milk_vs_one-month-age-infants-exposed-to-low-chemical-breast-milk_DOWN	NA	1578	29465
bsdb:192/1/2_irritable-bowel-sydrome:diarrhea-predominant-irritable-bowel-syndrome_vs_healthy-controls_DOWN	NA	216851
bsdb:192/2/1_irritable-bowel-sydrome:diarrhea-predominant-irritable-bowel-syndrome_vs_healthy-controls_UP	NA	253238
bsdb:194/1/1_ovarian-cancer:ovarian-cancer_vs_normal-tissue_UP	NA	236752	1357
bsdb:194/1/2_ovarian-cancer:ovarian-cancer_vs_normal-tissue_DOWN	NA	212791	283	1279	165695	407	106589	586	215579	504481	12916	13687	469
bsdb:195/1/1_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B_vs_healthy-controls_UP	NA	629	44259
bsdb:195/1/2_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B_vs_healthy-controls_DOWN	NA	32067	1016
bsdb:195/2/1_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B_vs_liver-cirrhosis_UP	NA	44259	157
bsdb:195/2/2_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B_vs_liver-cirrhosis_DOWN	NA	482
bsdb:196/1/1_Henoch-Schoenlein-purpura:Henoch-Schönlein-Purpura_vs_controls_UP	NA	29465	1350	158846	375288
bsdb:196/1/2_Henoch-Schoenlein-purpura:Henoch-Schönlein-Purpura_vs_controls_DOWN	NA	1301	1508657	570	1263	724	28050	577310	841	39948
bsdb:197/1/1_asthma:severe-asthma_vs_non-asthma_UP	NA	816	216851	841	1432051	1263	375288	1501226	239759	1730	946234	283168	459786	207244	1016	4753	5277	5533
bsdb:197/1/2_asthma:severe-asthma_vs_non-asthma_DOWN	NA	583	5615	5206	237557
bsdb:198/1/1_Henoch-Schoenlein-purpura:Henoch-Schönlein-Purpura_vs_controls_UP	NA	482	29465	838
bsdb:198/1/2_Henoch-Schoenlein-purpura:Henoch-Schönlein-Purpura_vs_controls_DOWN	NA	724	469
bsdb:199/1/2_ovarian-cancer:ovarian-cancer_vs_controls_DOWN	NA	44249	2251
bsdb:200/1/2_endometrial-cancer:post_vs_pre_DOWN	NA	39948	162289	836	194	1654	72763	1380	2740	816	285105	1485	33983	162290	572511	216851	184869
bsdb:200/2/1_endometrial-cancer:endometrial-cancer_vs_benign_UP	NA	165779	1578
bsdb:200/2/2_endometrial-cancer:endometrial-cancer_vs_benign_DOWN	NA	1578	836	838	150022	162289	848	194	1654	2740	162290	184869	28263
bsdb:201/1/1_leukemia:induction_vs_repeat-therapy_UP	NA	375288	816	216851	1263	459786
bsdb:201/1/2_leukemia:induction_vs_repeat-therapy_DOWN	NA	1654	84111	292632	1573536	1578	29465	1350
bsdb:202/1/1_autism:children-with-autism-mental-regression-AMR_vs_children-with-autism-non-mental-regression-ANMR_UP	NA	1350
bsdb:202/2/1_autism:children-with-autism-non-mental-regression-ANMR_vs_healthy-control_UP	NA	1678
bsdb:202/3/1_autism:children-with-autism-mental-regression-AMR_vs_healthy-control_UP	NA	1678	1350
bsdb:204/1/1_premature-birth:mothers-whose-newborns-were-delivered-at-<34-gestational-week_vs_mothers-whose-newborns-were-delivered-at-≥37-getastional-weeks_DOWN	NA	1678
bsdb:207/1/1_vulvovaginitis:BV_vs_NC_UP	NA	2701	168808	1380	118747	39948	2050	836
bsdb:207/1/2_vulvovaginitis:BV_vs_NC_DOWN	NA	1578
bsdb:207/2/1_vulvovaginitis:BV.VVC_vs_NC_UP	NA	838
bsdb:208/1/5_food-allergy:infants-with-food-allergies_vs_healthy-controls_UP	NA	1485	1350	1578	1279	216851	207244	838	946234
bsdb:208/1/6_food-allergy:infants-with-food-allergies_vs_healthy-controls_DOWN	NA	816	1301	29465	570	572511	158846	906
bsdb:208/2/1_food-allergy:infants-with-food-allergies_vs_healthy-controls_UP	NA	1485	580596	1827
bsdb:208/2/2_food-allergy:infants-with-food-allergies_vs_healthy-controls_DOWN	NA	906	68287	222	84111	237	40323	86331	59732	283
bsdb:208/3/1_food-allergy:infants-IgE-mediated_vs_infants-non-IgE-mediated_UP	NA	1485
bsdb:208/3/2_food-allergy:infants-IgE-mediated_vs_infants-non-IgE-mediated_DOWN	NA	816	1827
bsdb:208/4/1_food-allergy:infants-IgE-mediated_vs_infants-non-IgE-mediated_UP	NA	1485
bsdb:208/4/2_food-allergy:infants-IgE-mediated_vs_infants-non-IgE-mediated_DOWN	NA	816
bsdb:209/1/1_cesarean-section:c-section-delivery_vs_vaginal-delivery_UP	NA	29465	407	544	1279	1716	1301	12916	1743	117563	469	374	80865	1302778	1578	222	65551	28209	40323	114248	724	88	283	28067	504481	1357	547	150247	357
bsdb:209/1/2_cesarean-section:c-section-delivery_vs_vaginal-delivery_DOWN	NA	561	816	1485	1678	1350	544	570	158851	620	1279	1716	1301
bsdb:210/1/1_food-allergy:children-with-food-sensitization_vs_healthy-controls_UP	NA	13687	40544	1678	102106	1485	1350	1578	841	216851	1263	292632	239934
bsdb:210/1/2_food-allergy:children-with-food-sensitization_vs_healthy-controls_DOWN	NA	816	375288	838	239759	1301	29465
bsdb:210/2/1_food-allergy:children-with-food-sensitization_vs_healthy-controls_UP	NA	292632
bsdb:210/2/2_food-allergy:children-with-food-sensitization_vs_healthy-controls_DOWN	NA	816	29465
bsdb:211/1/1_diet:low-fiber-(Q1-and-Q2)_vs_high-fiber-(Q3-and-Q4)_UP	NA	1654
bsdb:212/1/1_diet:low-fiber-(Q1-and-Q2)_vs_high-fiber-(Q3-and-Q4)_UP	NA	283168
bsdb:213/1/1_diet:low-fiber-(Q1-and-Q2)_vs_high-fiber-(Q3-and-Q4)_UP	NA	1654	283168
bsdb:213/2/1_diet:low-fiber-from-FRUITS/VEGETABLES-(Q1-and-Q2)_vs_high-fiber-from-FRUITS/VEGETABLES-(Q3-and-Q4)_UP	NA	1654	283168
bsdb:213/3/1_diet:low-fiber-from-BEANS-(Q1-and-Q2)_vs_high-fiber-from-BEANS-(Q3-and-Q4)_UP	NA	283168
bsdb:213/3/2_diet:low-fiber-from-BEANS-(Q1-and-Q2)_vs_high-fiber-from-BEANS-(Q3-and-Q4)_DOWN	NA	216851
bsdb:214/1/1_milk-allergic-reaction:children-with-milk-allergy-persistence_vs_milk-allergy-resolution_UP	NA	590	547	158851
bsdb:214/1/2_milk-allergic-reaction:children-with-milk-allergy-persistence_vs_milk-allergy-resolution_DOWN	NA	1263	1730	572511
bsdb:214/1/3_milk-allergic-reaction:children-with-milk-allergy-persistence_vs_milk-allergy-resolution_UP	NA	590	547	158851
bsdb:214/1/4_milk-allergic-reaction:children-with-milk-allergy-persistence_vs_milk-allergy-resolution_DOWN	NA	1263	1730	572511
bsdb:214/1/6_milk-allergic-reaction:children-with-milk-allergy-persistence_vs_milk-allergy-resolution_DOWN	NA	1730
bsdb:214/1/7_milk-allergic-reaction:children-with-milk-allergy-persistence_vs_milk-allergy-resolution_UP	NA	158851	547	590
bsdb:214/1/8_milk-allergic-reaction:children-with-milk-allergy-persistence_vs_milk-allergy-resolution_DOWN	NA	572511
bsdb:214/1/9_milk-allergic-reaction:children-with-milk-allergy-persistence_vs_milk-allergy-resolution_UP	NA	547	158851
bsdb:214/1/10_milk-allergic-reaction:children-with-milk-allergy-persistence_vs_milk-allergy-resolution_DOWN	NA	1263
bsdb:214/1/11_milk-allergic-reaction:children-with-milk-allergy-persistence_vs_milk-allergy-resolution_UP	NA	590	547	158851
bsdb:214/1/12_milk-allergic-reaction:children-with-milk-allergy-persistence_vs_milk-allergy-resolution_DOWN	NA	1730	572511
bsdb:215/1/1_eczema:infant-with-eczema_vs_healthy-control_UP	NA	239934	207244	35832	33042	872	547	216851	946234	204475	44249	375288	577309	33024	836	379	841	29465
bsdb:215/1/2_eczema:infant-with-eczema_vs_healthy-control_DOWN	NA	904	209879	156454	244127	1678	43668	1696	580596	1485	102106	1716	39948	189330	538	117563	724	570	1578	906	459786	838	1263	1301	40544	191303
bsdb:216/1/1_cesarean-section:C-section_vs_vaginal-delivery_DOWN	NA	1380	1350
bsdb:217/3/1_age:infant-at-18-months_vs_infant-at-6-months_UP	NA	848	583
bsdb:217/3/2_age:infant-at-18-months_vs_infant-at-6-months_DOWN	NA	1678
bsdb:218/1/1_hepatocellular-carcinoma:non-HBV-non-HCV-related-HCC_vs_healthy-control_UP	NA	244127
bsdb:218/1/2_hepatocellular-carcinoma:non-HBV-non-HCV-related-HCC_vs_healthy-control_DOWN	NA	158846	28050
bsdb:218/2/1_hepatocellular-carcinoma:HBV-related-HCC_vs_healthy-control_UP	NA	838	33024	244127
bsdb:218/3/1_hepatocellular-carcinoma:non-HBV-non-HCV_vs_HBV-related-HCC_UP	NA	32199	28050	33024	1283313
bsdb:219/2/1_diet:week-8_vs_baseline_UP	NA	28050
bsdb:219/2/2_diet:week-8_vs_baseline_DOWN	NA	239759	574697	283168
bsdb:219/3/1_diet:lower-fiber-(cracker)_vs_higher-fiber-(almonds)_DOWN	NA	40544
bsdb:220/1/1_age:older-age-European-women_vs_younger-age_UP	NA	1663	168808	1716	2745
bsdb:220/1/2_age:older-age-European-women_vs_younger-age_DOWN	NA	1743
bsdb:221/1/1_urinary-track-infection:urinary-track-infection_vs_healthy-controls_UP	NA	547
bsdb:221/1/2_urinary-track-infection:urinary-track-infection_vs_healthy-controls_DOWN	NA	150022	724	149698	39948
bsdb:223/1/1_HIV-infection:HIV-infected-patients_vs_healthy-controls_UP	NA	1578	1506553	1301	1350
bsdb:223/1/2_HIV-infection:HIV-infected-patients_vs_healthy-controls_DOWN	NA	816	838	158846	292632	216851	39948	33024
bsdb:223/2/1_HIV-infection:HIV-infected-homosexual-patients_vs_healthy-controls_UP	NA	1350	1505663
bsdb:223/2/2_HIV-infection:HIV-infected-homosexual-patients_vs_healthy-controls_DOWN	NA	838	39948	216851	33024
bsdb:223/3/1_HIV-infection:Intravenous-drug-abuse-HIV-patients_vs_healthy-controls_UP	NA	1301	1578
bsdb:223/4/1_HIV-infection:homosexual_vs_hetersexual_DOWN	NA	838	1506553	33024	375288
bsdb:223/5/1_HIV-infection:HAART_vs_healty-control_UP	NA	561	620	1301	1506553
bsdb:223/5/2_HIV-infection:HAART_vs_healty-control_DOWN	NA	816	838	158846	292632	216851	39948	33024
bsdb:223/6/1_HIV-infection:HAART-untreated_vs_healthy-control_UP	NA	1350	1578
bsdb:224/1/1_diet:barley-(WGB)_vs_baseline_UP	NA	572511
bsdb:224/1/2_diet:barley-(WGB)_vs_baseline_DOWN	NA	283168
bsdb:224/3/1_diet:brown-rice-+-barley-(BR-+-WGB)_vs_baseline_UP	NA	572511
bsdb:224/3/2_diet:brown-rice-+-barley-(BR-+-WGB)_vs_baseline_DOWN	NA	816
bsdb:225/1/1_atopic-eczema:infant-with-atopic-eczema_vs_healthy-infant_UP	NA	1350
bsdb:226/1/1_HIV-infection:HIV-1-infected_vs_healthy-control_UP	NA	838	158846	216851	577310	1350	547	135858	580596	189330
bsdb:226/1/2_HIV-infection:HIV-1-infected_vs_healthy-control_DOWN	NA	33042	397864	39948	816
bsdb:226/2/1_HIV-infection:HIV-1-treated_vs_untreated_UP	NA	1350	572511	1654	29465	158846
bsdb:226/2/2_HIV-infection:HIV-1-treated_vs_untreated_DOWN	NA	838	216851	39948	239759	638847	2753	397864	459786	283168
bsdb:227/1/2_atopic-eczema:infant-with-transient-atopic-dermatitis_vs_healthy-control_UP	NA	1678	239934
bsdb:227/2/1_atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_healthy-controls_UP	NA	1301
bsdb:227/2/2_atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_healthy-controls_DOWN	NA	1485
bsdb:227/3/1_atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_transient-atopic-dermatitis_UP	NA	1301
bsdb:227/3/2_atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_transient-atopic-dermatitis_DOWN	NA	239934
bsdb:227/4/1_atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_healthy-controls_UP	NA	1301	1505657	216851	375288	1505652	1501226	117563	100883
bsdb:227/4/2_atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_healthy-controls_DOWN	NA	1504576	84111	160674	1330547	544	547	1654	100883
bsdb:227/5/1_atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_transient-atopic-dermatitis_UP	NA	100883	189330	469	1501226	375288	216851	1301
bsdb:227/5/2_atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_transient-atopic-dermatitis_DOWN	NA	239934	547	1330547	160674
bsdb:227/6/1_atopic-eczema:infant-with-transient-atopic-dermatitis_vs_healthy-control_UP	NA	1678
bsdb:227/6/2_atopic-eczema:infant-with-transient-atopic-dermatitis_vs_healthy-control_DOWN	NA	32207
bsdb:228/1/1_diet:day-3-of-PECTIN-spike-in_vs_day-6-of-PECTIN-spike-in_DOWN	NA	841	816	44748
bsdb:229/1/1_diet:early_vs_late-pectin-incubation-time_UP	NA	1678	100883	846	283168	33042	574697	1263	207244	572511	375288	33024	841	816
bsdb:229/1/2_diet:early_vs_late-pectin-incubation-time_DOWN	NA	28050	40544	189330	1485
bsdb:230/1/1_food-allergy:infant-with-food-allergy_vs_non-allergy_DOWN	NA	1243	46255	29465
bsdb:230/1/2_food-allergy:infant-with-food-allergy_vs_non-allergy_UP	NA	1485
bsdb:232/1/1_HIV-infection:HIV-infected-cART-negative_vs_HC_UP	NA	165779	1257	836	848
bsdb:232/1/2_HIV-infection:HIV-infected-cART-negative_vs_HC_DOWN	NA	28050	33042	841	1730	1263	239759
bsdb:233/1/1_HIV-infection:HIV-infected_vs_uninfected_UP	NA	838	469
bsdb:233/1/2_HIV-infection:HIV-infected_vs_uninfected_DOWN	NA	816	572511	33042
bsdb:236/1/1_diet:before-walnut-diet_vs_after-walnut-diet_UP	NA	207244	572511
bsdb:236/1/2_diet:before-walnut-diet_vs_after-walnut-diet_DOWN	NA	1678
bsdb:236/2/1_diet:carbohydrate-replacement-(with-walnuts)_vs_replace-both_DOWN	NA	204475	1407607	816
bsdb:236/3/1_diet:replace-both_vs_fat-replacement-(with-walnuts)_UP	NA	204475	1407607	816
bsdb:237/1/1_chronic-hepatitis-C-virus-infection:cirrhosis-patients_vs_healthy-controls_UP	NA	1283313	1578	1301	29465	239934	561	620	724	1269	46255
bsdb:237/1/2_chronic-hepatitis-C-virus-infection:cirrhosis-patients_vs_healthy-controls_DOWN	NA	574697	172900	35832	52225	213484
bsdb:237/2/1_chronic-hepatitis-C-virus-infection:cirrhosis-patients_vs_no-cirrhosis_UP	NA	544	1485	1253
bsdb:237/3/1_chronic-hepatitis-C-virus-infection:hepatitis-C-patients_vs_healthy-controls_DOWN	NA	946234	906	1017280	35829
bsdb:238/1/1_cervical-cancer:cervical-cancer-patient_vs_healthy-controls_UP	NA	838	836	39948	1506553	40544	1505663	437755	946234	459786	1301
bsdb:238/1/2_cervical-cancer:cervical-cancer-patient_vs_healthy-controls_DOWN	NA	1505657	1501226	207244	1407607	375288	572511	547	239759	561	816	620
bsdb:238/2/1_cervical-cancer:cervical-cancer-patient_vs_healthy-controls_UP	NA	838	836	39948	1506553	1505663	946234	437755
bsdb:238/2/2_cervical-cancer:cervical-cancer-patient_vs_healthy-controls_DOWN	NA	1501226	207244	572511	239759
bsdb:238/3/1_cervical-cancer:cervical-cancer-patient_vs_healthy-controls_UP	NA	838	836	39948	1506553	1301	1505663	437755
bsdb:238/3/2_cervical-cancer:cervical-cancer-patient_vs_healthy-controls_DOWN	NA	1505657	1501226	1407607	207244	547	239759
bsdb:239/1/1_egg-allergy:infant-with-egg-allergy_vs_healthy-control_UP	NA	1263	1357
bsdb:239/1/2_egg-allergy:infant-with-egg-allergy_vs_healthy-control_DOWN	NA	1243
bsdb:239/2/1_egg-allergy:infant-with-egg-sensitization_vs_healthy-control_UP	NA	216851	841
bsdb:241/1/2_iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_DOWN	NA	39948
bsdb:242/1/1_iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_UP	NA	475	1357	286	1350	57493	1578
bsdb:242/1/2_iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_DOWN	NA	1716	482	416916	2717
bsdb:242/2/1_iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_UP	NA	1357	286	1350	475	57493
bsdb:242/2/2_iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_DOWN	NA	194	2717	32207	416916	215579	1016	482	1716
bsdb:242/3/1_iron-deficiency-anemia:iron-deficiency-anemia-severe_vs_iron-deficiency-anemia-moderate_UP	NA	57493	1111	1279	475	1350	286	1357
bsdb:243/1/1_gastric-cancer:current-H.pyloriI-infection_vs_non-current-H.pylori-infection_UP	NA	1378
bsdb:243/1/2_gastric-cancer:current-H.pyloriI-infection_vs_non-current-H.pylori-infection_DOWN	NA	12916	1827
bsdb:243/2/1_gastric-cancer:current-H.pyloriI-infection_vs_past-H.pylori-infection_UP	NA	40544
bsdb:243/3/1_gastric-cancer:past-H.pylori-infection_vs_H.pylori-negative_DOWN	NA	375288
bsdb:243/4/1_gastric-cancer:gastritis_vs_normal_UP	NA	189330	216851	244127	1301	191303	561	620
bsdb:243/5/1_gastric-cancer:metaplasia_vs_normal_UP	NA	1506553	189330	1501226	39948	191303
bsdb:244/1/3_age:18-62-years_vs_2-12-years_UP	NA	1743	1716	1279	1578	150022	165779
bsdb:244/1/4_age:18-62-years_vs_2-12-years_DOWN	NA	32207	1301	117563	1378	724
bsdb:244/2/1_atopic-eczema:lesional-skin_vs_non-lesional-skin_UP	NA	1279
bsdb:244/2/2_atopic-eczema:lesional-skin_vs_non-lesional-skin_DOWN	NA	1716	1654	1301	1378	29465	836	848
bsdb:244/3/1_age:13-62-years_vs_2-12-years_UP	NA	1743	1716	1578
bsdb:244/3/2_age:13-62-years_vs_2-12-years_DOWN	NA	1301	117563	1378	482	724
bsdb:244/3/3_age:13-62-years_vs_2-12-years_UP	NA	1743	1716	1578
bsdb:244/3/4_age:13-62-years_vs_2-12-years_DOWN	NA	32207	1301	117563	1378	29465	482	724
bsdb:245/1/1_kidney-stone:kidney-stone-group_vs_healthy-control_UP	NA	469	620	1506553	1283313	158846	1573534	85413	1730	561
bsdb:245/1/2_kidney-stone:kidney-stone-group_vs_healthy-control_DOWN	NA	1508657	39948	61170	168934	638847	1678	841	577310	547
bsdb:245/2/1_kidney-stone:kidney-stone-group_vs_healthy-control_UP	NA	1283313	1505663	33024	158846	469	561	620	40544
bsdb:245/2/2_kidney-stone:kidney-stone-group_vs_healthy-control_DOWN	NA	189330	1508657	207244	1407607	292632	1573535	39948	1263	577310	35832
bsdb:246/1/1_asthma:maternal-asthma_vs_no-asthma_UP	NA	1357	1654	158846
bsdb:246/1/2_asthma:maternal-asthma_vs_no-asthma_DOWN	NA	158851
bsdb:246/2/1_asthma:maternal-asthma_vs_no-asthma_UP	NA	286	816
bsdb:246/2/2_asthma:maternal-asthma_vs_no-asthma_DOWN	NA	906
bsdb:246/3/1_asthma:maternal-asthma_vs_no-asthma_DOWN	NA	1578
bsdb:246/4/1_asthma:maternal-asthma_vs_no-asthma_DOWN	NA	1578
bsdb:246/5/1_asthma:maternal-asthma_vs_no-asthma_UP	NA	816	189330
bsdb:246/6/1_asthma:maternal-asthma_vs_no-asthma_DOWN	NA	1578	906
bsdb:246/7/1_asthma:maternal-asthma_vs_no-asthma_UP	NA	239934
bsdb:246/7/2_asthma:maternal-asthma_vs_no-asthma_DOWN	NA	1654
bsdb:247/1/1_diet:placebo_vs_prebiotic-(inulin-type-fructan)_UP	NA	33042	189330	119852
bsdb:247/1/2_diet:placebo_vs_prebiotic-(inulin-type-fructan)_DOWN	NA	1678
bsdb:247/2/1_diet:placebo_vs_prebiotic-(inulin-type-fructan)---in-participants-with-low-dietary-fiber_DOWN	NA	1678
bsdb:247/3/1_diet:placebo_vs_prebiotic-(inulin-type-fructan)---in-participants-with-high-dietary-fiber_UP	NA	572511	33042	189330
bsdb:247/3/2_diet:placebo_vs_prebiotic-(inulin-type-fructan)---in-participants-with-high-dietary-fiber_DOWN	NA	1678
bsdb:247/4/1_diet:low-dietary-fiber_vs_high-dietary-fiber_DOWN	NA	216851
bsdb:248/1/1_human-papilloma-virus-infection:high-risk-hpv_vs_low-risk-hpv_UP	NA	33870
bsdb:248/1/2_human-papilloma-virus-infection:high-risk-hpv_vs_low-risk-hpv_DOWN	NA	724	28100
bsdb:248/2/1_human-papilloma-virus-infection:HPV_vs_no-HPV_UP	NA	2701
bsdb:248/2/2_human-papilloma-virus-infection:HPV_vs_no-HPV_DOWN	NA	286	28100
bsdb:249/1/1_hepatitis,-alcoholic:alcoholics_vs_NAC_UP	NA	33882	1843210	374
bsdb:249/1/2_hepatitis,-alcoholic:alcoholics_vs_NAC_DOWN	NA	2053	1839	53387	1678	816	397864	577309	838	239759	237	182709	94008	572511	1263	186650	265	780	114248	12916	47420	215579	29580	70774	642
bsdb:249/2/1_hepatitis,-alcoholic:HDC_vs_NAC_UP	NA	33882	57493	1883	59732	165779	20	374	1060	482	469
bsdb:249/2/2_hepatitis,-alcoholic:HDC_vs_NAC_DOWN	NA	2053	1839	1678	816	397864	838	237	1301	1485	114248	12916	70774
bsdb:249/3/1_hepatitis,-alcoholic:MAH_vs_NAC_UP	NA	1654	501783	117563	165779	374	407	281915	469
bsdb:249/3/2_hepatitis,-alcoholic:MAH_vs_NAC_DOWN	NA	1839	53387	838	237	1386	1485	29580	70774
bsdb:249/4/1_hepatitis,-alcoholic:SAH_vs_NAC_UP	NA	1654	1716	43668	33882	244698	1651
bsdb:249/4/2_hepatitis,-alcoholic:SAH_vs_NAC_DOWN	NA	1839	1678	397864	239759	237
bsdb:250/2/1_severe-aplastic-anemia:hematopoietic-stem-cell-transplantation-engraftment_vs_baseline_DOWN	NA	482
bsdb:251/1/1_milk-allergic-reaction:cows-milk-allergy_vs_healthy-control_UP	NA	1350	1263	100883	572511	375288
bsdb:251/1/2_milk-allergic-reaction:cows-milk-allergy_vs_healthy-control_DOWN	NA	1301	590
bsdb:252/1/1_pemphigus-vulgaris:pemphigus-vulgaris_vs_healthy-control_UP	NA	561	620	46123	117563	100883	946234
bsdb:252/1/2_pemphigus-vulgaris:pemphigus-vulgaris_vs_healthy-control_DOWN	NA	102106	33042
bsdb:253/1/1_asthma:asthma_vs_healthy-control_UP	NA	1279	838
bsdb:253/1/2_asthma:asthma_vs_healthy-control_DOWN	NA	724
bsdb:253/2/1_asthma:asthma-remission_vs_healthy-control_UP	NA	848	838	543311
bsdb:253/2/2_asthma:asthma-remission_vs_healthy-control_DOWN	NA	724
bsdb:254/1/1_kidney-stone:kidney-stone-patient_vs_healthy-control_UP	NA	816	375288	239759
bsdb:254/1/2_kidney-stone:kidney-stone-patient_vs_healthy-control_DOWN	NA	184869	838	150022	162289
bsdb:255/1/1_human-papilloma-virus-infection:high-grade-squamous-intraepithelial-lesions_vs_negative-for-intraepithelial-lesion-or-malignancy_UP	NA	1279
bsdb:255/1/2_human-papilloma-virus-infection:high-grade-squamous-intraepithelial-lesions_vs_negative-for-intraepithelial-lesion-or-malignancy_DOWN	NA	150022
bsdb:255/2/1_human-papilloma-virus-infection:high-grade-squamous-intraepithelial-lesions_vs_negative-for-intraepithelial-lesion-or-malignancy_UP	NA	1301	543311
bsdb:255/2/2_human-papilloma-virus-infection:high-grade-squamous-intraepithelial-lesions_vs_negative-for-intraepithelial-lesion-or-malignancy_DOWN	NA	150022
bsdb:255/3/1_HIV-infection:HIV+_vs_HIV-_UP	NA	1386	1257	1378	1375	117563	1301	1279	904	437755
bsdb:255/3/2_HIV-infection:HIV+_vs_HIV-_DOWN	NA	28263	2129	1678
bsdb:256/1/1_gastric-cancer:peritumoral-tissues_vs_normal-tissues_UP	NA	209	2745	1301	22	1578	29465	407	1257	970	45402
bsdb:256/1/2_gastric-cancer:peritumoral-tissues_vs_normal-tissues_DOWN	NA	838	13687	216851	286	816	1386	848	1743	1716	33024
bsdb:256/2/1_gastric-cancer:tumoral-tissues_vs_peritumoral-tissues_UP	NA	838	286	1386	1743
bsdb:256/2/2_gastric-cancer:tumoral-tissues_vs_peritumoral-tissues_DOWN	NA	2745	22	13687	216851	33024
bsdb:256/3/1_gastric-cancer:tumoral-tissues_vs_normal-tissues_UP	NA	2745	1301	22	1578	1386	970	848	1743	1716
bsdb:256/3/2_gastric-cancer:tumoral-tissues_vs_normal-tissues_DOWN	NA	209	13687	286	816
bsdb:256/9/1_gastric-cancer:normal-HP+_vs_normal-HP-_UP	NA	149698	1678	1716	1654	407	13687	1301	209
bsdb:256/9/2_gastric-cancer:normal-HP+_vs_normal-HP-_DOWN	NA	1263	39948	204475	572511	841	216851	2745	838	33024	22
bsdb:256/10/1_gastric-cancer:peritumor-HP+_vs_peritumor-HP-_UP	NA	1378	1386	1301	209
bsdb:256/10/2_gastric-cancer:peritumor-HP+_vs_peritumor-HP-_DOWN	NA	33024	841	216851	239759	39948	204475	158846	1386	375288
bsdb:256/11/1_gastric-cancer:tumor-HP+_vs_tumor-HP-_UP	NA	1279	816	41275	572511	149698	165696	209
bsdb:256/11/2_gastric-cancer:tumor-HP+_vs_tumor-HP-_DOWN	NA	469	1263	286	13687	1678
bsdb:257/1/1_colorectal-cancer:colorectal-cancer_vs_healthy-control_UP	NA	574697	283168	375288	836	990721	1485	51514	1257	119852	1263	970	848	846	35832	239934
bsdb:257/1/2_colorectal-cancer:colorectal-cancer_vs_healthy-control_DOWN	NA	158846
bsdb:258/1/1_colorectal-cancer:carcinoma_vs_healthy-control_UP	NA	848	836
bsdb:258/1/2_colorectal-cancer:carcinoma_vs_healthy-control_DOWN	NA	816
bsdb:260/1/2_food-allergy:allergic_vs_nonallergic_DOWN	NA	816
bsdb:262/1/1_atopic-asthma:nasal-brush_vs_bronchial-brush-specimen-type_UP	NA	1716	1279	1651	475
bsdb:262/1/2_atopic-asthma:nasal-brush_vs_bronchial-brush-specimen-type_DOWN	NA	1654	836	838	1301	32067
bsdb:262/2/1_atopic-asthma:oral-wash_vs_bronchial-brush-specimen-type_UP	NA	1654	1301	32067
bsdb:262/2/2_atopic-asthma:oral-wash_vs_bronchial-brush-specimen-type_DOWN	NA	1716	838	475	1279
bsdb:262/3/1_atopic-asthma:induced-sputum_vs_nasal-brush-specimen-type_UP	NA	1654	836	838	1301	32067
bsdb:262/3/2_atopic-asthma:induced-sputum_vs_nasal-brush-specimen-type_DOWN	NA	1716	1279	1651	475
bsdb:262/4/1_atopic-asthma:oral-wash_vs_nasal-brush-specimen-type_UP	NA	1654	836	838	1301	32067
bsdb:262/4/2_atopic-asthma:oral-wash_vs_nasal-brush-specimen-type_DOWN	NA	1716	1279	1651	475
bsdb:262/5/1_atopic-asthma:oral-wash_vs_induced-sputum-specimen-type_UP	NA	1654
bsdb:262/5/2_atopic-asthma:oral-wash_vs_induced-sputum-specimen-type_DOWN	NA	1716	838	1279
bsdb:262/6/1_atopic-asthma:induced-sputum_vs_bronchial-brush-specimen-type_UP	NA	1301	32067
bsdb:262/7/1_atopic-asthma:atopic-asthma_vs_healthy-control_UP	NA	482	848	838	724
bsdb:262/7/2_atopic-asthma:atopic-asthma_vs_healthy-control_DOWN	NA	1301
bsdb:263/1/1_crohn-disease:chron's-disease_vs_healthy-controls_UP	NA	1654	84111	32207	572511	1573536	1378	1505657	1301
bsdb:263/1/2_crohn-disease:chron's-disease_vs_healthy-controls_DOWN	NA	553372	1485	33042	216851	1407607	204475	28050	86331	459786	1501226	1263	44748	292632	191303
bsdb:263/2/1_ulcerative-colitis:ulcerative-colitis_vs_healthy-controls_UP	NA	1654	1678	84111	264995	1573536	1378	1301
bsdb:263/2/2_ulcerative-colitis:ulcerative-colitis_vs_healthy-controls_DOWN	NA	644652	204475	28050	86331	1263	44748
bsdb:263/3/1_multiple-sclerosis:multiple-sceloris_vs_healthy-controls_UP	NA	1654	84111	264995	1485	1573536	1301	191303
bsdb:263/3/2_multiple-sclerosis:multiple-sceloris_vs_healthy-controls_DOWN	NA	580596	39948	216851	1407607	204475	28050	100132	292632
bsdb:263/4/1_rheumatoid-arthritis:arthiritis_vs_healthy-controls_UP	NA	1654	84111	32207	1573536	1378	1301
bsdb:263/4/2_rheumatoid-arthritis:arthiritis_vs_healthy-controls_DOWN	NA	264995	580596	1485	216851	1407607	204475	28050	1501226	841	44748	292632
bsdb:264/1/1_human-papilloma-virus-infection:HPV+/HIV-_vs_HPV-/HIV-_UP	NA	28263	1257	39948	162289	906	168808	838
bsdb:264/1/2_human-papilloma-virus-infection:HPV+/HIV-_vs_HPV-/HIV-_DOWN	NA	56688
bsdb:265/1/1_human-papilloma-virus-infection:two-months_vs_at-birth_UP	NA	1301	29465	32207
bsdb:265/1/2_human-papilloma-virus-infection:two-months_vs_at-birth_DOWN	NA	1578	816	906	1279	1743	357	80865	286
bsdb:265/2/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	400634	2129
bsdb:265/2/2_human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	29465
bsdb:266/1/1_diet:healthy-vegetarian_vs_healthy-non-vegetarian_UP	NA	838	570
bsdb:266/1/2_diet:healthy-vegetarian_vs_healthy-non-vegetarian_DOWN	NA	375288	816	239759	239934
bsdb:267/1/1_atopic-asthma:atopic-asthma_vs_healthy-control_UP	NA	848	724	482	1654	838	157	29465	109326	836	194	32257	165697
bsdb:267/1/2_atopic-asthma:atopic-asthma_vs_healthy-control_DOWN	NA	407	1257	1578	713	32067
bsdb:267/2/1_atopic-asthma:atopic-no-asthma_vs_healthy-control_UP	NA	416916	848	117563	1716	1654	970	2353	724	29465	475	519427	165697
bsdb:267/2/2_atopic-asthma:atopic-no-asthma_vs_healthy-control_DOWN	NA	1578	1301	286	209	543311	838	836	32067
bsdb:267/3/1_atopic-asthma:atopic-asthma_vs_atopic-no-asthma_UP	NA	32067	848	838	970	724	2093	39948
bsdb:267/3/2_atopic-asthma:atopic-asthma_vs_atopic-no-asthma_DOWN	NA	165697	519427	1578	174708	1301	836	2353	1716	416916
bsdb:267/5/1_atopic-asthma:post-inhaled-corticosteroid-treatment_vs_baseline_UP	NA	482	475
bsdb:267/5/2_atopic-asthma:post-inhaled-corticosteroid-treatment_vs_baseline_DOWN	NA	848	39948
bsdb:267/6/1_atopic-asthma:post-placebo-treatment_vs_baseline_UP	NA	538
bsdb:267/6/2_atopic-asthma:post-placebo-treatment_vs_baseline_DOWN	NA	469
bsdb:268/1/1_cervical-glandular-intraepithelial-neoplasia:before_vs_after-loop-electrosurgical-excision-procedure_UP	NA	168808	1716	29465	1485	102106
bsdb:268/1/2_cervical-glandular-intraepithelial-neoplasia:before_vs_after-loop-electrosurgical-excision-procedure_DOWN	NA	1279	48736
bsdb:269/1/1_leukemia:Acute-Lymphoblastic-Leukemia-diagnosis-and-Pre--Chemotherapy-treatment_vs_healthy-control_UP	NA	816
bsdb:269/1/2_leukemia:Acute-Lymphoblastic-Leukemia-diagnosis-and-Pre--Chemotherapy-treatment_vs_healthy-control_DOWN	NA	194	1716	1678	1380	162289	1279	838	165779	836
bsdb:269/1/3_leukemia:Acute-Lymphoblastic-Leukemia-diagnosis-and-Pre--Chemotherapy-treatment_vs_healthy-control_UP	NA	1678
bsdb:269/1/4_leukemia:Acute-Lymphoblastic-Leukemia-diagnosis-and-Pre--Chemotherapy-treatment_vs_healthy-control_DOWN	NA	1380	816	838	848	1716
bsdb:270/1/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	168808	906	1253	1696	286
bsdb:270/1/2_human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	83618	1654	213484	222991
bsdb:270/2/1_human-papilloma-virus-infection:HPV+-(persistance)_vs_HPV+-(clearance)_UP	NA	1380	216851
bsdb:271/1/1_acute-lymphoblastic-leukemia:Minimal-Residual-Disease--(negativity)-with-Allogenic-Stem-Cell-Transplant_vs_Minimal-Residual-Disease--(positivity)-with-Allogenic-Stem-Cell-Transplant_UP	NA	216851	253238	44748
bsdb:271/1/2_acute-lymphoblastic-leukemia:Minimal-Residual-Disease--(negativity)-with-Allogenic-Stem-Cell-Transplant_vs_Minimal-Residual-Disease--(positivity)-with-Allogenic-Stem-Cell-Transplant_DOWN	NA	32207
bsdb:271/2/1_acute-lymphoblastic-leukemia:Minimal-Residual-Disease--(negativity)-with-Allogenic-Stem-Cell-Transplant_vs_Minimal-Residual-Disease--(positivity)-with-Allogenic-Stem-Cell-Transplant_UP	NA	1730
bsdb:271/2/2_acute-lymphoblastic-leukemia:Minimal-Residual-Disease--(negativity)-with-Allogenic-Stem-Cell-Transplant_vs_Minimal-Residual-Disease--(positivity)-with-Allogenic-Stem-Cell-Transplant_UP	NA	216851
bsdb:272/1/1_pneumonia:S.pneumoniae-positive_vs_negative_UP	NA	475	1301
bsdb:272/1/2_pneumonia:S.pneumoniae-positive_vs_negative_DOWN	NA	1716	1279
bsdb:274/1/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	838
bsdb:274/1/2_human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	2701	1678	1578	39948	1654
bsdb:274/2/1_cervical-glandular-intraepithelial-neoplasia:low-grade-dysplasia_vs_HPV-_UP	NA	543311
bsdb:274/2/2_cervical-glandular-intraepithelial-neoplasia:low-grade-dysplasia_vs_HPV-_DOWN	NA	1578	1301	561	71655	620	162289
bsdb:274/3/1_cervical-glandular-intraepithelial-neoplasia:high-grade-dysplasia_vs_HPV-_UP	NA	2701	1485	543311	168808	1380	906	177971
bsdb:274/3/2_cervical-glandular-intraepithelial-neoplasia:high-grade-dysplasia_vs_HPV-_DOWN	NA	1678	1301	2129	39948	836	1578
bsdb:274/4/2_cervical-cancer:invasive-cervical-carcinoma_vs_HPV-_DOWN	NA	1578	1301	2129	561	71655	620	404402	1678	39948	1716
bsdb:274/5/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	133925	177971	1578	838	906
bsdb:274/5/2_human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	1375	165779	2701	1678
bsdb:274/6/1_cervical-glandular-intraepithelial-neoplasia:low-grade-dysplasia_vs_HPV-_UP	NA	168808	836	838	1678	1485	1578	39948
bsdb:274/6/2_cervical-glandular-intraepithelial-neoplasia:low-grade-dysplasia_vs_HPV-_DOWN	NA	1578
bsdb:274/7/1_cervical-glandular-intraepithelial-neoplasia:high-grade-dysplasia_vs_HPV-_UP	NA	1485	2701	906	543311	168808	177971
bsdb:274/7/2_cervical-glandular-intraepithelial-neoplasia:high-grade-dysplasia_vs_HPV-_DOWN	NA	1375	2701	39948	404402	1678	836	165779	162290
bsdb:274/8/1_cervical-cancer:invasive-cervical-carcinoma_vs_HPV-_DOWN	NA	165779	1678	2701	1578	437755
bsdb:274/9/1_NA:normal-pH_vs_abnormal-pH_UP	NA	838	1301	29465	1380	1485	1257	1350	543311	1279	168808	1378	2701	437755	906	177971	1678
bsdb:274/9/2_NA:normal-pH_vs_abnormal-pH_DOWN	NA	1578	561	71655	620	1485
bsdb:274/10/1_human-papilloma-virus-infection:Hispanic_vs_non-Hispanic_UP	NA	29465	1301	1375	2701	1350	437755	906	168808	1380	177971	836
bsdb:274/10/2_human-papilloma-virus-infection:Hispanic_vs_non-Hispanic_DOWN	NA	1578
bsdb:275/1/1_acute-lymphoblastic-leukemia:ALL-patient_vs_healthy-sibling-control_UP	NA	1301	39948	1485	397864	459786	1578	207244	40544	577309	1263	204475	1678	239934	841	239759	572511	375288	216851	838	816
bsdb:275/1/2_acute-lymphoblastic-leukemia:ALL-patient_vs_healthy-sibling-control_DOWN	NA	1301	39948	1485	397864	459786	1578	207244	40544	577309	1263	204475	1678	239934	841	239759	572511	375288	216851	838	816
bsdb:276/2/1_multiple-myeloma:Multiple-Myeloma-patient_vs_healthy-control_UP	NA	816	191303	413496
bsdb:276/2/2_multiple-myeloma:Multiple-Myeloma-patient_vs_healthy-control_DOWN	NA	1508657	1730	207244	84108	135858	904
bsdb:276/3/1_multiple-myeloma:Multiple-Myeloma-patient_vs_healthy-control_DOWN	NA	816	216851	841	29465	1481960	904	1472649
bsdb:277/1/1_crohn-disease:crohn's-disease_vs_healthy-control_DOWN	NA	216851	1263	841	239759	1730	46239	206664	836	28138	375288	830
bsdb:278/1/1_non-alcoholic-fatty-liver-disease:non-alcoholic-fatty-liver-disease_vs_healthy-control_UP	NA	1578
bsdb:278/1/2_non-alcoholic-fatty-liver-disease:non-alcoholic-fatty-liver-disease_vs_healthy-control_DOWN	NA	239759	207244	816	572511	189330	216851
bsdb:280/1/1_cervical-glandular-intraepithelial-neoplasia:high-grade-squamus-intraepithelial-lesion_vs_low-grade-squamus-intraepithelial-lesion_UP	NA	165779	168808
bsdb:281/1/1_acute-lymphoblastic-leukemia:Fecal-bacterial-composition-in-small-intestines-of-leukemia-mice_vs_Fecal-bacterial-composition-in-small-intestines-of-control-mice_UP	NA	119852	2086	830	189330	1263	1485	33042	207244	239934	572511
bsdb:281/1/2_acute-lymphoblastic-leukemia:Fecal-bacterial-composition-in-small-intestines-of-leukemia-mice_vs_Fecal-bacterial-composition-in-small-intestines-of-control-mice_DOWN	NA	1578	447020	191303	207244	239934	572511
bsdb:282/1/2_graft-versus-host-disease:Grades-II-IV-(acute-graft-host-disease)_vs_Grades-0-I-(non-acute-graft-host-disease)_DOWN	NA	1506553	572511
bsdb:283/1/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	84111	1378
bsdb:284/1/1_chronic-kidney-disease:Chronic-kidney-disease_vs_healthy-controls_UP	NA	1301	1716	1654	32207	59735
bsdb:284/1/2_chronic-kidney-disease:Chronic-kidney-disease_vs_healthy-controls_DOWN	NA	848	836
bsdb:285/1/1_multiple-sclerosis:pediatric-multiple-sclerosis_vs_healthy-controls_UP	NA	35832	1678	872	135858	33024
bsdb:285/1/2_multiple-sclerosis:pediatric-multiple-sclerosis_vs_healthy-controls_DOWN	NA	28050	577309	816	119852
bsdb:285/3/1_multiple-sclerosis:IMD-naive-cases-multiple-sclerosis_vs_healthy-controls_UP	NA	904	1380	1678	35832	135858	33042	872	189330	1730	158846	906	2172	119852	33024	113286	1263	40544
bsdb:285/3/2_multiple-sclerosis:IMD-naive-cases-multiple-sclerosis_vs_healthy-controls_DOWN	NA	577309	816	1263	574697	33042	207244	40544	135858	39948	189330
bsdb:286/1/2_graves-ophthalmopathy:graves-orbitopathy_vs_Healthy-controls_DOWN	NA	207244	572511	574697	102106	1407607	1263
bsdb:288/1/1_phenylketonuria:phenylketonuric-with-Phe-restricted-diet_vs_mild-hyperphenylalaninemic-with-unrestricted-diet_DOWN	NA	841	1578
bsdb:289/1/1_health-trait:suboptimal-health-status_vs_healthy-controls_UP	NA	59732	119852	1263	841
bsdb:289/1/2_health-trait:suboptimal-health-status_vs_healthy-controls_DOWN	NA	581	48736	40544
bsdb:290/1/1_oral-mucositis:ulcerative-oral-mucositis_vs_no-ulcerative-oral-mucositis_UP	NA	29465	1350	1301	1279	848	838
bsdb:290/1/2_oral-mucositis:ulcerative-oral-mucositis_vs_no-ulcerative-oral-mucositis_DOWN	NA	1301	1654
bsdb:290/2/1_oral-mucositis:pre--and-three-month-after-auto-stem-cell-transplant_vs_one-and-two-weeks-after-stem-cell-transplant_UP	NA	838	32067
bsdb:290/2/2_oral-mucositis:pre--and-three-month-after-auto-stem-cell-transplant_vs_one-and-two-weeks-after-stem-cell-transplant_DOWN	NA	1578
bsdb:290/3/1_oral-mucositis:pre--and-three-month-after-auto-stem-cell-transplant_vs_one-and-two-weeks-after-stem-cell-transplant_UP	NA	1654
bsdb:290/4/1_oral-mucositis:0.1%-or-higher-fungi-load_vs_low-or-no-fungi-load_UP	NA	196081	1279	1578
bsdb:290/4/2_oral-mucositis:0.1%-or-higher-fungi-load_vs_low-or-no-fungi-load_DOWN	NA	29465	1654	838	32067	906	1301
bsdb:291/1/1_graves-disease:graves-disease_vs_healthy-controls_UP	NA	838	724
bsdb:291/1/2_graves-disease:graves-disease_vs_healthy-controls_DOWN	NA	239759	216851
bsdb:292/1/1_graft-versus-host-disease:allogeneic-hematopoietic-stem-cell-transplant_vs_community-dwelling_UP	NA	1485	469	1016	286	32067
bsdb:292/1/2_graft-versus-host-disease:allogeneic-hematopoietic-stem-cell-transplant_vs_community-dwelling_DOWN	NA	1301	838	482	1654	32207	29465	117563	724	848	1378	1283313	32067	1380	123375	265975	194	1164882
bsdb:293/1/1_human-papilloma-virus-infection:Baseline-HPV+_vs_Baseline-HPV-_UP	NA	2129
bsdb:293/1/2_human-papilloma-virus-infection:Baseline-HPV+_vs_Baseline-HPV-_DOWN	NA	216851	1582879	2755	873565	848
bsdb:293/2/1_human-papilloma-virus-infection:new-acquisition-of-HPV-within-a-year_vs_no-new-acquisition-of-HPV-within-a-year_DOWN	NA	1654
bsdb:295/1/1_human-papilloma-virus-infection:low-risk-HPV_vs_negative-control_UP	NA	1654	239759	1678	35832	572511	574697	1485	1348911	33042	80865	39948	212791	1407607	204475	70774	906	745	1257	33024	841	1263	1200657	168808	40544
bsdb:295/1/2_human-papilloma-virus-infection:low-risk-HPV_vs_negative-control_DOWN	NA	286	237	68	83770	497726	209
bsdb:297/1/1_human-papilloma-virus-infection:non-pregnant-high-risk-HPV_vs_non-pregnant-no-HPV_UP	NA	1678	1386
bsdb:297/1/2_human-papilloma-virus-infection:non-pregnant-high-risk-HPV_vs_non-pregnant-no-HPV_DOWN	NA	1578
bsdb:297/2/1_human-papilloma-virus-infection:pregnant-high-risk-HPV_vs_pregnant-no-HPV_UP	NA	12916
bsdb:297/2/2_human-papilloma-virus-infection:pregnant-high-risk-HPV_vs_pregnant-no-HPV_DOWN	NA	1301
bsdb:298/1/1_acute-myeloid-leukemia:stool_vs_oral_UP	NA	239934	1578	1357	375288	838	46205	286	1301	1279	292632
bsdb:298/1/2_acute-myeloid-leukemia:stool_vs_oral_DOWN	NA	838	1279	1301
bsdb:298/2/1_acute-myeloid-leukemia:infection_vs_no-infection_UP	NA	40323	1301
bsdb:298/3/1_acute-myeloid-leukemia:infection_vs_no-infection_UP	NA	1301
bsdb:300/1/2_graft-versus-host-disease:acute-graft--versus--host-disease_vs_non--graft--versus--host-disease_DOWN	NA	1470353
bsdb:301/1/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	39948	906	168808
bsdb:301/2/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	168808
bsdb:301/3/1_human-papilloma-virus-infection:HR-HPV+_vs_HPV-_UP	NA	168808
bsdb:302/3/1_asthma:exacerbated-asthma_vs_non-exacerbated-asthma_UP	NA	838	222991	2701
bsdb:302/3/2_asthma:exacerbated-asthma_vs_non-exacerbated-asthma_DOWN	NA	39948
bsdb:303/1/1_non-hodgkins-lymphoma:post-chemotherapy_vs_pre-chemotherapy_UP	NA	544	375288	1350
bsdb:303/1/2_non-hodgkins-lymphoma:post-chemotherapy_vs_pre-chemotherapy_DOWN	NA	189330	1263	33042	1380	841	1485	570	572511	119852	28050	906	1678	447020	165779	102106
bsdb:304/1/1_antimicrobial-agent:oral-intake-of-vancomycin-(directed-against-Gram-positive-bacteria)_vs_or-placebo-(microcrystalline-cellulose)_UP	NA	102106	1678	1380
bsdb:305/1/1_female-reproductive-organ-cancer:cancer_vs_healthy_UP	NA	838	836	162289	848	165779	39948	168808	2093	1582879	437755	543311	1257	2050
bsdb:305/1/2_female-reproductive-organ-cancer:cancer_vs_healthy_DOWN	NA	177971	1678	1578
bsdb:306/1/1_graft-versus-host-disease:post--allogeneic-hematopoietic-stem-cell-transplant_vs_pre--allogeneic-hematopoietic-stem-cell-transplant_UP	NA	160674	416916	838	1578
bsdb:306/1/2_graft-versus-host-disease:post--allogeneic-hematopoietic-stem-cell-transplant_vs_pre--allogeneic-hematopoietic-stem-cell-transplant_DOWN	NA	413496	160674	416916	838	1578
bsdb:307/1/1_antimicrobial-agent:moxifloxacin-treated-group-(MXF)_vs_Negative-control-group-(CLT)_UP	NA	572511
bsdb:307/1/2_antimicrobial-agent:moxifloxacin-treated-group-(MXF)_vs_Negative-control-group-(CLT)_DOWN	NA	239759	572511	574697	135858	1485	100883	1730	216851	459786
bsdb:307/2/1_antimicrobial-agent:DAV132+moxifloxacin-treated-group-(MXF+DAV132)_vs_moxifloxacin-treated-group-(MXF)_UP	NA	239759	216851	572511	459786	100883	1730	574697	135858
bsdb:307/2/2_antimicrobial-agent:DAV132+moxifloxacin-treated-group-(MXF+DAV132)_vs_moxifloxacin-treated-group-(MXF)_DOWN	NA	572511
bsdb:307/3/2_antimicrobial-agent:DAV132+moxifloxacin-treated-group-(MXF+DAV132)_vs_Negative-control-group-(CLT)_DOWN	NA	135858
bsdb:308/1/2_air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	1279	1578
bsdb:308/2/2_air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	816	1279	1578	191303
bsdb:308/3/2_air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	816	1279	191303	1263	119852
bsdb:308/4/2_air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	1578
bsdb:308/5/1_air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_UP	NA	375288
bsdb:308/5/2_air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	191303	2086	1485
bsdb:308/6/1_air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_UP	NA	1279	1578
bsdb:309/1/1_cervical-glandular-intraepithelial-neoplasia:CIN2+_vs_CIN1_UP	NA	1578	816	375288	59195	574697
bsdb:309/2/1_cervical-glandular-intraepithelial-neoplasia:>38.8%-8-OHdG-positive-cervical-cells_vs_<=38.8%-8-OHdG-positive-cervical-cells_UP	NA	286	357	665874	20
bsdb:310/1/1_non-hodgkins-lymphoma:post-chemotherapy_vs_pre-chemotherapy_UP	NA	816	561
bsdb:310/1/2_non-hodgkins-lymphoma:post-chemotherapy_vs_pre-chemotherapy_DOWN	NA	46123	165779	264995	28263	1716	150022	906	2316	2050	44249	196082	1257	638847	32207	1279	184869	572511	216851	841	1678
bsdb:311/1/1_graft-versus-host-disease:post--engraftment_vs_pre--engraftment_DOWN	NA	572511	189330	841	216851	119852
bsdb:311/2/1_graft-versus-host-disease:post--engraftment_vs_pre--engraftment_DOWN	NA	1678	33042	189330	28050	841	1263	119852
bsdb:312/2/1_antimicrobial-agent:Infants-born-by-mothers-positive-to-GBS-and-received-IAP_vs_infants-born-by-mothers-negative-to-GBS_DOWN	NA	1678
bsdb:313/1/1_non-hodgkins-lymphoma:bloodstream-infection_vs_non-bloodstream-infection_UP	NA	29465
bsdb:313/1/2_non-hodgkins-lymphoma:bloodstream-infection_vs_non-bloodstream-infection_DOWN	NA	216851	51514	40544	846	990721	119852	574697
bsdb:314/1/1_cervical-glandular-intraepithelial-neoplasia:CIN-non-regression_vs_CIN-regression_UP	NA	1380	168808	906	543311	838
bsdb:314/1/2_cervical-glandular-intraepithelial-neoplasia:CIN-non-regression_vs_CIN-regression_DOWN	NA	1578
bsdb:317/1/1_antimicrobial-agent:infants-delivered-to-mothers-with_vs_without-prenatal-antibiotics-usages_UP	NA	1485
bsdb:317/2/1_antimicrobial-agent:infants-delivered-to-mothers-with_vs_without-peripartum-antibiotics-usages_UP	NA	357	1301
bsdb:317/2/2_antimicrobial-agent:infants-delivered-to-mothers-with_vs_without-peripartum-antibiotics-usages_DOWN	NA	1350
bsdb:318/2/1_graft-versus-host-disease:acute-graft-versus-host-disease_vs_non-acute-graft-versus-host-disease_UP	NA	216851	1730
bsdb:319/1/1_air-pollution:mice-exposed-to-filtered-air-(FA)_vs_mice-exposed-to-PM-2.5-(CAP)_UP	NA	248744	2093
bsdb:319/1/2_air-pollution:mice-exposed-to-filtered-air-(FA)_vs_mice-exposed-to-PM-2.5-(CAP)_DOWN	NA	1501226	209
bsdb:320/1/1_antimicrobial-agent:infants(6-weeks)-to-mothers-exposed-to-intrapartum-antibiotic_vs_infants-(6-weeks)-to-mothers-unexposed-to--intrapartum-antibiotic_UP	NA	119852	113286	184869
bsdb:320/1/2_antimicrobial-agent:infants(6-weeks)-to-mothers-exposed-to-intrapartum-antibiotic_vs_infants-(6-weeks)-to-mothers-unexposed-to--intrapartum-antibiotic_DOWN	NA	816	1678	572511	841	1263
bsdb:320/2/1_antimicrobial-agent:infants(1-year)-to-mothers-exposed-to-intrapartum-antibiotic_vs_infants-(1-year)-to-mothers-unexposed-to--intrapartum-antibiotic_UP	NA	119852	113286	184869
bsdb:320/2/2_antimicrobial-agent:infants(1-year)-to-mothers-exposed-to-intrapartum-antibiotic_vs_infants-(1-year)-to-mothers-unexposed-to--intrapartum-antibiotic_DOWN	NA	816	1678	572511	841
bsdb:320/3/1_antimicrobial-agent:infants(6-weeks)-to-mothers-exposed-to--antibiotics-(amoxicillin,-penicillin-or-ampicillin)_vs_infants-(6-weeks)-to-mothers-unexposed-to--antibiotic_DOWN	NA	816	1678
bsdb:320/4/1_antimicrobial-agent:infants(1-year)-to-mothers-exposed-to--antibiotics-(amoxicillin,-penicillin-or-ampicillin)_vs_infants-(1-year)-to-mothers-unexposed-to--antibiotic_UP	NA	33042
bsdb:320/4/2_antimicrobial-agent:infants(1-year)-to-mothers-exposed-to--antibiotics-(amoxicillin,-penicillin-or-ampicillin)_vs_infants-(1-year)-to-mothers-unexposed-to--antibiotic_DOWN	NA	816	1485	158846	1301
bsdb:321/1/1_antimicrobial-agent:10-d-old-7-10-day-treatment-infants_vs_10-d-old-2-day-treatment-infants_DOWN	NA	1357	816
bsdb:322/1/1_oral-mucositis:newly-diagnosis-maligancies_vs_reference_UP	NA	46123	1357	203697
bsdb:322/1/2_oral-mucositis:newly-diagnosis-maligancies_vs_reference_DOWN	NA	1716	346096	1378	848	22	2745	713
bsdb:322/2/1_oral-mucositis:oral-mucositis_vs_no-oral-mucositis_UP	NA	1016	1357	146
bsdb:322/3/1_oral-mucositis:during-chemotherapy_vs_at-malignancy-diagnosis_UP	NA	1279
bsdb:322/3/2_oral-mucositis:during-chemotherapy_vs_at-malignancy-diagnosis_DOWN	NA	203697
bsdb:322/4/1_oral-mucositis:during-chemotherapy_vs_at-malignancy-diagnosis_UP	NA	338
bsdb:322/5/1_oral-mucositis:mucositis-lesions_vs_all-samples_UP	NA	1654	196081	1386	1279	46123	1357
bsdb:322/5/2_oral-mucositis:mucositis-lesions_vs_all-samples_DOWN	NA	713	416916	724	40323	2093
bsdb:323/1/1_necrotizing-enterocolitis:NEC_vs_non-NEC_UP	NA	1485	1279
bsdb:323/2/1_necrotizing-enterocolitis:NEC_vs_non-NEC_DOWN	NA	28196	150022	29330	1654	286	59732	283	1301	1716
bsdb:323/3/1_necrotizing-enterocolitis:NEC_vs_non-NEC_UP	NA	1279
bsdb:324/1/1_thyroid-carcinoma:thyroid-carcinoma_vs_healthy-control_UP	NA	1505657	570	207244	561	620	33042	191303	292632	1301	1578
bsdb:324/1/2_thyroid-carcinoma:thyroid-carcinoma_vs_healthy-control_DOWN	NA	816	838	841	158846	1506553	1283313	33024
bsdb:325/1/1_psoriasis:psoriasis_vs_healthy-controls_UP	NA	572511	1263	216851	1678	33042	86331	189330	990721	1654	102106
bsdb:325/1/2_psoriasis:psoriasis_vs_healthy-controls_DOWN	NA	574697	35832	283168	375288	838	40544	28050	577309
bsdb:326/1/1_NA:Responders_vs_Non-Responders_UP	NA	1392389	838
bsdb:326/1/2_NA:Responders_vs_Non-Responders_DOWN	NA	838	572511
bsdb:326/2/1_NA:Progressive--Free--Survival-more-than-30-days_vs_Progressive--Free--Survival-more-less-than-30-days_UP	NA	239759	1392389	572511	1263
bsdb:327/1/1_antimicrobial-agent:infants-received-short-term(<3days)-antibiotic-treatment_vs_control(no-treatment)_UP	NA	1578
bsdb:327/1/2_antimicrobial-agent:infants-received-short-term(<3days)-antibiotic-treatment_vs_control(no-treatment)_DOWN	NA	561	1301
bsdb:327/2/1_antimicrobial-agent:infants-received-long-term(>5days)-antibiotic-treatment_vs_control(no-treatment)_UP	NA	1578	1350
bsdb:327/2/2_antimicrobial-agent:infants-received-long-term(>5days)-antibiotic-treatment_vs_control(no-treatment)_DOWN	NA	561	1301
bsdb:328/1/1_psoriatic-arthritis:psoriatic-arthiritis_vs_healthy-controls_DOWN	NA	239934	46205	1263	33042
bsdb:328/2/1_psoriatic-arthritis:skin-psoriasis_vs_healthy-controls_DOWN	NA	375288	100883	33042
bsdb:328/3/1_psoriatic-arthritis:psoriatic-arthiritis_vs_skin-psoriasis_UP	NA	100883
bsdb:329/1/1_antimicrobial-agent:Postnatal-antibiotic-group-(2-day-old-infant)_vs_control-group_UP	NA	1578
bsdb:329/1/2_antimicrobial-agent:Postnatal-antibiotic-group-(2-day-old-infant)_vs_control-group_DOWN	NA	816
bsdb:329/2/1_antimicrobial-agent:IAP-group-(4-day-old-infant)_vs_control-group_DOWN	NA	816
bsdb:329/3/1_antimicrobial-agent:IAP-group-(6-month-old-infant)_vs_control-group_UP	NA	1485
bsdb:329/4/1_antimicrobial-agent:IAP+postnatal-antibiotic-group-(2-day-old-infant)_vs_control-group_UP	NA	1578
bsdb:329/4/2_antimicrobial-agent:IAP+postnatal-antibiotic-group-(2-day-old-infant)_vs_control-group_DOWN	NA	816
bsdb:329/5/1_antimicrobial-agent:IAP+postnatal-antibiotic-group-(4-day-old-infant)_vs_control-group_DOWN	NA	816
bsdb:329/6/1_antimicrobial-agent:IAP+postnatal-antibiotic-group-(6-month-old-infant)_vs_control-group_UP	NA	1485
bsdb:330/1/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	1578	2129
bsdb:330/2/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	1578	2129
bsdb:330/2/2_human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	724	1257
bsdb:330/3/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	150022
bsdb:330/3/2_human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	724
bsdb:331/1/1_hashimoto's-thyroiditis:hashimoto's-thyroiditis-patients_vs_healthy-controls_UP	NA	572511	841	1301	1407607	207244	1501226	33042	189330	292632	724	580596
bsdb:331/1/2_hashimoto's-thyroiditis:hashimoto's-thyroiditis-patients_vs_healthy-controls_DOWN	NA	816	216851	838	1283313	33024	1506553	375288	577309	1154586
bsdb:333/1/1_antimicrobial-agent:infants-with-(Abx)_vs_without-(non-Abx)-use-of-maternal-antimicrobial-agents-at-delivery_DOWN	NA	1678
bsdb:334/1/1_antimicrobial-agent:infants(14-d-old)-exposed-to-prenatal-antibiotic-therapy-(PAT-group)_vs_prenatal-antibiotic-free-group-(PAF-group)_UP	NA	1618113
bsdb:334/1/2_antimicrobial-agent:infants(14-d-old)-exposed-to-prenatal-antibiotic-therapy-(PAT-group)_vs_prenatal-antibiotic-free-group-(PAF-group)_DOWN	NA	1678
bsdb:334/2/2_antimicrobial-agent:infants-exposed-to-antibiotic->7day-(H-group)_vs_infants-exposed-to-antibiotic-<=7day-(L-group)_DOWN	NA	1678
bsdb:336/1/1_antimicrobial-agent:combination-of-penicillin-and-moxalactam-group-(PM-group_3d-sample)_vs_Antibiotic-free-group-(AF-group_3d-sample)_UP	NA	13687	816	1578
bsdb:336/1/2_antimicrobial-agent:combination-of-penicillin-and-moxalactam-group-(PM-group_3d-sample)_vs_Antibiotic-free-group-(AF-group_3d-sample)_DOWN	NA	1485
bsdb:336/3/1_antimicrobial-agent:combination-of-penicillin-and-moxalactam-group-(PM-group_7d-sample)_vs_Antibiotic-free-group-(AF-group_7d-sample)_UP	NA	816
bsdb:336/4/1_antimicrobial-agent:piperacillin-tazobactam-group-(PT-group_7d-sample)_vs_Antibiotic-free-group-(AF-group_7d-sample)_UP	NA	816	1350
bsdb:336/4/2_antimicrobial-agent:piperacillin-tazobactam-group-(PT-group_7d-sample)_vs_Antibiotic-free-group-(AF-group_7d-sample)_DOWN	NA	570
bsdb:337/1/1_antimicrobial-agent:3-month-old-infants-either-exposed_vs_not-exposed-to-antibiotics-during-the-second-trimester_UP	NA	1407607
bsdb:337/2/1_antimicrobial-agent:3-month-old-infants-exposed_vs_not-exposed-to-antibiotics-during-the-second-trimester_DOWN	NA	1301	816	29465	1279
bsdb:337/3/1_antimicrobial-agent:12-month-old-infants-either-exposed_vs_not-exposed-to-antibiotics-during-the-second-trimester_UP	NA	29465	1485
bsdb:337/3/2_antimicrobial-agent:12-month-old-infants-either-exposed_vs_not-exposed-to-antibiotics-during-the-second-trimester_DOWN	NA	239934	816	239759	29465	572511	204475	1485	1506553
bsdb:338/1/1_obesity:obese_vs_normal-weight_UP	NA	216851	33024	28050	158846	724
bsdb:338/1/2_obesity:obese_vs_normal-weight_DOWN	NA	119852	39948
bsdb:338/2/1_obesity:obese_vs_normal-weight_UP	NA	713	416916	194	848	117563	724	28050	158846	33024	32207	1301	40544	191303	29465
bsdb:338/2/2_obesity:obese_vs_normal-weight_DOWN	NA	447020	239759	244127	1678	35832	990721	1485	102106	1185408	872	1730	1769729	61170	119852	846	838	1263	44748
bsdb:340/1/1_obesity:obese/overweight_vs_non-overweight/non-obese-children_UP	NA	189330
bsdb:340/1/2_obesity:obese/overweight_vs_non-overweight/non-obese-children_DOWN	NA	1263	239934	375288
bsdb:340/2/1_obesity:obese/overweight_vs_non-overweight/non-obese-children_UP	NA	189330
bsdb:340/3/1_obesity:obese/overweight_vs_non-overweight/non-obese-children_UP	NA	189330	841	1301
bsdb:340/3/2_obesity:obese/overweight_vs_non-overweight/non-obese-children_DOWN	NA	375288
bsdb:341/1/1_nicotine-dependence:patients-with-FD,-ID,or-CD-who-currently-smoked_vs_never-smoked_UP	NA	32207	1301	29465
bsdb:341/2/1_nicotine-dependence:patients-with-FD,-ID,or-CD-who-currently-smokes_vs_never-smoked_DOWN	NA	482	838
bsdb:342/1/1_asthma:Children-who-experienced-exacerbtion_vs_children-who-did-not-experience-more-than-one-exacerbation_DOWN	NA	724
bsdb:342/2/1_asthma:Children-with-any-rhinovirus-infection_vs_children-with-no-rhinovirus-infection_UP	NA	1301
bsdb:342/2/2_asthma:Children-with-any-rhinovirus-infection_vs_children-with-no-rhinovirus-infection_DOWN	NA	1279
bsdb:342/3/1_asthma:Children-with-rhinovirus-A-(RV-A)_vs_children-RV-_UP	NA	724	1301
bsdb:342/3/2_asthma:Children-with-rhinovirus-A-(RV-A)_vs_children-RV-_DOWN	NA	1279
bsdb:342/4/1_asthma:Younger-children_vs_older-children_DOWN	NA	475
bsdb:342/5/1_asthma:Children-who-experienced-exacerbation_vs_children-who-did-not-experience-more-than-one-exacerbation_UP	NA	475
bsdb:342/5/2_asthma:Children-who-experienced-exacerbation_vs_children-who-did-not-experience-more-than-one-exacerbation_DOWN	NA	1651	1716	724	1279
bsdb:342/6/1_asthma:Viral-illnesses_vs_no-viral-illnesses_UP	NA	475
bsdb:342/6/2_asthma:Viral-illnesses_vs_no-viral-illnesses_DOWN	NA	1279
bsdb:342/7/1_asthma:Children-with-any-rhinovirus-infection_vs_children-with-no-rhinovirus-infection_UP	NA	1301
bsdb:342/7/2_asthma:Children-with-any-rhinovirus-infection_vs_children-with-no-rhinovirus-infection_DOWN	NA	1279
bsdb:342/8/1_asthma:Children-with-rhinovirus-A-infection_vs_children-rhinovirus-negative_UP	NA	724	1301
bsdb:342/8/2_asthma:Children-with-rhinovirus-A-infection_vs_children-rhinovirus-negative_DOWN	NA	1279
bsdb:342/9/1_asthma:Children-with-rhinovirus-C-infection_vs_children-rhinovirus-neagtive_UP	NA	1301
bsdb:342/9/2_asthma:Children-with-rhinovirus-C-infection_vs_children-rhinovirus-neagtive_DOWN	NA	1279
bsdb:342/10/1_asthma:Respiratory-illness_vs_no-respiratory-illness_UP	NA	1301
bsdb:342/10/2_asthma:Respiratory-illness_vs_no-respiratory-illness_DOWN	NA	1716	1279
bsdb:343/1/1_leukemia:Antileukemic_vs_Allogeneic-Hematopoeitic-Stem-Cell-Transplant_UP	NA	1350	1578	375288
bsdb:343/1/2_leukemia:Antileukemic_vs_Allogeneic-Hematopoeitic-Stem-Cell-Transplant_DOWN	NA	1350	816
bsdb:344/1/1_air-pollution:mice-exposed-to-Pm-2.5-suspension_vs_mice-exposed-suspension-from-extracts-of-“blank”-filter_UP	NA	946234	459786	848
bsdb:344/1/2_air-pollution:mice-exposed-to-Pm-2.5-suspension_vs_mice-exposed-suspension-from-extracts-of-“blank”-filter_DOWN	NA	286	13687	173479	80865	1301	1386	55968	248038	283168
bsdb:345/1/1_obesity:obese_vs_normal_UP	NA	158846
bsdb:345/1/2_obesity:obese_vs_normal_DOWN	NA	207244	459786	61170	816
bsdb:346/1/1_unipolar-depression:severe-depression_vs_mild-depression_UP	NA	1263
bsdb:346/2/1_unipolar-depression:moderate-depression_vs_mild-depression_UP	NA	946234
bsdb:346/3/2_anxiety-disorder:severe-anxiety_vs_mild-anxiety_DOWN	NA	1847725
bsdb:350/1/1_obesity:obese_vs_normal-weight_UP	NA	836	216851
bsdb:350/1/2_obesity:obese_vs_normal-weight_DOWN	NA	33024
bsdb:350/2/1_obesity:obesity-with-metabolic-syndrome_vs_normal-weight_UP	NA	102106	33042	135858
bsdb:351/1/1_obesity:overweight/obesity_vs_normal_UP	NA	1578
bsdb:351/1/2_obesity:overweight/obesity_vs_normal_DOWN	NA	1678
bsdb:352/1/1_NA:Low-Grade-Squamous-Intraepithelial-Lesion_vs_Atypical-Squamous-Cells-of-Undetermined-Significance_DOWN	NA	4930
bsdb:352/2/1_NA:High-risk-HPV_vs_Low-risk-HPV_UP	NA	55193
bsdb:352/4/1_NA:High-risk-HPV_vs_Low-risk-HPV_UP	NA	55193
bsdb:354/1/2_obesity:overweight/obese_vs_control-(BMI-at-normal-range)_DOWN	NA	872
bsdb:356/1/1_air-pollution:ICR-male-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-3_UP	NA	841	239759
bsdb:356/1/2_air-pollution:ICR-male-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-3_DOWN	NA	66831	482
bsdb:356/2/1_air-pollution:ICR-male-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-10_UP	NA	583
bsdb:356/3/1_air-pollution:ICR-male-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-21_UP	NA	1378	459786	841
bsdb:356/3/2_air-pollution:ICR-male-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-21_DOWN	NA	816	872	244127
bsdb:356/4/1_air-pollution:ICR-male-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-35_UP	NA	1301
bsdb:356/5/2_air-pollution:ICR-female-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-10_DOWN	NA	580024
bsdb:356/6/2_air-pollution:ICR-female-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-21_DOWN	NA	1578
bsdb:357/1/1_air-pollution:post-smog-swabs_vs_pre-smog-swabs_UP	NA	838
bsdb:357/1/2_air-pollution:post-smog-swabs_vs_pre-smog-swabs_DOWN	NA	32067
bsdb:358/1/1_NA:CIN2/3-CC_vs_Healthy-controls_UP	NA	1301	212791	46255	1279	1912216	1269
bsdb:359/1/3_smoking-behavior:current-smoker_vs_former-smoker_UP	NA	1380	1678	1578	1301
bsdb:359/1/4_smoking-behavior:current-smoker_vs_former-smoker_DOWN	NA	482	724	416916	1016	1716	836	838	32067	1257	46123	970
bsdb:360/1/1_air-pollution:mice-exposed-to-MVE_vs_mice-exposed-to-Filtered-Air_UP	NA	191303	1485
bsdb:360/1/2_air-pollution:mice-exposed-to-MVE_vs_mice-exposed-to-Filtered-Air_DOWN	NA	119852	1578
bsdb:360/2/2_air-pollution:mice-exposed-to-WS_vs_mice-exposed-to-Filtered-Air_DOWN	NA	119852	1485	1578
bsdb:361/1/1_air-pollution:male-mice-exposed-to-cigarette-smoke_vs_control_UP	NA	239934
bsdb:361/1/2_air-pollution:male-mice-exposed-to-cigarette-smoke_vs_control_DOWN	NA	239759
bsdb:361/2/1_air-pollution:female-mice-exposed-to-cigarette-smoke_vs_control_UP	NA	816
bsdb:361/2/2_air-pollution:female-mice-exposed-to-cigarette-smoke_vs_control_DOWN	NA	2697	1918540	283168
bsdb:361/3/1_air-pollution:ovariectomized-female-mice-exposed-to-cigarette-smoke_vs_control_UP	NA	28138	830
bsdb:361/4/1_air-pollution:mice-exposed-to-smoke_vs_control_UP	NA	816	459786
bsdb:361/4/2_air-pollution:mice-exposed-to-smoke_vs_control_DOWN	NA	239759
bsdb:363/1/1_smoking-behavior:current-smokers_vs_never-smokers_UP	NA	32207	1301	1380	906	1716	346096	109326	195950	44259	2093
bsdb:363/1/2_smoking-behavior:current-smokers_vs_never-smokers_DOWN	NA	2740	1016	482	2717	47670	1257	43996	848	1283313	836	1164882	32067	265975	1730	194	123375	724	1213720	1378
bsdb:364/1/1_smoking-behavior:smoker_vs_non-smoker_UP	NA	1654	29465
bsdb:365/1/1_diet:mice-exposed-to-American-Diet_vs_mice-fed-control-rodent-diet._UP	NA	119852	33042	1263
bsdb:365/1/2_diet:mice-exposed-to-American-Diet_vs_mice-fed-control-rodent-diet._DOWN	NA	1263	838	816
bsdb:366/1/1_non-alcoholic-fatty-liver-disease:nonalcoholic-fatty-liver-disease_vs_healthy-controls_UP	NA	1578	588605	841	189330
bsdb:366/1/2_non-alcoholic-fatty-liver-disease:nonalcoholic-fatty-liver-disease_vs_healthy-controls_DOWN	NA	459786
bsdb:367/1/2_obesity:obese_vs_normal-weight_DOWN	NA	119852
bsdb:367/2/2_obesity:overweight_vs_normal-weight_DOWN	NA	119852
bsdb:368/1/1_smoking-behavior:shammah-users_vs_non-shammah-users_UP	NA	1301	32207	1578	419014
bsdb:368/1/2_smoking-behavior:shammah-users_vs_non-shammah-users_DOWN	NA	538	1257	265975	47
bsdb:369/1/1_obesity:obese_vs_normal-weight_UP	NA	816	28050	841
bsdb:369/1/2_obesity:obese_vs_normal-weight_DOWN	NA	84108	838	119852
bsdb:369/2/1_obesity:after-onset-of-obesity_vs_before-onset-of-obesity_UP	NA	135858	40544
bsdb:369/2/2_obesity:after-onset-of-obesity_vs_before-onset-of-obesity_DOWN	NA	1263
bsdb:370/1/1_air-pollution:farmworker-exposure_vs_non-farmworker-exposure_DOWN	NA	1378	117563	724	2745	1301
bsdb:372/1/1_air-pollution:Diesel-exhaust-particle-(DEP)-exposed-mice_vs_mice-exposed-to-FRA_UP	NA	1578
bsdb:372/1/2_air-pollution:Diesel-exhaust-particle-(DEP)-exposed-mice_vs_mice-exposed-to-FRA_DOWN	NA	816
bsdb:374/1/1_cervical-glandular-intraepithelial-neoplasia:cervical-intraepithelial-neoplasia-cases_vs_normal-control_UP	NA	114627	1643951	953
bsdb:374/1/2_cervical-glandular-intraepithelial-neoplasia:cervical-intraepithelial-neoplasia-cases_vs_normal-control_DOWN	NA	53246	497
bsdb:374/2/1_cervical-cancer:cervical-cancer-cancer_vs_normal-control_UP	NA	114627	1643951	953
bsdb:374/2/2_cervical-cancer:cervical-cancer-cancer_vs_normal-control_DOWN	NA	1578	1279	1263978
bsdb:375/1/2_obesity:obese_vs_normal-weight_DOWN	NA	838
bsdb:376/1/1_antimicrobial-agent:patients-that-took-amoxiclav_vs_before-antibiotic-exposure_UP	NA	816
bsdb:376/2/1_antimicrobial-agent:patients-that-took-levofloxacin/Metronidazole_vs_before-antibiotic-exposure_UP	NA	816
bsdb:376/3/1_antimicrobial-agent:patients-that-took-Piperacilin/Tazobactam_vs_before-antibiotic-exposure_UP	NA	816
bsdb:376/4/1_antimicrobial-agent:patients-that-took-Ceftriaxone/Azithromycin_vs_before-antibiotic-exposure_UP	NA	816
bsdb:376/5/1_antimicrobial-agent:patients-that-took-Ciprofloxacin_vs_before-antibiotic-exposure_UP	NA	816
bsdb:377/1/1_smoking-behavior:never-smoker_vs_E-cigarette-smoker_UP	NA	836
bsdb:378/1/1_graft-versus-host-disease:Severe-acute-graft-versus-host-disease_vs_non-acute-graft-versus-host-disease_UP	NA	47670	40323	1357
bsdb:378/1/2_graft-versus-host-disease:Severe-acute-graft-versus-host-disease_vs_non-acute-graft-versus-host-disease_DOWN	NA	1506553	572511	1769710	1378	946234	459786	1505663	207244	1392389	1508657
bsdb:378/2/1_graft-versus-host-disease:Severe-acute-graft-versus-host-disease_vs_non-acute-graft-versus-host-disease_UP	NA	40323
bsdb:378/2/2_graft-versus-host-disease:Severe-acute-graft-versus-host-disease_vs_non-acute-graft-versus-host-disease_DOWN	NA	572511	1506553	1769710	946234	1505663
bsdb:379/1/1_obesity:non-obese_vs_obese_UP	NA	1678	1578
bsdb:379/2/1_obesity:obese_vs_non-obese_UP	NA	1378	117563
bsdb:379/2/2_obesity:obese_vs_non-obese_UP	NA	419014	156454
bsdb:381/1/1_response-to-allogeneic-hematopoietic-stem-cell-transplant:hematopoietic-stem-cell-transplant-recipients_vs_healthy-volunteers_UP	NA	1350
bsdb:381/1/2_response-to-allogeneic-hematopoietic-stem-cell-transplant:hematopoietic-stem-cell-transplant-recipients_vs_healthy-volunteers_DOWN	NA	46205	292632
bsdb:381/2/1_response-to-allogeneic-hematopoietic-stem-cell-transplant:high-fecal-butyrate-levels_vs_low-fecal-butyrate-levels_UP	NA	84111	1508657	1506553	572511	46205	1505663
bsdb:381/2/2_response-to-allogeneic-hematopoietic-stem-cell-transplant:high-fecal-butyrate-levels_vs_low-fecal-butyrate-levels_DOWN	NA	1578	1350
bsdb:382/1/1_chlamydia-trachomatis-infectious-disease:patient-with-chlamydia-infection_vs_healthy-control_UP	NA	1375
bsdb:382/1/2_chlamydia-trachomatis-infectious-disease:patient-with-chlamydia-infection_vs_healthy-control_DOWN	NA	1578
bsdb:382/2/1_NA:patient-with-chlamydia-infection_vs_HPV-positive-women_UP	NA	810
bsdb:382/2/2_NA:patient-with-chlamydia-infection_vs_HPV-positive-women_DOWN	NA	1578
bsdb:383/1/1_food-allergy:child-with-food-sensitization_vs_no-food-sensitization_DOWN	NA	724	39948	189330	1485
bsdb:383/2/1_food-allergy:child-with-food-allergy_vs_no-food-allergy_DOWN	NA	544	119852	1357	189330
bsdb:384/1/1_schizophrenia:FSCZ_vs_healthy-controls_UP	NA	561	620	29465
bsdb:384/2/1_schizophrenia:TSCZ_vs_healthy-controls_UP	NA	561	1350	1578	620	1301	29465
bsdb:384/3/1_schizophrenia:TSCZ_vs_FSCZ_UP	NA	561	848	906	1350	1578	620	1301
bsdb:384/3/2_schizophrenia:TSCZ_vs_FSCZ_DOWN	NA	29465
bsdb:385/1/1_gastric-adenocarcinoma:gastric-adenocarcinoma-(GC)_vs_superficial-gastritis-(SG)_UP	NA	416916	482	1283313
bsdb:385/1/2_gastric-adenocarcinoma:gastric-adenocarcinoma-(GC)_vs_superficial-gastritis-(SG)_DOWN	NA	165695	150203	1654	561
bsdb:387/1/1_antimicrobial-agent:Before-ciprofloxacin-exposure_vs_after-antibiotic-exposure_UP	NA	816
bsdb:387/1/2_antimicrobial-agent:Before-ciprofloxacin-exposure_vs_after-antibiotic-exposure_DOWN	NA	216851	239759
bsdb:387/2/1_antimicrobial-agent:Before-clindamycin-exposure_vs_after-antibiotic-exposure_DOWN	NA	33042	841	28050	189330	1263
bsdb:388/1/1_oral-squamous-cell-carcinoma:cancerous--lesions_vs_paracancerous-tissues_UP	NA	44259	195950	543311	2747	1257	1301	157	848
bsdb:388/1/2_oral-squamous-cell-carcinoma:cancerous--lesions_vs_paracancerous-tissues_DOWN	NA	1663	248038	872	33882	44249	41275
bsdb:389/1/1_schizophrenia:schizophrenia_vs_healthy-controls_UP	NA	1301
bsdb:389/1/2_schizophrenia:schizophrenia_vs_healthy-controls_DOWN	NA	838
bsdb:389/2/1_schizophrenia:schizophrenia_vs_healthy-controls_UP	NA	1301	215579
bsdb:389/2/2_schizophrenia:schizophrenia_vs_healthy-controls_DOWN	NA	838
bsdb:390/1/1_schizophrenia:acute-schizphrenia_vs_healthy-controls_UP	NA	1505657	946234	258514	244127	1654	35832
bsdb:390/1/2_schizophrenia:acute-schizphrenia_vs_healthy-controls_DOWN	NA	1432051	1392389	1774107
bsdb:390/2/1_schizophrenia:scizophrenia-during-remission_vs_healthy-controls_UP	NA	1485	1505657	375288	191303
bsdb:390/2/2_schizophrenia:scizophrenia-during-remission_vs_healthy-controls_DOWN	NA	580596	577309	1432051
bsdb:390/3/1_schizophrenia:acute-schizphrenia_vs_symptomatic-remission_DOWN	NA	1485
bsdb:391/1/1_neuromyelitis-optica:neuromyelitis-optica-spectrum-disorder_vs_healthy-controls_UP	NA	561	620	265975	1486725	156454	946234	1301
bsdb:391/1/2_neuromyelitis-optica:neuromyelitis-optica-spectrum-disorder_vs_healthy-controls_DOWN	NA	40544	1407607	33042	1501226	572511	841	216851
bsdb:392/1/1_milk-allergic-reaction:non-IgE-mediated-cow's-milk-allergy_vs_healthy-controls_UP	NA	1266	816	239759
bsdb:392/2/1_milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy-treated-with-EHCF_vs_infant-with-non-IgE-mediated-cow's-milk-allergy-at-diagnosis_DOWN	NA	816
bsdb:392/3/1_milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy-treated-with-EHCF+LGG_vs_infant-with-non-IgE-mediated-cow's-milk-allergy-at-diagnosis_DOWN	NA	239759	816	1883
bsdb:392/4/1_milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy-treated-with-EHCF+LGG_vs_infant-with-non-IgE-mediated-cow's-milk-allergy-treated-with-EHCF_UP	NA	119852	28050	1263	1578
bsdb:392/4/2_milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy-treated-with-EHCF+LGG_vs_infant-with-non-IgE-mediated-cow's-milk-allergy-treated-with-EHCF_DOWN	NA	239759	816	39948
bsdb:393/1/1_milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy-tolerant-to-cow's-milk-protein_vs_infant-with-non-IgE-mediated-cow's-milk-allergy-non-tolerant-to-cow's-milk-protein_UP	NA	1678
bsdb:393/2/2_milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy_vs_healthy-control_DOWN	NA	816
bsdb:394/1/1_asthma:child-with-asthma-at-age-6_vs_healthy-control_UP	NA	29465	838
bsdb:396/1/3_atopic-eczema:atopic-dermatitis_vs_healthy-control_UP	NA	1279
bsdb:396/1/4_atopic-eczema:atopic-dermatitis_vs_healthy-control_DOWN	NA	47670	106589
bsdb:396/2/1_atopic-eczema:atopic-dermatitis-after-treatment-with-TCS-+-Bleach_vs_baseline_UP	NA	1716	469	838
bsdb:396/2/2_atopic-eczema:atopic-dermatitis-after-treatment-with-TCS-+-Bleach_vs_baseline_DOWN	NA	1279
bsdb:396/3/1_atopic-eczema:atopic-dermatitis-after-treatment-with-TCS_vs_baseline_UP	NA	1716	469	838
bsdb:396/3/2_atopic-eczema:atopic-dermatitis-after-treatment-with-TCS_vs_baseline_DOWN	NA	1279
bsdb:397/1/1_atopic-eczema:severe-atopic-dermatitis_vs_healthy-control_UP	NA	1279	1827	1651	114248
bsdb:397/1/2_atopic-eczema:severe-atopic-dermatitis_vs_healthy-control_DOWN	NA	1301	32207	29465	838	836	131079	32067	357	1380
bsdb:398/1/1_atopic-eczema:atopic-dermatitis_vs_healthy-control_DOWN	NA	1279
bsdb:399/1/1_age:non-healthy-aging-(NHA)_vs_healthy-aging-(HA)_UP	NA	1301	32207	29465
bsdb:399/1/2_age:non-healthy-aging-(NHA)_vs_healthy-aging-(HA)_DOWN	NA	482	724	848	1016
bsdb:399/2/1_age:non-healthy-aging-(NHA)_vs_healthy-aging-(HA)_UP	NA	1578	1301	561	620
bsdb:399/2/2_age:non-healthy-aging-(NHA)_vs_healthy-aging-(HA)_DOWN	NA	239934	816
bsdb:400/1/1_asthma:asthma_vs_healthy-control_UP	NA	561	1350	1485	1578	1730
bsdb:400/1/2_asthma:asthma_vs_healthy-control_DOWN	NA	216851	841	39948
bsdb:400/2/1_allergic-rhinitis:allergic-rhinitis_vs_healthy-control_UP	NA	447020
bsdb:400/2/2_allergic-rhinitis:allergic-rhinitis_vs_healthy-control_DOWN	NA	189330	39948
bsdb:401/1/1_asthma:asthma_vs_healthy-control_UP	NA	970
bsdb:401/1/2_asthma:asthma_vs_healthy-control_DOWN	NA	830	543311
bsdb:401/2/1_allergic-rhinitis:allergic-rhinitis_vs_healthy-control_UP	NA	475	482	724	848	836
bsdb:401/2/2_allergic-rhinitis:allergic-rhinitis_vs_healthy-control_DOWN	NA	830	416916	437755
bsdb:402/2/1_atopic-eczema:Mothers-whose-infants-developed-IgE-associated-eczema_vs_mothers-whose-infants-remained-non-allergic_UP	NA	1301
bsdb:403/1/1_eczema:child-with-eczema_vs_healthy-control_UP	NA	841	551
bsdb:403/1/2_eczema:child-with-eczema_vs_healthy-control_DOWN	NA	1678	547
bsdb:403/2/2_eczema:child-with-eczema_vs_healthy-control_DOWN	NA	1678
bsdb:403/3/1_eczema:child-with-eczema_vs_healthy-control_UP	NA	551
bsdb:403/3/2_eczema:child-with-eczema_vs_healthy-control_DOWN	NA	216851	28050
bsdb:403/5/1_eczema:child-with-eczema_vs_healthy-control_UP	NA	551
bsdb:403/5/2_eczema:child-with-eczema_vs_healthy-control_DOWN	NA	1678	1301	194
bsdb:403/6/1_eczema:child-with-eczema_vs_healthy-control_DOWN	NA	216851	1678	547
bsdb:403/7/1_eczema:child-with-eczema_vs_healthy-control_DOWN	NA	1678	29465	1301	570	547
bsdb:403/9/1_eczema:child-with-eczema_vs_healthy-control_DOWN	NA	1678	40544	1485	102106	35832
bsdb:403/10/1_eczema:child-with-eczema_vs_healthy-control_DOWN	NA	1678
bsdb:404/1/1_atopic-eczema:patient-with-atopic-dermatitis_vs_healthy-control_UP	NA	1263	375288	216851	292632	140625	158846	207244	239759
bsdb:404/1/2_atopic-eczema:patient-with-atopic-dermatitis_vs_healthy-control_DOWN	NA	561	620
bsdb:404/2/1_atopic-eczema:patient-with-atopic-dermatitis_vs_healthy-control_UP	NA	1263
bsdb:404/2/2_atopic-eczema:patient-with-atopic-dermatitis_vs_healthy-control_DOWN	NA	191303	100883
bsdb:404/3/1_atopic-eczema:patient-with-atopic-dermatitis_vs_healthy-control_UP	NA	588605
bsdb:404/3/2_atopic-eczema:patient-with-atopic-dermatitis_vs_healthy-control_DOWN	NA	577309	244127	574697	102106	33042	61170
bsdb:405/1/1_asthma:child-with-asthma-at-5-years-old_vs_no-asthma-at-5-years-old_UP	NA	29465
bsdb:405/1/2_asthma:child-with-asthma-at-5-years-old_vs_no-asthma-at-5-years-old_DOWN	NA	841	239759	946234
bsdb:405/2/1_asthma:child-with-asthma-at-5-years-old-among-mothers-with-asthma_vs_no-asthma-at-5-years-old_UP	NA	29465
bsdb:405/2/2_asthma:child-with-asthma-at-5-years-old-among-mothers-with-asthma_vs_no-asthma-at-5-years-old_DOWN	NA	216851	1678	841	239759	1263	39948
bsdb:406/1/1_lung-cancer:non-smoking-female-lung-cancer-patients_vs_healthy-controls_UP	NA	13687	150203	963
bsdb:406/1/2_lung-cancer:non-smoking-female-lung-cancer-patients_vs_healthy-controls_DOWN	NA	283	59732	1301	469
bsdb:407/1/1_peptic-esophagitis:reflux-esophagus-patients_vs_healthy-controls_UP	NA	123375	1730	265975	1164882	1380	1257	906	29465	838
bsdb:407/1/2_peptic-esophagitis:reflux-esophagus-patients_vs_healthy-controls_DOWN	NA	416916	194	1716	538	44259	2701	1378	940557	52228	43994	1508421	482	113286	32207	1301	157	843
bsdb:408/2/1_asthma:asthma-at-1-year_vs_healthy-controls_UP	NA	32207
bsdb:409/1/1_milk-allergic-reaction:IgE-mediated-cow's-milk-allergy_vs_healthy-controls_UP	NA	1263	216851
bsdb:409/1/2_milk-allergic-reaction:IgE-mediated-cow's-milk-allergy_vs_healthy-controls_DOWN	NA	1678	561
bsdb:410/1/1_HIV-infection:ART-treated-HIV-infected-MSM_vs_HIV-uninfected-MSM_UP	NA	162289	150022	165779	194
bsdb:410/1/2_HIV-infection:ART-treated-HIV-infected-MSM_vs_HIV-uninfected-MSM_DOWN	NA	838
bsdb:410/2/1_NA:MSM-with-gonorrhea_vs_MSM-with-no-gonorrhea_UP	NA	838
bsdb:411/1/1_HIV/AIDS-pre-exposure-prophylaxis:HIV-negative-MSM-on-PrEP_vs_HIV-negative-MSM-not-on-PrEP_UP	NA	1301	848	52225
bsdb:411/1/2_HIV/AIDS-pre-exposure-prophylaxis:HIV-negative-MSM-on-PrEP_vs_HIV-negative-MSM-not-on-PrEP_DOWN	NA	561	620
bsdb:411/2/1_HIV/AIDS-pre-exposure-prophylaxis:HIV-negative-MSM-on-PrEP_vs_HIV-negative-MSM-not-on-PrEP_UP	NA	1301
bsdb:412/1/1_NA:HIV-positive-MA-users_vs_HIV-positive-non-MA-users_UP	NA	1654	75984	909928	34104
bsdb:412/2/1_methamphetamine-dependence:Methamphetamine-users_vs_non-users_UP	NA	1161127	724	1730	29465	37914	1301	543311	150022	1716	848	162289	836	1257	165779	86331
bsdb:412/2/2_methamphetamine-dependence:Methamphetamine-users_vs_non-users_DOWN	NA	580596	216851	1283313
bsdb:412/3/1_methamphetamine-dependence:MSM-who-tested-positive-on-MA-urine-drug-screening_vs_MSM-who-did-not-test-positive-on-MA-urine-drug-screening_UP	NA	1161127	37914	1730	150022	162289	836	848	86331	1257	1716	165779
bsdb:412/3/2_methamphetamine-dependence:MSM-who-tested-positive-on-MA-urine-drug-screening_vs_MSM-who-did-not-test-positive-on-MA-urine-drug-screening_DOWN	NA	216851	1485	1578	1313210	83770
bsdb:412/4/1_NA:HIV-positive-men-who-have-sex-with-men-who-tested-positive-in-a-methamphetamine-drug-screening_vs_HIV-positive-men-who-have-sex-with-men-who-did-not-test-positive-in-a-methamphetamine-drug-screening_UP	NA	34104
bsdb:412/4/2_NA:HIV-positive-men-who-have-sex-with-men-who-tested-positive-in-a-methamphetamine-drug-screening_vs_HIV-positive-men-who-have-sex-with-men-who-did-not-test-positive-in-a-methamphetamine-drug-screening_DOWN	NA	846
bsdb:412/5/1_NA:HIV-negative-MSM-who-tested-positive-in-a-MA-drug-screening_vs_HIV-negative-MSM-who-did-not-test-positive-in-a-MA-drug-screening_UP	NA	1485
bsdb:412/5/2_NA:HIV-negative-MSM-who-tested-positive-in-a-MA-drug-screening_vs_HIV-negative-MSM-who-did-not-test-positive-in-a-MA-drug-screening_DOWN	NA	292632	117563	397864	34104	168808
bsdb:413/1/1_obsessive-compulsive-disorder:OCD_vs_healthy-controls_DOWN	NA	119852	283168	207244
bsdb:414/1/1_epilepsy:before-keto-diet_vs_after-keto-diet_UP	NA	1678	39948
bsdb:414/1/2_epilepsy:before-keto-diet_vs_after-keto-diet_DOWN	NA	561
bsdb:415/1/1_HIV-infection:HIV-positive-women-who-have-been-taking-ART-for-more-than-1-year_vs_Age-matched-HIV-uninfected-women_UP	NA	265975	437755
bsdb:415/2/1_NA:HIV-positive-women-with-oral-candidiasis_vs_Age-matched-HIV-uninfected-womenn_UP	NA	29465
bsdb:415/3/1_age:HIV-uninfected-women-who-are-50-years-of-age-or-older_vs_HIV-uninfected-women-who-are-less-than-35-years-of-age_UP	NA	265975	437755
bsdb:417/1/1_NA:Women-with-diabetes_vs_Women-without-diabetes_DOWN	NA	150022	165779
bsdb:418/1/1_HIV-infection:immunological-non-responders-assigned-to-treatment-for-12-weeks_vs_baseline_UP	NA	158846	872
bsdb:418/1/2_HIV-infection:immunological-non-responders-assigned-to-treatment-for-12-weeks_vs_baseline_DOWN	NA	135858
bsdb:418/2/1_HIV-infection:immunological-responders-assigned-to-treatment-for-12-weeks_vs_baseline_UP	NA	158846	872
bsdb:418/2/2_HIV-infection:immunological-responders-assigned-to-treatment-for-12-weeks_vs_baseline_DOWN	NA	135858
bsdb:419/1/1_HIV-infection:combination-antiretroviral-therapy-treated-individuals-after-taking-LGG-probiotic-for-8-weeks_vs_baseline_UP	NA	1508657
bsdb:420/1/1_HIV-infection:HIV-infected-on-antiretroviral-therapy-allocated-to-probiotic-intervention_vs_baseline_UP	NA	1678
bsdb:420/1/2_HIV-infection:HIV-infected-on-antiretroviral-therapy-allocated-to-probiotic-intervention_vs_baseline_DOWN	NA	816
bsdb:420/2/1_HIV-infection:HIV-infected-on-antiretroviral-therapy-allocated-to-probiotic-intervention_vs_nonprobiotic-intervention_UP	NA	1578
bsdb:421/1/1_HIV-infection:Vertically-HIV-infected-children_vs_uninfected-siblings-or-children-born-to-HIV-infected-mothers_UP	NA	848	100883
bsdb:421/2/1_HIV-infection:Vertically-HIV-infected-children_vs_uninfected-siblings-or-children-born-to-HIV-infected-mothers_DOWN	NA	216851	189330	1485	1357
bsdb:422/1/1_HIV-infection:Perinatally-HIV-infected-children_vs_uninfected-age-matched-controls_UP	NA	838	906	970	1485	32067	53335
bsdb:422/1/2_HIV-infection:Perinatally-HIV-infected-children_vs_uninfected-age-matched-controls_DOWN	NA	816	216851	1263	724	48463	475961	51514
bsdb:423/1/2_NA:ALS-patients_vs_Healthy-controls_DOWN	NA	158846
bsdb:424/1/1_pancreatic-carcinoma:PC_vs_Healthy-control_UP	NA	239934	906	283168
bsdb:424/1/2_pancreatic-carcinoma:PC_vs_Healthy-control_DOWN	NA	207244	216851	292632
bsdb:424/3/1_pancreatic-carcinoma:BO-PC_vs_NBO-PC_DOWN	NA	572511
bsdb:424/4/1_pancreatic-carcinoma:NBO-PC_vs_Healthy-control_DOWN	NA	216851
bsdb:424/4/2_pancreatic-carcinoma:NBO-PC_vs_Healthy-control_UP	NA	239934
bsdb:426/1/1_NA:autoimmune-hepatits-cases_vs_healthy-controls_UP	NA	570	1578	1301	29465
bsdb:426/1/2_NA:autoimmune-hepatits-cases_vs_healthy-controls_DOWN	NA	33042	119852	375288
bsdb:428/1/2_COVID-19:COVID-19-cases_vs_Healthy-controls_DOWN	NA	292632
bsdb:428/2/2_COVID-19:Recovered-COVID-19-cases_vs_Healthy-controls_DOWN	NA	292632
bsdb:428/3/1_COVID-19:Recovered-COVID-19-cases_vs_Healthy-controls_UP	NA	375288
bsdb:428/3/2_COVID-19:Recovered-COVID-19-cases_vs_Healthy-controls_DOWN	NA	292632
bsdb:428/4/2_COVID-19:COVID-19-patients-treated-with-antibiotics_vs_Healthy-controls_UP	NA	100883
bsdb:431/1/1_cervical-glandular-intraepithelial-neoplasia:persistent-HPV+-with-HSIL_vs_persistent-HPV+-with-LSIL_DOWN	NA	283	162290	2745	68	407	1839	33024	152161	270	1079922	286	1243	1522432	265	149698	1357	222	84036	207599
bsdb:431/1/2_cervical-glandular-intraepithelial-neoplasia:persistent-HPV+-with-HSIL_vs_persistent-HPV+-with-LSIL_DOWN	NA	283	162290	1839	2745	152161	33024	68	407
bsdb:431/3/1_cervical-glandular-intraepithelial-neoplasia:transient-HPV+-with-LSIL_vs_HPV-_DOWN	NA	168808	177971	29465	906	46913	2701
bsdb:431/4/1_cervical-glandular-intraepithelial-neoplasia:persistent-HPV+-with-HSIL_vs_HPV-_DOWN	NA	168808	177971	906	1257
bsdb:431/5/2_cervical-glandular-intraepithelial-neoplasia:persistent-HPV+-with-HSIL_vs_persistent-HPV+-with-LSIL_DOWN	NA	216851	1847725	162289	165779	39948	838	2701	1243	404402	150022	1279	1350
bsdb:431/6/2_cervical-glandular-intraepithelial-neoplasia:persistent-HPV+-with-LSIL_vs_transient-HPV+-with-HSIL_DOWN	NA	836	1567	1506577	73029
bsdb:431/7/1_cervical-glandular-intraepithelial-neoplasia:transient-HPV+-with-HSIL_vs_transient-HPV+-with-LSIL_UP	NA	501783	1578	231454
bsdb:431/8/1_cervical-glandular-intraepithelial-neoplasia:transient-HPV+-with-LSIL_vs_HPV-_DOWN	NA	168808	1578	286	177971
bsdb:431/9/1_cervical-glandular-intraepithelial-neoplasia:persistent-HPV+-with-HSIL_vs_HPV-_UP	NA	581
bsdb:431/9/2_cervical-glandular-intraepithelial-neoplasia:persistent-HPV+-with-HSIL_vs_HPV-_DOWN	NA	39948	838	40544	1257	286
bsdb:432/1/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	2093
bsdb:432/1/2_human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	2077
bsdb:433/1/1_cervical-glandular-intraepithelial-neoplasia:CIN-2+_vs_healthy-controls_UP	NA	2701
bsdb:433/1/2_cervical-glandular-intraepithelial-neoplasia:CIN-2+_vs_healthy-controls_DOWN	NA	1578
bsdb:433/2/1_cervical-cancer:cervical-cancer_vs_healthy-controls_UP	NA	1301	162289	150022	165779	838
bsdb:433/2/2_cervical-cancer:cervical-cancer_vs_healthy-controls_DOWN	NA	1578
bsdb:434/1/1_human-papilloma-virus-infection:HPV-+_vs_healthy-control_UP	NA	906
bsdb:434/1/2_human-papilloma-virus-infection:HPV-+_vs_healthy-control_DOWN	NA	1380	1578
bsdb:434/2/2_cervical-glandular-intraepithelial-neoplasia:LSIL_vs_healthy-control_DOWN	NA	1380	1578
bsdb:434/3/1_cervical-glandular-intraepithelial-neoplasia:HSIL_vs_healthy-control_UP	NA	838	177971
bsdb:434/3/2_cervical-glandular-intraepithelial-neoplasia:HSIL_vs_healthy-control_DOWN	NA	1380	1578
bsdb:434/4/1_cervical-cancer:cervical-cancer_vs_healthy-control_UP	NA	1386	168808	12916	848	182709	836	165779
bsdb:434/4/2_cervical-cancer:cervical-cancer_vs_healthy-control_DOWN	NA	1380	1578
bsdb:435/1/1_human-papilloma-virus-infection:HPV+-persistence_vs_HPV-_UP	NA	28100	13687	165779	838	836	39948	162289
bsdb:435/1/2_human-papilloma-virus-infection:HPV+-persistence_vs_HPV-_DOWN	NA	1578
bsdb:435/2/2_human-papilloma-virus-infection:HPV+-transient_vs_HPV-_DOWN	NA	1578
bsdb:439/1/1_NA:Individuals-diagnosed-with-severe-alcoholic-hepatitis_vs_Healthy-controls_UP	NA	29465
bsdb:441/1/1_COVID-19:COVID-19-cases_vs_Healthy-controls_UP	NA	1301	32207	29465	1505663	1654
bsdb:441/1/2_COVID-19:COVID-19-cases_vs_Healthy-controls_DOWN	NA	1766253	207244	189330	216851	1407607	1505657	570	1501226	191303	1485
bsdb:441/2/1_NA:H1N1-cases_vs_Healthy-controls_DOWN	NA	572511	1501226	102106	1678	1766253	1407607	207244	189330
bsdb:441/2/2_NA:H1N1-cases_vs_Healthy-controls_UP	NA	1350	838	150022	162289
bsdb:441/3/1_COVID-19:COVID-19-cases_vs_H1N1-cases_UP	NA	1766253	207244	1678	572511	102106	189330	1407607	32207	1263	1301	1485
bsdb:441/3/2_COVID-19:COVID-19-cases_vs_H1N1-cases_DOWN	NA	838	1582879	239934	1161127	836
bsdb:441/4/1_COVID-19:COVID-19-cases_vs_Healthy-controls_UP	NA	1301
bsdb:443/1/1_irritable-bowel-sydrome:IBS_vs_Health-Control_UP	NA	572511	29465	816
bsdb:443/1/2_irritable-bowel-sydrome:IBS_vs_Health-Control_DOWN	NA	1678
bsdb:443/2/1_irritable-bowel-sydrome:IBS-C_vs_Health-Control_UP	NA	816	572511	1578	29465
bsdb:443/3/1_irritable-bowel-sydrome:IBS-D_vs_Health-Control_UP	NA	572511	29465	816
bsdb:443/3/2_irritable-bowel-sydrome:IBS-D_vs_Health-Control_DOWN	NA	1578
bsdb:443/4/1_irritable-bowel-sydrome:IBS-U_vs_Health-Control_UP	NA	816
bsdb:443/4/2_irritable-bowel-sydrome:IBS-U_vs_Health-Control_DOWN	NA	1578	572511	29465
bsdb:447/1/1_gestational-diabetes:Individuals-with-gestational-diabetes_vs_Healthy-controls_UP	NA	724
bsdb:447/1/2_gestational-diabetes:Individuals-with-gestational-diabetes_vs_Healthy-controls_DOWN	NA	239759	33024
bsdb:447/2/1_gestational-diabetes:Individuals-with-gestational-diabetes_vs_Healthy-controls_UP	NA	1678	970
bsdb:447/2/2_gestational-diabetes:Individuals-with-gestational-diabetes_vs_Healthy-controls_DOWN	NA	1164882	32067	1243
bsdb:448/1/1_NA:Pneumonia-patients-with-pH1N1-infection_vs_Pneumonia-patients-without-any-influenza-A-infection_UP	NA	469	286	1386
bsdb:448/1/2_NA:Pneumonia-patients-with-pH1N1-infection_vs_Pneumonia-patients-without-any-influenza-A-infection_DOWN	NA	482	838	29465
bsdb:448/1/5_NA:Pneumonia-patients-with-pH1N1-infection_vs_Pneumonia-patients-without-any-influenza-A-infection_UP	NA	469	1386	286
bsdb:448/1/6_NA:Pneumonia-patients-with-pH1N1-infection_vs_Pneumonia-patients-without-any-influenza-A-infection_DOWN	NA	482	838	29465
bsdb:452/1/1_gestational-diabetes:Pregnant-women-with-Gestational-Diabetes-Mellitus_vs_euglycemic-(control)-singleton-pregnant-women_UP	NA	244127	33042	189330	577309	838	1263
bsdb:452/1/2_gestational-diabetes:Pregnant-women-with-Gestational-Diabetes-Mellitus_vs_euglycemic-(control)-singleton-pregnant-women_DOWN	NA	29465
bsdb:453/1/1_COVID-19:SARS-CoV-2-infected-patients_vs_Non-infected-patients-with-unrelated-respiratory-medical-conditions_UP	NA	1716	194	150022	2050	165779	1582879	836	838	1161127	236752	66831	162290	1279	1380	990721	39948	577310	1649459	1392389
bsdb:453/1/2_COVID-19:SARS-CoV-2-infected-patients_vs_Non-infected-patients-with-unrelated-respiratory-medical-conditions_DOWN	NA	1578	1505657	189330	572511	32207	216851	561	2039302	292632	1301	29465	841	1407607	1766253	570
bsdb:453/2/1_COVID-19:SARS-CoV-2-recovered-patients_vs_SARS-CoV-2-infected-patients_DOWN	NA	194	1716	2050	1686313	1582879	1161127	236752	66831	1279	162290	1847725	150022	40544	162289	836	1380	255204	508459	1769710	191303	31983	165779	36739	872
bsdb:453/2/2_COVID-19:SARS-CoV-2-recovered-patients_vs_SARS-CoV-2-infected-patients_UP	NA	1357	207244	1926663	216851	561	1505657	135858	570	292632	117563	572511	1766253
bsdb:453/3/1_COVID-19:Recovered-COVID-19-patients_vs_Non-infected-patients-with-unrelated-respiratory-medical-conditions_UP	NA	207244	1926663
bsdb:453/3/2_COVID-19:Recovered-COVID-19-patients_vs_Non-infected-patients-with-unrelated-respiratory-medical-conditions_DOWN	NA	248744	1470349	35832	577309	39948	40544	1263
bsdb:453/4/1_COVID-19:Positive-for-COVID-19-viral-RNA-in-feces_vs_Negative-for-COVID-19-viral-RNA-in-feces_UP	NA	283	399320	2753	158846	588605	1505657	570	577309	171413	1870884	583	848	1505663	1573535	1769710	2129	1766253
bsdb:453/4/2_COVID-19:Positive-for-COVID-19-viral-RNA-in-feces_vs_Negative-for-COVID-19-viral-RNA-in-feces_DOWN	NA	171412	53456	447020	72763	1269	1357	944321	1926663	156973	168808	36739	1501226	547	1505652	1213720	1273095	1696	1912216	255204
bsdb:455/1/1_gingivitis:pregnant-women_vs_non-pregnant-women_UP	NA	848	157
bsdb:455/1/2_gingivitis:pregnant-women_vs_non-pregnant-women_DOWN	NA	1301	724	1378	59735
bsdb:455/2/1_gingivitis:pregnant-women-with-gingivitis_vs_pregnant-women_UP	NA	157	195950	44259	194
bsdb:455/2/2_gingivitis:pregnant-women-with-gingivitis_vs_pregnant-women_DOWN	NA	1301	1654	32207	117563
bsdb:455/2/3_gingivitis:pregnant-women-with-gingivitis_vs_pregnant-women_DOWN	NA	157	195950	44259	194
bsdb:455/3/1_gingivitis:pregnant-women_vs_non-pregnant-women_UP	NA	265975	32067	970	1743
bsdb:455/3/2_gingivitis:pregnant-women_vs_non-pregnant-women_DOWN	NA	157
bsdb:455/4/1_gingivitis:pregnant-women_vs_non-pregnant-women_UP	NA	1257	194	59735	265975
bsdb:456/1/1_type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	207244	816	35832	572511	1485	33042	216851	28050	248744	283168	577310	33024	46205	841	1263	13687	40544
bsdb:456/1/2_type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	292632	239934	1350	1678	570	1578	906	544	1301	375288	102106	46255	1654	244127	160674	84111
bsdb:458/1/1_COVID-19:COVID-19-cases_vs_Non-intubated-controls-with-non-incubation-viral-pneumonia-or-non-incubation-non-infectious-diseases_UP	NA	469	570	48736	13687
bsdb:458/1/2_COVID-19:COVID-19-cases_vs_Non-intubated-controls-with-non-incubation-viral-pneumonia-or-non-incubation-non-infectious-diseases_DOWN	NA	1654	724	482	838	1301	29465
bsdb:459/1/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-patients_DOWN	NA	1283313	165779	38501	580596	194	1016	59732	150022	237	1378	57493	1269	475	162289	836	838	32207	970	29465	662
bsdb:459/1/2_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-patients_UP	NA	432330	397456
bsdb:462/1/1_type-I-diabetes-mellitus:Individuals-diagnosed-with-Type-1-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	165440	4930
bsdb:462/1/2_type-I-diabetes-mellitus:Individuals-diagnosed-with-Type-1-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	4855	42658	1124675
bsdb:462/2/1_type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	4970	5314	1851509	5605	148959
bsdb:462/2/2_type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	1500560	42658	1891946
bsdb:462/3/1_diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Individuals-diagnosed-with-Type-1-Diabetes-Mellitus_DOWN	NA	4970	5314	1851509	42658
bsdb:462/3/2_diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Individuals-diagnosed-with-Type-1-Diabetes-Mellitus_UP	NA	4930	1500560
bsdb:464/1/1_COVID-19:Confirmed-COVID-19-patients_vs_Healthy-controls_DOWN	NA	43996	86331	44259	2717	543311	1378	1716	123375	265975	1331051	1257	1301	848	724	836
bsdb:464/1/2_COVID-19:Confirmed-COVID-19-patients_vs_Healthy-controls_UP	NA	146	32067	117563	906	194	970	195950
bsdb:464/2/1_COVID-19:Recovered-COVID-19-patients_vs_Healthy-controls_DOWN	NA	1331051	724	543311	836
bsdb:464/2/2_COVID-19:Recovered-COVID-19-patients_vs_Healthy-controls_UP	NA	82202	32067	906	970
bsdb:464/3/1_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	816	572511	216851	46205	724	40544	13687	283168	189330	577310	102106	375288	35832	1392389	191303	570	33042	1485	39948	239759	1263	28050	61170	841
bsdb:464/3/2_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	239934	1678	1350	1301	32207	2745	207244	265975	29465	123375	1380	946234	1082930	1378	117563
bsdb:465/1/1_diabetic-neuropathy:Individuals-diagnosed-with-peripheral-neuropathy-associated-with-type-2-diabetes_vs_Healthy-controls_UP	NA	572511	1506553	906	561
bsdb:465/1/2_diabetic-neuropathy:Individuals-diagnosed-with-peripheral-neuropathy-associated-with-type-2-diabetes_vs_Healthy-controls_DOWN	NA	816	216851
bsdb:467/1/1_NA:Her2-positive-tumor_vs_Her2-negative-tumor_UP	NA	904
bsdb:467/1/2_NA:Her2-positive-tumor_vs_Her2-negative-tumor_DOWN	NA	872	1263
bsdb:467/2/2_NA:later-age-at-menarche-(≥12)_vs_early-age-at-menarche-(≤11)_DOWN	NA	2172	1263
bsdb:467/3/1_NA:ER-_vs_ER+_DOWN	NA	724	29465
bsdb:467/5/1_NA:Grade-High-(III)_vs_Grade-Low-(I/II)_UP	NA	84111
bsdb:467/5/2_NA:Grade-High-(III)_vs_Grade-Low-(I/II)_DOWN	NA	207244
bsdb:467/6/1_NA:Stage-High-(III)_vs_Stage-Low-(I/II)_UP	NA	1485	29465	724
bsdb:467/6/2_NA:Stage-High-(III)_vs_Stage-Low-(I/II)_DOWN	NA	904	135858
bsdb:467/7/1_age:Age-≤50_vs_Age-50+_UP	NA	1485	1357
bsdb:467/8/1_NA:Nulliparous_vs_Parous_DOWN	NA	135858
bsdb:467/9/1_body-mass-index:BMI≥25_vs_BMI<25_UP	NA	239934
bsdb:468/1/1_NA:Stage-3/4-endometriosis-patients_vs_Healthy-controls_DOWN	NA	1380	1378
bsdb:468/2/1_NA:Stage-3/4-endometriosis-patients_vs_Healthy-controls_DOWN	NA	1380	168808
bsdb:468/2/2_NA:Stage-3/4-endometriosis-patients_vs_Healthy-controls_UP	NA	1283313
bsdb:468/3/1_NA:Stage-3/4-endometriosis-patients_vs_Healthy-controls_DOWN	NA	2701	168808	397864
bsdb:470/1/1_colorectal-cancer:colorectal-cancer_vs_controls_UP	NA	165779	1730	848	1378	1649459	1506553	32067	543311	1257	836	123375	292632
bsdb:470/1/2_colorectal-cancer:colorectal-cancer_vs_controls_UP	NA	165779	1730	848	1378	1649459	1506553	32067	543311	1257	836	123375	292632
bsdb:473/1/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-controls_DOWN	NA	32067	848	724
bsdb:476/1/1_COVID-19:Recovered-COVID-19-patients_vs_Healthy-controls_UP	NA	343821	41949	32207	1505663
bsdb:476/1/2_COVID-19:Recovered-COVID-19-patients_vs_Healthy-controls_DOWN	NA	119852	216851	102106
bsdb:477/1/1_COVID-19:Severe-COVID-19-patients_vs_COVID-19-negative-patients_UP	NA	1283313	838	43996	1164882	265975
bsdb:477/2/1_COVID-19:Severe-COVID-19-patients-requiring-ICU_vs_COVID-19-negative-patients_UP	NA	157
bsdb:477/3/1_COVID-19:Severe-COVID-19-patients_vs_Mild-COVID-19-patients_UP	NA	838
bsdb:478/1/1_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	2801844	2050	265975	32207	84108
bsdb:478/1/2_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	29465
bsdb:478/2/1_COVID-19:COVID-19-patients_vs_Flu-patients_DOWN	NA	2801844	265975	32207	84108
bsdb:478/3/1_COVID-19:Flu-patients_vs_Healthy-controls_UP	NA	29465
bsdb:478/3/2_COVID-19:Flu-patients_vs_Healthy-controls_DOWN	NA	265975	2801844	32207	2050
bsdb:478/4/1_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	76833	1678	118747	1707	1716	84162	44259	57499	1164882	86331	543311	1743	2529408	970	1301	1654	32207	265975	186188	2801844	2717	184869	2050
bsdb:478/4/2_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	906	29465	46123
bsdb:478/5/1_COVID-19:Flu-patients_vs_Healthy-controls_DOWN	NA	1301	1654	32207	265975	186188	2801844	2717	184869
bsdb:478/5/2_COVID-19:Flu-patients_vs_Healthy-controls_UP	NA	906	29465
bsdb:479/1/1_COVID-19:ICU-COVID-19-patients_vs_Healthy-controls_DOWN	NA	469	642	1663	59735	1678	32008	830	1485	1298	44259	397456	43994	33882	745	335058	48736	42255	1193515	203470	1754	28895	261684	34072
bsdb:479/1/2_COVID-19:ICU-COVID-19-patients_vs_Healthy-controls_UP	NA	547	561	570	1506553	1847725	1269	133925	44249	53335	1827	590	196081	613	40323
bsdb:479/2/1_COVID-19:Mild-moderate-COVID-19-patients_vs_Healthy-controls_DOWN	NA	1663	118747	32008	1298	397456	43994	57493	1357	948104	335058	48736	42255	1193515	203470	1754	28895	261684	34072
bsdb:479/2/2_COVID-19:Mild-moderate-COVID-19-patients_vs_Healthy-controls_UP	NA	2330	407	34104
bsdb:479/3/1_COVID-19:ICU-COVID-19-patients_vs_Mild-Moderate-COVID-19-patients_DOWN	NA	469	642	59735	1678	118747	830	1485	44259	2330	407	745
bsdb:479/3/2_COVID-19:ICU-COVID-19-patients_vs_Mild-Moderate-COVID-19-patients_UP	NA	547	561	570	57493	1506553	1357	1847725	1269	948104	133925	44249	53335	1827	590	196081	613	40323	286
bsdb:479/4/1_COVID-19:ICU-COVID-19-patients_vs_Patients-infected-with-other-human-coronaviruses_DOWN	NA	469	642	239759	207244	637	1663	59735	1678	38501	572511	1696	41275	32008	1715793	75	59732	1485	106589	189330	66831	44259	1573535	53457	149698	407	33882	1763	909928	1839	283168	375288	265	84567	335058	48736	841	42255	1508657	1263	1835	1193515	13687	1506577	338
bsdb:479/4/2_COVID-19:ICU-COVID-19-patients_vs_Patients-infected-with-other-human-coronaviruses_UP	NA	1357	590	196081	613
bsdb:480/1/1_NA:Confirmed-endometriosis-patients_vs_Healthy-controls_UP	NA	1378	1301
bsdb:480/1/2_NA:Confirmed-endometriosis-patients_vs_Healthy-controls_DOWN	NA	1375
bsdb:480/2/1_NA:Confirmed-endometriosis-patients_vs_Healthy-controls_UP	NA	1678
bsdb:480/2/2_NA:Confirmed-endometriosis-patients_vs_Healthy-controls_DOWN	NA	59753	1380	194	42054	2050
bsdb:480/3/1_NA:Confirmed-endometriosis-patients_vs_Healthy-controls_UP	NA	1375	1279	13687	111142	286	1350
bsdb:480/3/2_NA:Confirmed-endometriosis-patients_vs_Healthy-controls_DOWN	NA	838	1380	1033	2050	194	66831
bsdb:481/1/1_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	84111	100883
bsdb:481/2/1_COVID-19:Antibiotic-treated-COVID-19-patients_vs_Antibiotic-naive-COVID-19-patients_UP	NA	100883
bsdb:481/3/1_COVID-19:Severe-COVID-19-patients_vs_Mild-COVID-19-patients_UP	NA	80865
bsdb:482/1/1_COVID-19:Severe-COVID-19-patients_vs_Mild-COVID-19-patients_DOWN	NA	29465	482	1301	838
bsdb:482/1/2_COVID-19:Severe-COVID-19-patients_vs_Mild-COVID-19-patients_UP	NA	1279	561
bsdb:482/2/1_COVID-19:Severe-COVID-19-patients_vs_Mild-COVID-19-patients_UP	NA	375288
bsdb:483/2/1_COVID-19:Antibiotic-treated-COVID-19-patients_vs_Antibiotic-naive-COVID-19-patients_DOWN	NA	572511	216851	1730	841	33042
bsdb:483/3/1_COVID-19:Pneumonia-controls_vs_Healthy-controls_DOWN	NA	100883
bsdb:485/1/1_COVID-19:COVID-19-patients-with-fever_vs_COVID-19-patients-without-fever_UP	NA	4930	1350
bsdb:485/1/2_COVID-19:COVID-19-patients-with-fever_vs_COVID-19-patients-without-fever_DOWN	NA	207244	838	375288	33024	84111
bsdb:485/2/1_COVID-19:COVID-19-patients-with-fever_vs_COVID-19-patients-without-fever_UP	NA	1350	544	4930	724
bsdb:485/2/2_COVID-19:COVID-19-patients-with-fever_vs_COVID-19-patients-without-fever_DOWN	NA	577310	644652
bsdb:486/1/1_COVID-19:Asymptomatic-COVID-19-patients_vs_Healthy-volunteers_UP	NA	84111	547	1350	666060	1263	620	46255
bsdb:486/1/2_COVID-19:Asymptomatic-COVID-19-patients_vs_Healthy-volunteers_DOWN	NA	904	207244	194	28050	906	52225	133925	841	83770
bsdb:486/2/1_COVID-19:Asymptomatic-COVID-19-patients_vs_Healthy-volunteers_UP	NA	1350	620	33969	469	46255
bsdb:486/2/2_COVID-19:Asymptomatic-COVID-19-patients_vs_Healthy-volunteers_DOWN	NA	292632	970	189330	133925	904	33042	1485	207244	52225	547	1263	906	841	28050	39948	216851	83770
bsdb:486/3/1_COVID-19:Severe-COVID-19-patients_vs_Healthy-volunteers_UP	NA	816	1350	620	1380	33969
bsdb:486/3/2_COVID-19:Severe-COVID-19-patients_vs_Healthy-volunteers_DOWN	NA	580596	189330	133925	1485	904	33042	547	906	194	841	28050	39948	216851	83770
bsdb:487/2/1_COVID-19:Recovered-COVID-19-samples-(respiratory-negative)_vs_Healthy-controls_DOWN	NA	841	207244	2039302	1407607	33042
bsdb:487/2/2_COVID-19:Recovered-COVID-19-samples-(respiratory-negative)_vs_Healthy-controls_UP	NA	102106	1350	1578	1301	1501226	1253	544
bsdb:487/3/1_COVID-19:Infected-COVID-19-samples-(respiratory-positive)_vs_Healthy-controls_DOWN	NA	816	216851	375288	40544	239759	283168	841	207244	1263	1506553	1766253	28050	580596	2039302	1980681	577309	574697	838	459786	33042	397864
bsdb:487/3/2_COVID-19:Infected-COVID-19-samples-(respiratory-positive)_vs_Healthy-controls_UP	NA	102106	1350	1578	1301	191303	1501226	1253	572511	620	1678	1485	1505657
bsdb:488/1/1_irritable-bowel-sydrome:IBS-D_vs_Healthy-Control_UP	NA	1283313	1678	216851	1263
bsdb:488/1/2_irritable-bowel-sydrome:IBS-D_vs_Healthy-Control_DOWN	NA	1301
bsdb:489/1/1_COVID-19:COVID-positive-patients-admitted-to-ICU-(i-COVID-19)_vs_COVID-negative-controls_UP	NA	1663	909928	2737	84108	1269	1827	57493	1883	33926	1763	86331	1935176	404402	1434004	724	1926667	1696	1350	1716	66831	44249	1386	1935461	577310
bsdb:489/1/2_COVID-19:COVID-positive-patients-admitted-to-ICU-(i-COVID-19)_vs_COVID-negative-controls_DOWN	NA	35829	244127	544	102106	1348911	872	1432051	216851	1686313	946234	1407607	117563	2330	1243	2093	265975	2740	1017280	638847	588605	590	292632	662	1653174	1980689	2005359	1738645	1649459	574697	1508657	1506577	207244	570
bsdb:489/2/1_COVID-19:COVID-positive-patients-admitted-to-ICU-(i-COVID-19)_vs_COVID-positive-patients-admitted-to-infectious-disease-ward-(w-COVID-19)_UP	NA	1663	84108	2737	33882	44249	1269	1827	57493	1883	33926	1763	642	86331	404402	1434004	724	1926667	1279	1716	1696	1935461	577310
bsdb:489/2/2_COVID-19:COVID-positive-patients-admitted-to-ICU-(i-COVID-19)_vs_COVID-positive-patients-admitted-to-infectious-disease-ward-(w-COVID-19)_DOWN	NA	1375	59753	544	102106	100883	1348911	413496	872	216851	1686313	946234	117563	1937007	28050	1357	1980689	1161127	133925	590	970	292632	40544	662	33024	574697	547	561	1649459	1508657	207244
bsdb:489/3/1_COVID-19:COVID-positive-patients-admitted-to-infectious-disease-ward-(w-COVID-19)_vs_COVID-negative-controls_UP	NA	59753	1375	40544	51196	100883	133925	909928	1357	1795789	1935176	904	1931105	970	1573535	241189	119977	906	35832	561	662	66831	547
bsdb:489/3/2_COVID-19:COVID-positive-patients-admitted-to-infectious-disease-ward-(w-COVID-19)_vs_COVID-negative-controls_DOWN	NA	583	1653174	1432051	33882	2005359	244127	1738645	2740	1407607	1017280	44249	642	588605	35829	1243	1905344	2093	1378	469	1200657	1506577	580596
bsdb:490/1/1_irritable-bowel-sydrome:IBS_vs_Healthy-Control_UP	NA	29465
bsdb:491/1/1_irritable-bowel-sydrome:IBS_vs_Healthy-Control_UP	NA	2740
bsdb:492/1/1_type-II-diabetes-mellitus:Individuals-having-Type-2-Diabetes-Mellitus-without-Diabetic-Retinopathy_vs_Healthy-controls_DOWN	NA	207244	572511	283	33042	724	28050	33024	841	40544	191303
bsdb:492/1/2_type-II-diabetes-mellitus:Individuals-having-Type-2-Diabetes-Mellitus-without-Diabetic-Retinopathy_vs_Healthy-controls_UP	NA	904	574697	547	561	140625	2172	157	46255
bsdb:492/2/1_NA:Individuals-diagnosed-with-Type-2-Diabetes-and-clinically-manifest-Diabetic-Retinopathy-(DR)_vs_Healthy-controls_DOWN	NA	82373	2152	1678	572511	118747	830	1485	283	872	551	216851	724	28050	1578	52225	841	32207	1301	40544	191303
bsdb:492/2/2_NA:Individuals-diagnosed-with-Type-2-Diabetes-and-clinically-manifest-Diabetic-Retinopathy-(DR)_vs_Healthy-controls_UP	NA	904	239934	239759	508459	547	1350	561	158846	846	375288	620
bsdb:492/3/1_type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-and-clinically-manifest-Diabetic-Retinopathy-(DR)_vs_Individuals-diagnosed-with-type-2-diabetes-Mellitus_DOWN	NA	82373	2152	1678	872	551	724	570	140625	2172	52225	1301	157	46255
bsdb:492/3/2_type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-and-clinically-manifest-Diabetic-Retinopathy-(DR)_vs_Individuals-diagnosed-with-type-2-diabetes-Mellitus_UP	NA	239934	239759	508459	1350	33024	620
bsdb:494/1/1_type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	239934	1678	375288
bsdb:494/1/2_type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	189330	848	1301
bsdb:495/1/1_type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	1283313	906	838
bsdb:495/1/2_type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	577309	816
bsdb:495/2/1_NA:Individuals-with-Prediabetes-(PreDM)_vs_Healthy-controls_UP	NA	906
bsdb:496/1/1_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	561	1301	1485	29465	1578	1678	196081	209	1654	437755	583	32207	177971	1350	165779	174708	265975	118747	84111	1380	1716
bsdb:496/1/2_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	172900	61170	629	283168	239759	1485	574697	283	207244	32008	482	106589	48736	189330	838	119852	28050	375288	1263	40544	33042	216851	841
bsdb:496/2/1_COVID-19:COVID-19-patients_vs_Seasonal-flu-patients_UP	NA	561	1678	1485	1301	375288	29465	40544	848
bsdb:496/2/2_COVID-19:COVID-19-patients_vs_Seasonal-flu-patients_DOWN	NA	33024	572511	724	1485	189330	119852	1654	40323	209	177971	106589	32008	1730	1243	48736	437755	638847	416916	265975	118747
bsdb:498/1/1_COVID-19:COVID-19-patients_vs_Asymptomatic-uninfected-controls_UP	NA	1582879
bsdb:498/2/2_COVID-19:COVID-19-patients-with-high-viral-load_vs_COVID-19-patients-with-low-viral-load_DOWN	NA	40323	469
bsdb:499/1/1_irritable-bowel-sydrome:IBS-A_vs_Healthy-Control_DOWN	NA	239759	216851	283168	375288	195950
bsdb:499/1/2_irritable-bowel-sydrome:IBS-A_vs_Healthy-Control_UP	NA	572511	39948	189330	248744	100175	1263
bsdb:499/2/1_irritable-bowel-sydrome:IBS-C_vs_Healthy-Control_DOWN	NA	239759	283168	375288	195950
bsdb:499/2/2_irritable-bowel-sydrome:IBS-C_vs_Healthy-Control_UP	NA	244127	109326	55079	189330	28050	248744	100175	2740	44748
bsdb:499/3/1_irritable-bowel-sydrome:IBS-D_vs_Healthy-Control_DOWN	NA	283168	375288	195950
bsdb:499/3/2_irritable-bowel-sydrome:IBS-D_vs_Healthy-Control_UP	NA	830	189330	28050	2740	841
bsdb:499/4/1_irritable-bowel-sydrome:IBS-(All-patients)_vs_Healthy-Control_DOWN	NA	1678	239759	283168	375288	195950
bsdb:499/4/2_irritable-bowel-sydrome:IBS-(All-patients)_vs_Healthy-Control_UP	NA	55079	100175	39948	2740	109326	572511	248744	189330	28050	841
bsdb:500/1/1_COVID-19:COVID-19-patients_vs_Non-COVID-19-pneumonia-patients_UP	NA	469	28453
bsdb:500/1/2_COVID-19:COVID-19-patients_vs_Non-COVID-19-pneumonia-patients_DOWN	NA	43996	265975	195950	437755	970	1380	29465	194	1378	906	838	32067	1016	836	1654	482	117563	1301
bsdb:502/1/1_irritable-bowel-sydrome:IBS_vs_Healthy-Control_UP	NA	194
bsdb:502/1/2_irritable-bowel-sydrome:IBS_vs_Healthy-Control_DOWN	NA	1283313	816	29465
bsdb:502/2/2_irritable-bowel-sydrome:IBS-C_vs_Healthy-Control_DOWN	NA	1283313	816
bsdb:502/3/2_irritable-bowel-sydrome:IBS-D_vs_Healthy-Control_DOWN	NA	1283313	816
bsdb:502/4/1_irritable-bowel-sydrome:IBS-M_vs_Healthy-Control_UP	NA	194
bsdb:504/4/1_NA:TPBC-tumor-tissue_vs_TPBC-normal-tissue_UP	NA	1301
bsdb:504/5/2_race:BNH_vs_WNH_DOWN	NA	20
bsdb:504/6/1_race:BNH_vs_WNH_UP	NA	29465	28100
bsdb:504/6/2_race:BNH_vs_WNH_DOWN	NA	20	1578
bsdb:506/1/2_irritable-bowel-sydrome:IBS-D_vs_Healthy-Control_DOWN	NA	1678
bsdb:507/1/1_antibiotic:Patients-after-Rifaximin-treatment_vs_Patients-before-Rifaximin-treatment_DOWN	NA	724	841	29465
bsdb:507/2/1_antibiotic:Patients-1-month-after-Rifaximin-treatment_vs_Patients-before-Rifaximin-treatment_UP	NA	1578
bsdb:507/2/2_antibiotic:Patients-1-month-after-Rifaximin-treatment_vs_Patients-before-Rifaximin-treatment_DOWN	NA	841
